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Infectious keratitis is a sight threatening disease which can cause 
permanent visual loss if not diagnosed and treated at an early stage. It 
can be caused by different types of microbes which are either 
commensals or transferred from the environment.  To fight against 
these threats, the ocular surface (OS) has developed innate and 
adaptive immune mechanisms. Antimicrobial peptides (AMPs) are 
natural effectors on the OS with actions that range from microbicidal 
effects to cell signalling. Human beta defensin (hBD) 1-3 and 9, Liver 
expressed antimicrobial peptide (LEAP) 1 and 2, human cathelicidin 
(LL37), ribonuclease7 (RNase7) are the main AMPs on the OS. 
 
In this work, the pattern of ocular AMPs gene expression in human OS 
cells treated with Acanthamoeba castellanii, Pseudomonas aeruginosa 
(P. aeruginosa) and Staphylococcus aureus (S. aureus) was studied and 
established. This was examined by quantitative real-time PCR (RT-PCR) 
using the Taqman assay. Among the studied AMPs, hBD3 gene showed 
the most significant increase in human OS cells infected with 
Acanthamoeba. LL37 demonstrated the highest level of gene expression 
in the samples infected with bacteria.  
 
In a different study, the gene expression of two AMPs (hBD3 and 9) 
was studied in OS samples taken from patients with different types of 
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infectious keratitis both during and after the infection. This was 
compared with the expression in healthy subjects. Impression cytology 
(IC) was used to obtain samples of OS epithelium from recruited 
subjects. An optimized method for RNA extraction of IC samples was 
developed. Corresponding to the results of the in vitro study, hBD3 
showed an overall up-regulation in all categories whereas hBD9 was 
down-regulated. These changes were most significant in patients with 
acute Acanthamoeba keratitis. The gene expression of both hBD3 and 9 
showed a tendency towards returning to the levels found in healthy 
subjects when healing of the corneal infection was complete. 
 
In another study carried out to examine the antimicrobial activity of 
hBD3 we were surprised to find that we could not replicate this. We 
were unable to reproduce the previously reported antimicrobial activity 
of hBD3 but were able to demonstrate that the antimicrobial effect 
could be attributed to the acidic solvent used in preparing the hBD3 
protein.  
 
The clinical significance of application of corneal densitometry as 
measured by the Pentacam system was assessed for the first time in 
patients with infectious keratitis. We demonstrated that corneal 
densitometry varied with levels of inflammation and was not confined to 
the site of infection only. It affected the whole cornea and reverted 
towards normal values as the inflammation settled when the infection 
was brought under control. We were able to demonstrate that 
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densitometry can be used as a measure of the corneal response to 
infection and inflammation and could be used to monitor response to 
therapy.   
 
Finally, separate comprehensive prospective and retrospective studies 
of the clinical profile of severe infectious keratitis in Nottinghamshire 
were conducted. These two studies covered a total period of 7 years. 
The results of both studies were similar. Indeed, OS disease, CL wear 
and previous ocular surgery were found to be the most common risk 
factors. Positive results of corneal scraping were obtained only in about 
40% of cases. Acanthamoeba, S. aureus, and P. aeruginosa were the 
most frequent causative organisms. Fortified topical antibiotics were 
effective in treating most cases. Therapeutic corneal grafting was found 
to be an effective and safe procedure in refractive infectious keratitis. 
  
vi 
 
 
Mohammed I, Suleman H, Otri AM, Kulkarni BB, Chen P, Hopkinson A, 
Dua HS. (2010) Localization and gene expression of human beta-
defensin 9 at the human ocular surface epithelium. Investigative 
Ophthalmology & Visual Science,51, 4677-82.  
Otri AM, Mohammed I, Abedin A, Cao Z, Hopkinson A, Panjwani N, Dua 
HS. (2010) Antimicrobial peptides expression by ocular surface cells in 
response to Acanthamoeba castellanii: an in vitro study. British Journal 
of Ophthalmology, 94,1523-7 (awarded best scientific poster prize 
in Nottingham Eye Symposium, 2009).  
Said DG, Otri M, Miri A, Kailasanathan A, Khatib T, Dua HS. (2011) The 
challenge of fungal keratitis. British Journal of Ophthalmology, 
95,1623-4.  
Otri AM, Fares U, Al-Aqaba MA, Dua HS. (2012) Corneal densitometry 
as an indicator of corneal health. Ophthalmology,119,501-8.  
Otri AM, Mohammed I, Al-Aqaba MA, Fares U, Peng C, Hopkinson A, 
Dua HS. (2012) Variable expression of human beta defensins 3 and 9 
at the human ocular surface in Infectious Keratitis. Investigative 
Ophthalmology & Visual Science,53,757-61.  
Otri AM, Fares U, A. Al-Aqaba M, Miri A, Faraj LA, Said DG, Maharajan 
S, Dua HS. Profile of Sight Threatening infectious keratitis: A 
prospective study. (Accepted for publication in ACTA Ophthalmologica 
in April 2012 subject to minor revision) 
vii 
 
viii 
 
 
I dedicate my work  
To the Almighty øAllahù who provided me with the motivation, 
patience and strength to preserve through to the end of the road and 
to embark upon and complete this thesis. 
7RP\EHORYHGFRXQWU\ø6\ULDùDQGP\JUDFLRXVSHRSOHø7KH6\ULDQVù 
To my parents, for their never ending support and sense of security 
they have given me when I needed it most, they have waited so long 
for this moment to come true; I am pleased that their waiting has 
finally been rewarded. 
To my mother in law and the soul of my father in law who gave me 
the incentive and reassurance  
To my soul mate and DGRUDEOH ZLIH ø1RXUù ZKR SURYLGHG PH ZLWK
love, support and encouragement during this long trip. 
7RP\ ORYHO\ VRQV ø1DML DQG 7DUHNùZKR HQOLJKWHQHGP\ ZKROH OLIH
and gave me the hope with better future. 
To my lovely brotheUDQGP\FORVHIULHQGø7DODOù 
ix 
 
To my beloved sisters, their husbands and kids, who always kept me 
thinking that øwonderful people are still thereù. 
 
  
x 
 
 
I would like to thank my gracious supervisor Professor Harminder S. 
Dua, for his unlimited support, guidance, advice and encouragement. 
His never ending wisdom and knowledge always inspired me and 
gave me the strength to face all the difficulties. Also I would like to 
thank my second supervisor and (friend) Dr. Andrew Hopkinson for 
his un-limited kindness and co-operation. 
Special thanks go to my sponsor, the University of Aleppo, Aleppo, 
Syria for its kindness in providing the necessary financial support for 
the completion of my study. 
I owe my deepest gratitude to my colleagues at the Division of 
Ophthalmology and Visual Sciences in Nottingham. I specifically 
thank my close friends; Usama Fares, Saker Saker, Yamen Badr and 
Mouhamed Al-Aqaba who shared this long trip with me including its 
difficult and cheerful periods. Also, special thanks to my dear friends: 
Imran Mohammed, Khurram Hashmani, Ammar Miri, Dalai Said and 
Lana Faraj who helped me a lot and were always kind and supportive. 
  
xi 
 
 
CONTENTS 
Abstract ......................................................................................................................................... iii 
List OF PUBLICATIONS ARISING FROM WORK PRESENTED IN THIS THESIS ....... vi 
DEDICATION .............................................................................................................................. viii 
ACKNOWLEDGMENTS ................................................................................................................ x 
CONTENTS .................................................................................................................................... xi 
List of Figures ........................................................................................................................... xvii 
LIST OF TABLES ........................................................................................................................ xix 
LIST OF COMMON ABBREVIATIONS .................................................................................. xxi 
Rationale and Aims ................................................................................................................ xxii 
Chapter One .................................................................................................................................. 1 
1 Introduction ........................................................................................................................ 1 
1.1 The Ocular Surface ............................................................ 1 
1.1.1 Anatomy of the ocular surface ..................................................... 1 
1.1.2 General mechanisms of the ocular surface defense ........................ 4 
1.1.3 Antimicrobial peptides ................................................................ 7 
1.2 Microbial keratitis ............................................................ 15 
1.2.1 Corneal morbidity in microbial keratitis ........................................ 16 
1.2.2 Types of Microbial Keratitis ........................................................ 17 
xii 
 
Chapter Two ............................................................................................................................... 40 
2 Antimicrobial peptides gene expression by ocular surface cells in response 
to Acanthamoeba castellanii: An in vitro study ............................................................. 40 
2.1 Introduction ................................................................... 40 
2.2 Methods ......................................................................... 42 
2.2.1 Human cell culture .................................................................... 42 
2.2.2 Isolation and culture of Acanthamoeba castellanii trophozoites ....... 43 
2.2.3 Acanthamoeba exposure of HCLE ................................................ 43 
2.2.4 Isolation of total RNA ................................................................ 44 
2.2.5 Complementary DNA (cDNA) synthesis ........................................ 45 
2.2.6 Quantitative real-time PCR ......................................................... 45 
2.3 Results .......................................................................... 50 
2.4 Discussion ...................................................................... 53 
Chapter Three ............................................................................................................................ 59 
3 Antimicrobial peptide gene expression by ocular surface cells in response 
to Pseudomonas aeruginosa and Staphylococcus aureus ........................................... 59 
3.1 Introduction ................................................................... 59 
3.2 Methods ......................................................................... 60 
3.2.1 Cell culture .............................................................................. 60 
3.2.2 Bacterial exposure/ stimulation of HCECs ..................................... 62 
3.2.3 Isolation of total RNA and cDNA synthesis. ................................... 63 
3.2.4 Quantitative RT-PCR .................................................................. 63 
3.3 Results .......................................................................... 64 
3.3.1 Modulation of AMPs gene expression in HCEC cells in response to 
challenge with P. aeruginosa: ............................................................... 64 
xiii 
 
3.3.2 Modulation of AMPs gene expression in HCEC cells in response to 
challenge with S. aureus: .................................................................... 66 
3.4 Discussion ...................................................................... 68 
Chapter Four............................................................................................................................... 76 
4 Variable Gene Expression of Human Beta Defensins 3 and 9 at the Human 
Ocular Surface in Infectious Keratitis. .............................................................................. 76 
4.1 Introduction: .................................................................. 76 
4.2 Methods ......................................................................... 79 
4.2.1 Overview ................................................................................. 79 
4.2.2 Ethical approval ........................................................................ 79 
4.2.3 Impression cytology samples collection ........................................ 79 
4.2.4 Extraction of total RNA .............................................................. 80 
4.2.5 RNA quality and quantity control ................................................. 82 
4.2.6 Complementary DNA synthesis ................................................... 82 
4.2.7 Quantitative real-time polymerase chain reaction (Taqmann assay) 83 
4.2.8 Data analysis ........................................................................... 84 
4.3 Results .......................................................................... 85 
4.3.1 The RNA yield using the original and the optimized methods .......... 85 
4.3.2 Disease diagnosis ..................................................................... 88 
4.3.3 Gene analysis ........................................................................... 89 
4.4 Discussion ...................................................................... 94 
Chapter Five ............................................................................................................................. 100 
5 Does Human Beta Defensin-3 have Anti-bacterial Effect? ............................ 100 
5.1 Introduction ................................................................. 100 
5.2 Methods ....................................................................... 101 
xiv 
 
5.3 Results ........................................................................ 103 
5.3.1 Testing the antibacterial effect of the HBD3 against S. aureus ...... 104 
5.3.2 Testing the antibacterial effect of the HBD3 against E. coli ........... 107 
5.4 Discussion: ................................................................... 109 
Chapter Six ............................................................................................................................... 117 
6 Corneal Densitometry as an Indicator of Corneal Health .............................. 117 
6.1 Introduction ................................................................. 117 
6.2 Methods ....................................................................... 122 
6.2.1 Normal Eyes ........................................................................... 122 
6.2.2 Patients with Bacterial keratitis ................................................. 125 
6.2.3 Statistical analysis .................................................................. 130 
6.3 Results ........................................................................ 131 
6.3.1 Control group ......................................................................... 131 
6.3.2 Study group with infectious keratitis.......................................... 132 
6.4 Discussion .................................................................... 136 
Chapter Seven ......................................................................................................................... 143 
7 Profile of Sight Threatening Infectious Keratitis: A Prospective Study ... 143 
7.1 Introduction ................................................................. 143 
7.2 Methods ....................................................................... 144 
7.3 Results ........................................................................ 146 
7.3.1 Demographics ........................................................................ 146 
7.3.2 Seasonal variations ................................................................. 146 
7.3.3 Microbiology ........................................................................... 148 
7.3.4 Predisposing factors: ............................................................... 150 
7.3.5 Acanthamoeba Keratitis ........................................................... 152 
xv 
 
7.3.6 Clinical Signs .......................................................................... 152 
7.3.7 Complications ......................................................................... 154 
7.3.8 Visual acuity change ................................................................ 155 
7.3.9 Period of healing:.................................................................... 156 
7.3.10 Treatment .............................................................................. 157 
7.4 Discussion: ................................................................... 161 
Chapter Eight ........................................................................................................................... 172 
8 Profile of Sight Threatening Infectious Keratitis in Nottinghamshire: A 
Retrospective Study .............................................................................................................. 172 
8.1 Introduction ................................................................. 172 
8.2 Methods ....................................................................... 172 
8.3 Results ........................................................................ 174 
8.3.1 Demographics ........................................................................ 174 
8.3.2 Seasonal variations ................................................................. 174 
8.3.3 Period of treatment ................................................................. 175 
8.3.4 Microbiology ........................................................................... 176 
8.3.5 Predisposing factors ................................................................ 178 
8.3.6 Signs ..................................................................................... 180 
8.3.7 VA during and after ................................................................. 180 
8.3.8 Complications ......................................................................... 181 
8.3.9 Correlation between Healing period and age and correlation 
between healing period and initial VA in bacterial and Acanthamoeba 
keratitis patients .............................................................................. 182 
8.3.10 Period of healing ..................................................................... 183 
8.3.11 Treatment .............................................................................. 183 
8.4 Discussion .................................................................... 187 
xvi 
 
Chapter Nine ............................................................................................................................ 194 
9 Summary, general discussion and Conclusion .................................................. 194 
9.1 Overview: .................................................................... 194 
9.2 Brief description ............................................................ 195 
9.3 General Discussion and conclusion .................................. 200 
Bibliography ............................................................................................................................ 208 
 
  
xvii 
 
 
Figure 1. Another three step view of the TaqMan probe. ............................. 47 
Figure 2 The AMPs gene expression in HCLE stimulated with Acanthamoeba 
castellani.. ........................................................................................... 52 
Figure 3. Healthy HCECs with 70% confluence under the microscope ........... 61 
Figure 4. AMP gene profile in HCEC challenged with Pseudomonas aerugino ..65 
Figure 5. AMP gene expression in HCECs challenged with Staphylococcus 
aureus ................................................................................................. 67 
Figure 6. Poor samples of extracted RNA using the original method of RNA 
extraction............................................................................................. 87 
Figure 7. Good samples of extracted RNA using the optimized RNA extraction 
method ................................................................................................ 88 
Figure 8. Relative gene expression of hBD3 in impression cytology samples 
taken from patients with Acanthamoeba keratitis, Gram negative and positive 
bacterial keratitis compared to healthy controls. ....................................... 91 
Figure 9. Relative gene expression of hBD9 in impression cytology samples 
taken from patients with Acanthamoeba keratitis, Gram negative and positive 
bacterial keratitis compared to healthy control .......................................... 93 
Figure 10. The angles of the ordinary camera, using the example of a 
photographic lens. ............................................................................... 119 
Figure 11. The angles of the Scheimpflug principle, using the example of a 
photographic lens. ............................................................................... 120 
Figure 12 With a normal camera, when the subject is not parallel to the image 
plane, only a small region of the text is in focus. Conversely, with Scheimpflug 
xviii 
 
dependent devices, the whole text will be clear even with non-parallel planes.
......................................................................................................... 120 
Figure 13 The figure illustrates the 4 axes (45, 90, 135 and 180 degrees) and 
the 5 points on each axis where densitometry was performed. The inner points 
were 1.5 mm and the outer were 3.5 mm from the centre. ...................... 123 
Figure 14. This figure shows the two different methods in measuring the 
density of the cornea: the densitometry at different points (A) and the 
densitometry of the total cross sectional areas (B). ................................. 124 
Figure 15. Densitometry in patient with active infectious keratitis. s. ......... 126 
Figure 16. Densitometry in patient with healed infectious keratitis.. ........... 128 
Figure 17 Another example of Densitometry in patient with active infectious 
keratitis. s .......................................................................................... 129 
Figure 18 Another example of Densitometry in patient with healed infectious 
keratitis.. ........................................................................................... 130 
 
  
xix 
 
 
Table 1. Thermal cycler profile used in this study. The standard profile consistis 
of three stages (activation, hold and cycle. Data collection was performed at 
cycle stage). ......................................................................................... 48 
Table 2. showing detailed information about the genes  and primer codes used 
in our study .......................................................................................... 49 
Table 3. Details of genes and accession numbers used in the study ............. 84 
Table 4. Causative organisms and number of impression cytology samples 
taken in each group.  . ........................................................................... 89 
Table 5. Showing the Colony forming units in serial dilutions of S. aureus 
bacteria tested against 40, 20, 10 and 5 µg /ml of HBD3 reconstituted in 
distilled water. The colony forming units were also calculated in bacterial 
samples treated with distilled water alone .............................................. 105 
Table 6. Showing the Colony forming units in serial dilutions of S. aureus 
bacteria tested against 40 µg /ml of HBD3reconstituted in 10mM of acetic acid 
& 4 mM of hydrochloric acid ................................................................. 106 
Table 7. Showing the Colony forming units in serial dilutions of E. coli bacteria 
tested against 40, 20, 10 and 5 µg /ml of HBD3 reconstituted in distilled water
......................................................................................................... 108 
Table 8. Showing the Colony forming units in serial dilutions of E. coli bacteria 
tested against 40 µg /ml of HBD3reconstituted in 10mM of acetic acid & 4 mM 
of hydrochloric acid ............................................................................. 109 
Table 9 Densitometry values of healthy controls ...................................... 132 
Table 10 Densitometry measurements at points of infection in both the acute 
stage and 4-6 weeks after complete resolution. ...................................... 133 
xx 
 
Table 11 Densitometry measurements of total cross sectional area of infection 
in both the acute stage and 4-6 weeks after complete resolution............... 135 
Table 12 Shows the corneal densitometry values  1. Of healthy controls and 2. 
At sites of infectious infiltrates and 3. At points of clear cornea furthest away 
from the infiltrates. ............................................................................. 136 
Table 13. Seasonal distribution of the severe infectious keratitis in 
Nottinghamshire. ................................................................................ 147 
Table 14. Isolated organisms by culture) ................................................ 149 
Table 15. Predisposing factors of the severe corneal infections .................. 151 
Table 16. Clinical signs of microbial keratitis. .......................................... 153 
Table 17. Complication of severe microbial keratitis) ............................... 155 
Table 18. Medical treatment of severe infectious keratitis)........................ 158 
Table 19. Therapeutic interventions in refractory microbial keratitis. 
Therapeutic interventions in refractory microbial keratitis ......................... 160 
Table 20. Seasonal distribution of the severe infectious keratitis in 
Nottinghamshire. ................................................................................ 175 
Table 21. The isolated organisms and the correlated predisposing factors .. 177 
Table 22. The factors which predispose to infectious keratitis .................... 179 
Table 23. Complication of microbial keratitis ........................................... 182 
Table 24. Therapeutic interventions in refractory microbial keratitis) ......... 186 
  
xxi 
 
 
OS: Ocular surface 
AMPs: Antimicrobial peptides 
HBD: Human beta defensin 
LEAP: Liver expressed antimicrobial peptide  
LL37: Human cathelicidin 
RNase: Ribonuclease  
IC: Impression cytology 
CL: Contact lens 
BHIB: Brain-Heart Infusion Broth 
TLR: Toll like receptor 
 
  
xxii 
 
 
Microbial keratitis remains the most significant (important and 
common) cause of corneal blindness. The antimicrobial peptides (AMPs) 
are now recognised as an important first line of host defence against 
invading microorganisms which cause the corneal infection. The 
Division of Ophthalmology, University of Nottingham has pioneered 
research in this field of ocular AMPs and profiles the spectrum of 
expression at the ocular surface. In this study we plan to establish 
whether the in vitro profile of expression is determined by the infecting 
organism and whether specific profiles can be identified that represent 
bacterial or Acanthamoebal infections. The second part of the research 
will involve studying the AMP expression in eyes with specific microbial 
keratitis and data will be analysed to establish trends or profiles that 
may be specific for different organisms or groups of organisms. The 
main goal of these studies is to determine the in vitro and in vivo 
profile of the studied AMPs during the infection and decide whether 
these correlate together or not.  The other aim is to use any useful 
information about the gene expression of the AMPs in future studies 
about the diagnosis and the management of the infectious keratitis. 
 
AMPs proteins are known to have promising avenue in killing the 
invading bacteria in ocular surface cells. In this study, the AMPs 
xxiii 
 
antibacterial activity will be confirmed and then used as a control to 
study the anti-amoebic killing efficacy of the AMPs in infected ocular 
surface cells. This will be a novel study which has never studied before. 
 
To further study the course of the active infectious keratitis in addition 
the healing process, the cornea will also be studied using a novel 
technique.  The corneal density in patients with microbial keratitis at 
the active stage of the disease and during the healing process will be 
measured using the imaging capabilities of the Scheimpflug image 
SULQFLSOH3HQWDFDP7KLVZLOOEHFRPSDUHGZLWKµQRUPDO¶YDOXHVRIWKH
clear corneas which will be measured in healthy subjects with no 
previous ocular pathology. 
 
The profile of microbes, their virulence, infection rates and response to 
medication (drug sensitivity) presents an ever changing scenario which 
differs according to geography and time partly influenced by 
prescription habits prevailing amongst physicians dealing with such 
infections. Therefore what may be true for one part of the world may 
not apply to another part or even within a given country it may differ 
from region to region. It is well recognised that major centres dealing 
with a large number of infective keratitis need to establish diagnostic 
and therapeutic parameters that are applicable to their respective 
regions. Thus far these parameters have not been established for the 
Trent region generally and for Nottinghamshire specifically. This study 
xxiv 
 
will address this issue as it will yield data on the species of infective 
organisms, their relative frequency, the response to the commonly used 
drugs and the outcomes of management.  
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1 Introduction 
1.1 THE OCULAR SURFACE 
The ocular surface of the human eyes has the ability to refract the light 
and process it through its transparent tissues. Subsequently, the 
formed image is transported from the retina to the brain where it is 
interpreted into meaningful vision (Snell and Lemp, 1998). 
1.1.1 Anatomy of the ocular surface 
Human ocular surface (OS) is comprised of the cornea, conjunctiva, 
limbus and tear film (Snell and Lemp, 1998). 
1.1.1.1 The Cornea: 
The cornea is a transparent avascular tissue which refracts the light, 
contains the intraocular pressure and provides a protective interface. It 
provides about 70% (40-45 diopters) of the total ocular refractive 
power. Apart from the pre-corneal tear film, there are five layers of the 
corneal tissue; WKHVHDUHWKHHSLWKHOLXP%RZPDQ¶VOD\HUWKHVWURPD
'HVFHPHW¶V PHPEUDQH DQG WKH HQGRWKHOLXP (Snell and Lemp, 1998, 
Bron et al, 1997, Knop and Knop, 2007). 
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1.1.1.1.1 Epithelium 
The corneal epithelium is composed of stratified and non-keratinized 
squamous cells. It is about 50-90 µm thick and consists of five to six 
layers of nucleated cells (Bron et al, 1997, Snell and Lemp, 1998).  At 
the deepest layer the basal cells form the germinative layer of the 
epithelium. These basal cells arise from the the corneal epithelial stem 
cells reside at the limbus (Bron et al, 1997). It is believed that the 
epithelium is replaced approximately weekly by the division of basal 
epithelial cells (Hanna et al., 1961). The horizontal migration from the 
limbus towards the centre of the cornea may take as long as a year 
(Kaye, 1980). 
1.1.1.1.2 Basal lamina 
The basal lamina is secreted by the deep basal cells and it is made up 
of an filamentary materials besides collagen and glycoprotein 
constituents (Bron et al, 1997, Snell and Lemp, 1998). 
1.1.1.1.3 %RZPDQ¶VODyer  
%RZPDQ¶VOD\HULVDFHOOXODUUHJLRQRIWKHDQWHULRUVWURPDRIDERXW-12 
µm thick. It is very resistant because of the compact arrangement of 
the collagen fibrils and perforated by un-myelinated epithelial nerves in 
many places. Damaging of this layer can lead to fibrous tissue 
formation as it is incapable of regeneration (Snell and Lemp, 1998, 
Knop and Knop, 2007, Bron et al, 1997). 
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1.1.1.1.4 Stroma (substantia propria) 
The stroma, which is about 500 µm thick, consists of uniformly 
arranged laminated sheets of collagen bundles (mainly type I collagen). 
These collagenous lamellae are produced by keratocytes and lie in 
proteoglycan ground substance. The lamellae are arranged in layers 
parallel with each other and with the corneal surface. This unique 
arrangement is responsible for the corneal transparency (Bron et al, 
1997). Keratocytes are generally inert cells but with the aid of 
cytokines and other growth factors they can respond to injury turning 
into modified repair cells. Other cells like: Lymphocytes, macrophages, 
and polymorphnuclear leucocytes are also found in the corneal stroma 
(West-Mays and Dwivedi, 2006, Knop and Knop, 2007).  
1.1.1.1.5 'HVFHPHW¶VPHPEUDQH 
'HVFHPHW¶VPHPEUDQHLVORFDWHGLQGLUHFWDWWDFKPHQWZLWKWKHFRUQHDO
endothelium with collagen type IV forming its main component (Bron et 
al, 1997). 
1.1.1.1.6 Endothelium 
The endothelium is composed of single layer of hexagonal, cuboidal 
cells. Corneal transparency is preserved mainly by the endothelium 
which maintain relative deturgescence, and actively regulates the 
movements of glucose, amino acids, and oxygen to other corneal layers 
(Bron et al, 1997, Snell and Lemp, 1998).  
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1.1.1.2 The Limbus 
It is a transitional zone between the cornea and sclera where the stem 
cell niches of the corneal epithelium are thought to be located. The 
epithelium of this area is bridging the conjunctival and corneal 
epithelium (Snell and Lemp, 1998). 
1.1.1.3 The Conjunctiva 
It is a translucent mucous membrane divided into palpebral, fornical 
and bulbar conjunctiva. It has an epithelium and sub-mucosal lamina 
propria besides rich vascular component. It plays a major role in OS 
protection and lubrication by containing abundant goblet cells, 
melanocytes and immune cells (Snell and Lemp, 1998, Knop and Knop, 
2007). 
1.1.2 General mechanisms of the ocular surface 
defense 
The bony formation of the orbit and the eyelids are considered like an 
external shield which protect the OS from any injury (Snell and Lemp, 
1998). Also tears, corneal nerves, the epithelium, keratocytes, poly-
morphnuclear cells, antimicrobial peptides and cytokines represent the 
actual cellular protection against any invading micro-organisms on the 
corneal surface (Knop and Knop, 2007). 
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1.1.2.1 Tears:  
There are several functions of the tears; ie: to prevent drying of the 
cornea, flushing foreign particles from the OS and transporting 
antimicrobial proteins (Immunoglobulin [Ig] A and G, lactoferrin, 
lysozyme, lipocalin, and beta-lysin) on the OS to combat against any 
infection (Louis, 1997, Knop and Knop, 2007). 
1.1.2.2 Epithelial cells:  
Corneal epithelial cells participate in the immune defence by secreting 
cytokines (Interleukin 1a [IL-1a] which is essential in protecting against 
microbes). Antimicrobial peptides (AMPs) are also significant 
constituents of the innate immune defence system which are produced 
mainly by epithelial cells and neutrophils (see below) (Mondino and 
Brady, 1981, McDermott, 2004). 
1.1.2.3 Keratocytes:  
8QGHUWKHLQÀXHQFHRIWKHF\WRNLQHVNHUDWRF\WHVFDQSURGXFH,/-6 and 
defensins (major part of the AMPs group) (Gottsch et al., 1998, Ganz et 
al., 1985). 
1.1.2.4 Corneal nerves:  
Corneal nerves play a major role in protecting the cornea by conveying 
WKH VHQVRU\ VWLPXODWLRQV OHDGLQJ WR UHÀH[ PRYHPHQWV DQG SURGXFLQJ
neuropeptides. These peptides induce cytokine activity resulting in 
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QHXWURSKLOLQÀX[DVDUHVSRQVHWR26LUULWDWLRQ(Muller et al., 1996, Tran 
et al., 2000). 
1.1.2.5 Complement:  
Complements are enzymatic proteins that play a role in inflammation 
and can regulate the production of the opsonins, enzymes and 
chemotaxins (Law SKA, 1995). 
1.1.2.6 Interferons:  
Interferons (IFN) are cellular proteins produced in response to viral 
infection. On the OS, they are secreted from different types of cells; 
IFN-Į LV VHFUHWHG E\ OHXFRF\WHV ,)1-ǃ E\ ILEUREODVWV DQG ,)1-Ǆ E\
adaptive immune cells (Thacore et al., 1982). 
1.1.2.7 Cells of innate immunity:  
Neutrophils are major components of the innate immunity. They play a 
YLWDO UROH LQ SURWHFWLQJ WKH 26 IURP PLFUREHV¶ LQYDVLRQ 7KH\ DOVR
regulate the phagocytosis and microbial killing (Burg and Pillinger, 
2001). Moreover, eosinophils, which have IgE surface receptors, play a 
role in parasitic toxicity by their protein granules (Trocme and Aldave, 
1994). Also, macrophages have the ability to combat against microbial 
infections by secreting the inflammatory cytokines and their 
phagocytosis and antigen presenting capabilities (Underhill and 
Ozinsky, 2002). 
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1.1.3 Antimicrobial peptides  
1.1.3.1 General overview of AMPs 
AMPs are innate immunity effectors exist in plants, animals and 
vertebrates (Brown and Hancock, 2006). They are small amphipathic 
cationic peptides with 12 to 50 amino acids and 2±9 positively charged 
lysine or arginine.  They have antimicrobial activity against Gram-
positive and Gram-negative bacteria, viruses and fungi (Huang et al., 
2007a, Huang et al., 2006, Huang et al., 2007b, Ganz et al., 1985, 
McDermott, 2004, Gropp et al., 1999, Buck et al., 2006). They can play 
an important role in innate immunity by reducing the titer of microbes 
without producing damaging persistent inflammatory response 
(Chodosh and Kennedy, 2002). They also have other additional cellular 
effects in mammalians such as participating in adaptive immunity, 
wound healing and angiogenesis. Defensins and cathelicidins are the 
major subtypes of AMPs in humans; they are primarily secreted from 
the immune and epithelial cells (McDermott, 2004). 
1.1.3.2 Main subtypes of AMPs 
1.1.3.2.1 Defensins 
Mammalian defensins are 29 to 45 amino acids in length with 6 
cysteine residues forming 3 disulphide bonds. This linkage between the 
F\VWHLQHUHVLGXHVLVUHVSRQVLEOHIRUWKHǃ-sheet structure. According to 
the location and connectivity of these links, defensins can be divided 
LQWR WZR PDLQ JURXSV Į DQG ǃ GHIHQVLQV (Ganz, 2003) 2I QRWH Ǉ
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defensin, a third class of defensins with circular structure, has been 
identified in rhesus macaque leucocytes (but not in humans) (Leonova 
et al., 2001)6L[ĮDQGǃ-defensins has been isolated in humans. The 
Į-defensins are constitutively expressed and formed by 90±100 amino 
acids (Valore and Ganz, 1992). These are human neutrophil peptide 
(HNP) 1 to 4 and human defensin (HD) 5 and 6. HNP1±4 are mainly 
concentrated in the azurophil granules of the human neutrophils where 
they fuse with the vacuoles containing the invading micro-organism 
during phacocytosis (Ganz, 1987, Ganz, 2003). HNP are expressed in 
human monocytes, lymphocytes and macrophages (Agerberth et al., 
2000). Paneth cells of human intestine are the main repertoire of other 
Į-defensisns:  HD5 and HD6 (Jones and Bevins, 1992). HD5 has also 
been identified in female reproductive epithelium nasal and branchial 
epithelia (Quayle et al., 1998). 
7KH IRXU KXPDQ ǃ-defensin (hBD) 1±4 are mainly produced by the 
epithelial cells. However, immune cells (macrophages and dendritic 
cells) are known to produce hBD1 and 2 only (Duits et al., 2002). HBD1 
is constitutively expressed by epithelial cells in multiple human tissues 
including airway epithelia (McCray and Bentley, 1997), urogenital 
tissues (Valore et al., 1998), nasolacrimal duct (Paulsen et al., 2001), 
and mammary gland (Jia et al., 2001). HBD2 and 3 are inducible in 
many epithelia by bacterial products (via toll like receptors) and 
cytokines (Harder et al., 1997, Garcia et al., 2001a). The inducible 
expression of hBD4 in testes and epididymis has also been reported 
(Garcia et al., 2001b, Yamaguchi et al., 2002). More recently, hBD9 
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(gene analogue of DEFB109) has been shown to be constitutively 
expressed in gingival keratinocytes and to be reduced expression after 
in vitro stimulation with Candida albicans (Premratanachai et al., 
2004).  
1.1.3.2.2 Cathelicidins 
While other mammalians express different types of cathelicidins, 
humans only produce LL37. It is so called because it begins with 2 
leucine residues and 37 amino acids long (Agerberth et al., 1995, 
Cowland et al., 1995) Initially, LL37 was isolated from neutrophils, 
immune cells, mast cells and variety of epithelia (lung, skin, squamous 
epithelia of mouth, reproductive female epithelia and sweat glands) (Di 
Nardo et al., 2003, Murakami et al., 2002). LL37 expression is 
constitutive in many tissues but shows inducible nature by microbes 
and cytokines (Ooi et al., 2007, Wang et al., 2004). 
1.1.3.2.3 Other AMPs 
While defensins and cathelicidins comprise the main AMPs groups in 
humans, other AMPs have also been identified. Liver expressed 
antimicrobial peptide (LEAP1, also known as hepcidin) is 25 amino acid 
peptide highly expressed in liver. It plays a major role in iron 
homeostasis of the body which could enable it from excreting an 
antimicrobial effect by restricting the iron availability to invading 
pathogens (Ganz, 2006). LEAP2 has also been isolated from peripheral 
blood film and is mainly expressed in Liver (Krause et al., 2003). 
Furthermore, ribonuclease 7 (RNase7) has been found to exhibit in 
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vitro broad spectrum antimicrobial activity against different bacteria 
(including vancomycin-resistant Enterococcus faecium) and the yeast 
(Candida albicans) (Harder and Schroder, 2002, Torrent et al., 2010).  
Also, it has showed increased immune activity in normal human scalp 
skin treated with lipopolysDFFKDULGH/36DQGÀDJHOOLQ(Reithmayer et 
al., 2009, Mohammed et al., 2010b). Moreover, histatin is an AMP 
mainly produced by salivary glands and shows anti-fungal activity 
(Kavanagh and Dowd, 2004)$OVRWK\PRVLQǃ-4 has also been isolated 
from platelete and exhibited antimicrobial activity (Tang et al., 2002). 
1.1.3.3 $03V¶0HFKDQLVPRIDFWLRQ 
AMPs are mainly secreted in response to cell signalling from cellular toll 
like receptors (TLRs) which engage microbes to activate production of 
these peptides. Activation of these receptors induces a cascade of 
down-stream signals leading to activation of transcription factor NF-kB 
followed by release of cytokines, chemokines, and AMPs. These 
participate in inflammatory responses, which in turn switch on the 
adaptive immune system. The expression of these antimicrobial 
molecules renders epithelial cells and infiltrated poly-morphnuclear cells 
(PMN) the ability to kill the invading bacteria. This enhanced innate 
defense is believed to play a role in limiting infection when host-
pathogen interaction occurs (Redfern et al., 2011). The most 
DFFHSWDEOH K\SRWKHVLV FRQWULEXWHV WKH $03V¶ DQWL-microbial effect to 
their increased positive surface charge. They can interact with 
negatively charged components of the pathogen cell membranes, 
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especially phospholipids, of microbial cell membranes, leading to 
electrostatic disruption and increased permeability of these cell 
membranes and death. This preference of AMPs for miFUREHV¶ FHOO
membranes is because of the highly negative charge of these 
membranes compared with the human cell membranes which have 
neutral charge. In addition, the cholesterol layer in the human cells 
inhibits the lysis effect of these AMPs (Matsuzaki et al., 1995, Tytler et 
al., 1995). However, it should be noted that high concentrations of 
AMPs could be cytotoxic to body cells regardless of the mechanism 
involved (Ganz, 2003, Kagan et al., 1994). This antimicrobial effect 
shows its maximum peak during low micro-molar and high carbonate 
range (Dorschner et al., 2006). This leads to less in vivo antimicrobial 
activity of AMPs compared with their in vitro activity as the effect of 
tears is inhibiting. However, some defensins (like hBD3) are less salt 
sensitive than others (Schibli et al., 2002).  
1.1.3.4 AMPs at the ocular surface 
As on the human OS, defensins and cathelicidin are the major AMPs 
JURXSV DW WKH 26 5HJDUGLQJ WKH GHIHQVLQV ERWK Į DQG ǃ human 
defensins are expressed at the OS with infiltrating neutrophils being the 
PDMRU VRXUFH RI Į GHIHQVLQV DQG WKH 26 HSLWKHOLDO FHOOV VKRZLQJ WKH
PDLQ UHSHUWRLUH RI WKH ǃ GHIHQVLQV (Gottsch et al., 1998). However, 
expression by immune cells like monocytes, macrophages and dendritic 
cells has been described (Duits et al., 2002). The expression of HNP1-3 
has been detected in human corneal stroma in post immune rejection 
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and infection (but not in healthy corneal tissue) (Gottsch et al., 1998). 
Moreover, positive immune-reactivity for HNP1±3 in inflamed 
conjunctiva and samples of normal tear film has been reported. 
However, the gene expressiRQRIĮ-defensins HD5 and HD6 has never 
been detected on OS (Haynes et al., 1999, Haynes et al., 1998). 
+XPDQǃGHIHQVLQVDUHSURGXFHGIURPWKHHSLWKHOLDRIWKHFRQMXQFWLYD
and cornea. Indeed, hBD1 is constitutively expressed whereas the 
expression of hBD2 and hBD3 is mainly inducible by pathogens or 
cytokines and mainly mediated by TLRs (McDermott, 2004, Kumar et 
al., 2007a, Mcnamara et al., 1999, Kumar et al., 2007b, Kumar et al., 
2004). While HNP1±3  are consistently found in tears in any 
inflammation, there is no evidence that ß defensins are available in tear 
film (Zhou et al., 2004). HBD4 was not detected in OS cells (Huang et 
al., 2007a) although it was variably expressed in cultured OS cells 
(McIntosh et al., 2005). As reported by Abedin et al, The ex vivo gene 
expression of hBD9 in impression cytology samples has shown down-
regulation in samples taken from patients with infectious keratitis and 
dry eye syndrome (Abedin et al., 2008) 0RUHRYHU D VLJQL¿FDQW ODWH
down-regulation of hBD9 mRNA in response to cytokines stimulation in 
addition to a hBD9 constitutive protein expression on the OS epithelia 
has been reported by our group (Mohammed et al., 2010a).  
LL37 is expressed from epithelial cells and invading neutrophils showing 
constitutive and inducible pattern of expression. It has already been 
shown to have important effect in protecting the OS against 
Pseudomonal infections (Redfern et al., 2011). Indeed, LL37 has in 
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vitro bactericidal activity against both Gram-negative and Gram-
positive bacteria in addition to its anti-viral effect (Huang et al., 2007a, 
Gordon et al., 2005a).  It is derived from human cationic antimicrobial 
protein and has chemotactic effects for leukocytes stimulating cellular 
LQÀDPPDWLRQ (Befus et al., 1999, Niyonsaba et al., 2001, Mendez-
Samperio, 2010). Recently, Redfern et al have reported that the 
production of LL37 is stimulated by the TLR agonists which may play a 
role in providing the OS with direct defence against various pathogens 
and stimulating the innate and adaptive immunities through the 
immune and inflammatory activities (Redfern et al., 2011, Mendez-
Samperio, 2010). Furthermore, it has also been reported that LL-37 
can induce cellular migration and production of inflammatory mediators 
following injury or insult to the OS (Huang et al., 2007a, Mendez-
Samperio, 2010).  
The expression of LEAP1 and 2 mRNA was firstly detected by McIntosh 
et al (McIntosh et al., 2005). The role of LEAP1 as an antibacterial 
agent is limited on the OS but it may have a greater role against virus 
infections (Mohammed et al., 2011). The actual LEAP2 antimicrobial 
effect is not clear (Hocquellet et al., 2009).  
Recently, the constitutive presence of RNase-7, both protein and 
mRNA, on human OS has been reported by our group. This expression 
was increased in response to IL-1b suggesting an active role during 
LQÀDPPDWLRQUHODWHGWR26LQIHFWLRQ(Mohammed et al., 2010b).  
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,Q DGGLWLRQ WR WKH SUHYLRXV $03V WK\PRVLQ ǃ DQG KLVWDWLQ ZHUH
variably detected on the OS (Huang et al., 2007a). 
1.1.3.5 How do AMPs behave on the OS? 
AMPs express the bactericidal activity either by producing higher 
concentrations (Huang et al., 2006) or by synergy between each other 
(Nagaoka et al., 2000, Chen et al., 2005). Indeed, besides their 
essential role as bacteriocidal agents, these cationic host-defence 
peptides have a wide range of immune properties, including direct 
chemo attraction of immune cells, induction of chemokines, 
differentiation responses, promotion of wound healing and angiogenesis 
(Oppenheim and Yang, 2005, Bowdish et al., 2005, Finlay and Hancock, 
2004, Huang et al., 2006). The negative impact of the tears on the 
mechanism of killing pathogens has no influence on the non-
antimicrobial effects of the AMPs (Huang et al., 2007a, Huang et al., 
2007b). It has been shown that not all the effects of the antimicrobial 
peptides are beneficial to the eye. Occasionally, excessive recruitment 
of the immune cells can cause unpredicted inflammatory response 
which may damage the eye surface. For example, the angiogenic effect 
of the LL37 at the OS is not a desirable outcome (McDermott, 2004) 
and the up-regulation of hBD2 in non-Sjogren¶V GU\ H\H FDQ SURGXFH
severe ocular irritation (Narayanan et al., 2003). 
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1.1.3.6 Potential of antimicrobial peptides as ocular 
therapeutics 
There are a lot of difficulties in developing AMP peptides as therapeutic 
agents because of their sensitivity to ionic balance, cytotoxicity, 
susceptibility to proteolysis, and cost of pharmaceutical production 
(Marr et al., 2006, Hancock and Sahl, 2006). Nevertheless, as has been 
reported before, the application of AMPs can increase the antimicrobial 
property of contact lens cleaning solutions (Sousa et al., 1996) as well 
as that of corneal storage media (Schwab et al., 1992). Also, some 
peptides has been under development in the pharmaceutical industry 
such as (I-PREX) as a possible treatment for infected corneal ulcers 
(Ganz and Weiss, 1997). However, the direct application of synthetic 
AMPs on the OS in animal models has not shown encouraging results 
(Mannis, 2002, Brandt et al., 2007). As a result, some studies have 
reported an alternative approach by stimulating the production of AMPs 
on the OS to protect against the microbes infections. In accordance 
with this concept, Kumar et al have recently shown that prior 
application of flagillin (TLR5 agonist) can reduce the inflammatory 
response and corneal destruction in murine corneas infected with 
Pseudomoans aeruginosa (P. aeruginosa) (Kumar et al., 2008).  
1.2 MICROBIAL KERATITIS  
Microbial Keratitis is characterized by a defect of the corneal epithelium 
(the ulcer) with inflammation of the underlying corneal stroma (the 
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infiltrate or abscess) caused by pathogens like: bacteria, viruses, fungi 
and protozoa (Keay et al., 2006). 
1.2.1 Corneal morbidity in microbial keratitis 
The tissue destruction in infectious ulcers is a compound effect of 
inflammatory mediators released by the microorganism, host 
inflammatory cells and the metalloproteases that act on the collagen. 
Apoptotic cell loss may be an attempt by the host stroma to escape the 
necrosis and minimize the tissue damage. Breakdown of the 
physiological barrier of epithelium and the tear film leads to the entry 
of microorganisms, which proliferate in the stroma. This is followed by a 
sequence of events including oedema, inflammatory cell influx from 
tears, limbus, abscess formation and necrosis of the stroma. During the 
healing phase, there is cellular migration of the epithelial cells into the 
crater of the ulcer, growth of blood vessels into the stroma, 
proliferation and migration of stromal fibroblasts and influx of 
macrophages which results in the scar formation (Vemuganti et al., 
2004). This process involves several matrix metalloproteinase (MMPs) 
in the cornea which are up-regulated by transcription or activation. It 
has been demonstrated that MMP1-3 & 9 participate in epithelial repair 
and stromal remodelling. (Mulholland et al., 2005) Of note, the degree 
of opacification and visual dysfunction appears to be related to the 
number and density of inflammatory cells and their location, 
vascularisation and the enzymatic stromal damage. The visual recovery 
would therefore depend on the elimination of the inflammatory cell 
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infiltrates, regression of edema, location and density of scarring and the 
newly developed vessels (Vemuganti et al., 2004). 
1.2.2 Types of Microbial Keratitis 
The main types of the microbial keratitis are bacterial, amoebic 
(Acanthamoeba), fungal and viral keratitis (viral infections will not be 
discussed further in this chapter, as cases with active viral keratitis 
were excluded from our study). 
1.2.2.1 Bacterial keratitis 
Bacterial keratitis is considered the main cause of unilateral blindness in 
the developing world (Whitcher, 1990).  After the huge increase in the 
number of contact lens users, the relative incidence of Pseudomonal 
and Staphylococcal infection has gone up (Ormerod and Smith, 1986). 
1.2.2.1.1 Risk factors for bacterial keratitis 
Diseased or damaged corneal epithelium is the main predisposing factor 
for corneal infection. However, organisms such as Corynebacterium 
diphtheriae, Haemophilus aegyptius, Neisseria gonorrhoeae, Neisseria 
meningitidis, Shigella, and Listeria species can penetrate an intact 
epithelium causing corneal infection (Kanski, 2011). Risk factors for 
infectious corneal ulceraction due to non-viral pathogens are many. 
These include trauma to the eye, extended wear of contact lenses, 
chronic OS disease, prior ocular surgery, corneal exposure 
(lagophthalmos), systemic diseases such as diabetes mellitus and 
rheumatoid arthritis, use of topical corticosteroids or corneal 
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hypoesthesia. However, around 10% of individuals with infectious 
keratitis may not exhibit any risk factor of infection (Keay et al., 2006). 
1.2.2.1.2 Clinical features 
Early symptoms of bacterial ulceration include: redness, tearing, pain, 
photophobia, discharges and secretions, decreased vision (Thomas and 
Geraldine, 2007). The specific signs of the corneal infection are the 
following: Eyelids oedema, an epithelial defect with infiltrates in the 
stroma, stromal oedema, hypopyon, endothelial precipitates, melting, 
perforation and endophthalmitis (in severe cases). Scleritis may also 
develop in certain cases where infections are located at the periphery 
(Moshirfar et al., 2006). 
1.2.2.1.3 Causative organisms 
Bacterial culture may show positive results in 55% to 67% (Parmar et 
al., 2006b); the remaining sterile ulcers may be due to non-microbial 
causes or may be of infectious origin with no obvious isolated pathogen 
(Thomas and Geraldine, 2007). The main causes of failure in isolating 
the causative bacteria are: lack of sample material, delay in taking 
samples, inappropriate culture media or certain corneal stains such as 
rose bengal and lissamine green which have antimicrobial effect 
(Seitzman et al., 2006). Notably, topical antibiotics may only delay 
results of the culture because of the long time taken to reactivate 
pathogens in culture without affecting positive rates of culture of these 
organisms (Marangon et al., 2004a). 
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Causative pathogens and predisposing factors 
Demographic distribution plays the main role in isolating the agent 
which causes trauma-associated corneal infection. In an Australian 
study, corneal scrapings from patients with traumatic infectious 
keratitis aged 15±64 years showed no growth of organisms in 60% and 
growth of Gram-positive bacteria (mainly: Coagulase-negative 
Staphylococci) in 31% (Keay et al., 2006).  However, in India, the 
same age group of patients with corneal ulcers due to trauma yielded 
no growth in 35%, growth of filamentous fungi in 32.7% and 
Streptococcus pneumoniae and P. aeruginosa in 25%. (Parmar et al., 
2006b) In another Malaysian study, the commonest isolated bacteria in 
traumatic infectious keratitis were and Staphylococcus aureus (S. 
aureus) (Hooi and Hooi, 2005).  
Due to widespread use of contact lens (CL), microbial keratitis becomes 
a serious complication which occurs in 1 out of 10,000 rigid CL, 4 out of 
10,000 daily soft CL and 20 out of 10,000 extended soft CL wearers. 
Although there is no risk of visual loss due to sterile keratitis associated 
with contact lens wear, the risk of losing the vision from contact lens±
related microbial keratitis is approximately 0.3 to 3.6 per 10,000) 
(Keay et al., 2007). Worldwide, the common aetiological pathogens of 
lens-associated corneal ulcers appear to be P. aeruginosa and 
Acanthamoeba (Watt and Swarbrick, 2005, Sun et al., 2006b, Sun et 
al., 2006a, Parmar et al., 2006a). Non-tuberculous mycobacteria (NTM) 
is considered the main cause of infections in patients post laser-
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assisted in situ keratomileusis (LASIK) (Umapathy et al., 2005). 
Worldwide, Staphylococci (Moshirfar et al., 2006), fungi, Streptococci, 
Nocardia (Patel et al., 2005) and P. aeruginosa (Sharma et al., 2006) 
are frequently isolated bacteria from corneal infections related to 
previous ocular surgery and ocular surface diseases.  
Clinical characteristics of the most common causative bacteria 
Staphylococci 
S. aureus are Gram-positive cocci which form clusters in stained 
smears. They are generally commensal bacteria which may infect the 
cornea when the epithelium is compromised. The distinctive clinical 
signs of this infection are: round or oval epithelial defect with well-
defined creamy or gray stromal infiltrate and minimal stromal haze. S. 
epidermoids also gives the same clinical picture but with less 
aggressive course of action (Thomas and Geraldine, 2007,Kanski, 
2011) 
Streptococci 
Streptococci are Gram-positive cocci which mostly gather in chains. An 
epithelial defect is vital for Pneumococcal corneal infection. Generally, 
early infiltration can readily spread leading to deeper stromal abscess, 
plaque formation, fibrin deposition and anterior chamber reaction with 
hypopyon. Stromal melting of the cornea can induce an undermind 
leading edge with overhanging tissue. Streptococci viridans (S.viridans) 
tends to cause less aggressive infection than Streptococci pyogens (S. 
pyogens), as seen in infectious crystalline keratopathy (Kanski, 2011).  
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Bacillus 
Bacillus cereus (B. cereus) is an extremely virulent, Gram-positive rods. 
Corneal infection can aggressively be seen after penetrating injury, 
especially when there is soil contamination.  There is often microcystic 
oedema in the peripheral or whole cornea followed by a circumferential 
corneal abscess. Because of the huge virulence of this pathogen, 
perforation of the cornea can develop within hours (Yanoff and Duker, 
2004). 
Corynebacteria 
Corynebacteria diphtheriae (C. diphtheria) are Gram-positive, club-
shaped or pleomorphic rods. The infection frequently begins with 
diffuse epithelial haze, followed by stromal necrosis and melting (Yanoff 
and Duker, 2004). 
Listeria 
Listeria is an anaerobic, Gram-positive rod. Keratitis caused by this 
organism usually occurs in eyes of people who deal with animals. It can 
cause keratitis with necrosis. Typically, there is a ring ulcer and a 
severe anterior chamber reaction with fibrinous exudate and a 
hypopyon (Yanoff and Duker, 2004). 
Clostridium 
Clostridia are Gam-positive bacilli which form spores. Rarely, clostridial 
conjunctivitis may develop to marginal keratitis. Interestingly, it tends 
to produce gas in the epithelial, sub-epithelial and stromal layers of the 
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cornea leading to mild bullous keratitis and/or gas bubbles seen in the 
anterior chamber (Ostler HB, 1993).  
Propionibacterium Acnes 
Propionibacterium acne is Gram-positive, anaerobic rod which can 
produce spores. It is a commensal organism which can cause infection 
in the event of ocular trauma, eye surgery, CL wear or prolonged use of 
topical corticosteroids. The clinical picture looks like the classical 
infectious keratitis, although it can follow an indolent course in some 
cases. Growth in culture should be monitored for at least 10 days to 
exclude the diagnosis of this organism (Zaidman, 1992).  
P. aeruginosa  
It is an aerobic Gram-negative organism which tends to live in the 
moist places. At the OS, P. aeruginosa is the most frequent cause of 
the corneal ulcers caused by CL wear (Bharathi et al., 2007). The host 
response is very crucial in pathogenesis of P. aeruginosa keratitis 
(Thomas and Geraldine, 2007). The clinical signs comprise rapid 
invasion of the damaged epithelium and stroma with production of 
destructive enzymes such as protease, lipase, and elastase which in 
turn cause necrosis of the stroma. In some cases corneal haze in the 
VXUURXQGLQJ WLVVXH µ,PPXQH ULQJ¶ can also be found (Thomas and 
Geraldine, 2007).  
Serratia 
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Serratia are Gram-negative rods which can produce exotoxins and 
proteases.  Hydrophilic CL wear is a predisposing factor for ocular 
infection. The classical clinical signs are superficial, central or 
paracentral ulcers, which can develop to a deep, ring shaped ulcer. 
They can also cause intraepithelial corneal nodules and granular 
stromal appearance (Yanoff and Duker, 2004).  
Escherichia, Klebsiella, and Proteus 
Like the other Gram-negative bacteria, infection with these rods is 
usually accompanied by CL wear. The infection can resemble virulent 
pseudomonal keratitis with ring ulcers, necrosis and perforation. 
Suppurative keratitis caused by Escherichia coli (E. coli) is typically 
more indolent with hypopyon formation and severe iridocyclitis (Yanoff 
and Duker, 2004). 
Haemophilus 
Haemophilua Influenza (H. influenza) is a fastidious Gram-negative rod. 
It can frequently causes conjunctivitis which may lead to keratitis. The 
corneal infection is usually superficial but severe with suppuration and 
hypopyon formation (Yanoff and Duker, 2004). 
Moraxella 
Moraxella bacilli are large, Gram-negative or Gram-variable bacteria. 
The ocular infection is seen in alcoholic and debilitated patients. 
Clinically, the keratitis begins with blepharoconjunctivitis which may 
associate with marginal ulcers. It can cause disastrous visual outcomes 
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despite treatment because of both the predisposing factors and the 
nature of the disease (Das et al., 2006).  
Kingella kingae 
These are Gram-negative, aerobic, rod-shaped bacteria. It can rarely 
cause corneal ulcers and upper eyelid abscesses (Hiti et al., 2006, 
Mollee et al., 1992). 
Neisseria 
Neisseria gonorrhoeae (N. gonorrhoeae) and Neisseria meningitidis (N. 
meningitides) are intracellular Gram-negative diplococci. They can 
affect the intact corneal epithelium to produce diffuse edema or ring 
ulcer with hypopyon and necrosis (Kanski, 2011). 
Non-tuberculous mycobacteria 
Among the non-tuberculous Mycobacteria, Mycobacteria fortuitum (M 
fortuitum) and Mycobacteria chelonae (M chelonae) are most commonly 
associated with ocular infection. These acid fast, long rods can grow in 
disinfecting materials and are found in soil. Commonly, corneal 
infection with these bacteria follows eye trauma or ocular surgery 
(penetrating keratoplasty, lamellar refractive surgery) and tends to 
behave like indolent mycotic keratitis. The infiltrated cater of the ulcer 
shows a cracked wind-shield type of Appearance with multiple radiating 
lines and a non-suppurative infiltration (Thomas and Geraldine, 2007). 
25 
 
1.2.2.1.4 Diagnosis 
In recent years, there have been notable advances in non-invasive 
techniques for diagnosis of infectious keratitis and in molecular 
techniques for diagnosis of infectious keratitis (Thomas and Geraldine, 
2007). The following are the most common techniques used in isolating 
the causative organisms of the infectious keraritis: 
Non-invasive techniques 
Non-invasive methods of diagnosis include impression cytology, in vivo 
confocal microscopy and anterior segment optical coherence 
tomography. In our study, we have also used the Oculus Pentacam as a 
novel method in following up patients with microbial keratitis.  
Impression cytology (IC): This relatively non-invasive technique can be 
used as a diagnostic tool of ocular surface diseases (which include 
infectious keratitis). A cellulose acetate filter is applied to the corneal 
surface to remove the superficial layers of the epithelium. Then further 
histological, immunehistological or molecular analysis may be 
performed to the cells obtained (Singh et al., 2005) (further 
information are ellustrated in chapter four). 
In vivo confocal microscopy (IVCM): Advanced tandem scanning 
confocal microscopes and the Heidelberg retina tomograph II (HRT-II) 
with cornea module allow in vivo examination of the corneal cells. In 
vivo confocal microscopy is primarily of value in the diagnosis of fungal 
and Achanthamoeba keratitis wherein the organisms can be 
demonstrated rapidly without waiting for outcomes of in vitro 
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laboratory cultures (Vaddavalli et al., 2006, Pfister et al., 1996). 
Although it can be very useful in excluding fungal and Acanthamoeba 
keratitis, Its role is still limited in the diagnosis of the bacterial keratitis 
(Labbe et al., 2006).  
Anterior segment optical coherence tomography (AS-OCT): Recently, 
corneal imaging has been used as a means of recording extent of 
infiltrate and determining the initial response to treatment. This new 
technology is very useful in observing the progress of corneal 
infections. It can provide numerical values of the dimensions and depth 
of the infiltration and the overall inflammatory state of the cornea with 
high quality cross sections of the entire cornea (Konstantopoulos et al., 
2008, Konstantopoulos et al., 2007). 
The OCULUS Pentacam: The OCULUS Pentacam (Oculus Inc., Germany) 
is a non-invasive optical system, which has specifically been designed 
to assess the anterior segment of the eye. It can measure the corneal 
thickness, corneal topography, and densitometry (Oculus, 2003). These 
could be very useful in following up patients with corneal infections. 
(Further details are mentioned in chapter six) 
Conventional & invasive methods of specimen collection 
Corneal scrapings: Samples from cornea, usually scrapings, may be 
obtained to identify the aetiological bacteria in infectious keratitis.  The 
samples are examined microscopically by using various stains or 
inoculated on to appropriate culture media (Umapathy et al., 2005, 
Joseph et al., 2006). Corneal sampling is usually deferred for specific 
27 
 
cases of suspected bacterial ulcers such as advanced or central ulcers 
or if signs are suggestive of non-typical bacteria.  Treatment 
modification is usually not needed as 95% of cases respond to the 
initial antibiotic regimen (O'Brien et al., 1995, McLeod et al., 1996). 
There is also a significant role of scrapings performed with a calcium 
alginate swab moistened with soy broth in the recovery of organisms 
(Benson and Lanier, 1992). Gram and Giemsa stains are considered the 
most common stains used in diagnosing infectious ulcers. Gram stain is 
very useful in differentiating between bacteria and yeasts whereas 
Giemsa stain is helpful for cytology and to characterize bacteria, fungi, 
and chlamydia. Ziehl-Neelsen stain is the best choice if filamentous 
bacterial or non-tuberculous mycobacterial infection is suspected 
(Yanoff and Duker, 2004). 
Corneal biopsy: Corneal biopsy is considered in suspected protozoan, 
mycobacterial, or mycotic infections; isolating microorganism when 
classical antimicrobial treatment fails to resolve the infection which had 
no established diagnosis with prior scrapings. Also it should be 
considered in patients with infectious keratitis related to previous LASIK 
where material from the stromal bed should be examined. Like corneal 
scrapings, the corneal biopsy should involve the active edge and base 
of the ulcer. A lamellar technique is required if the infiltrate invades the 
stroma (Alexandrakis et al., 2000). 
 
28 
 
1.2.2.1.5 Treatment 
Medical treatment 
Infectious corneal ulcers are potential emergencies where treatment 
should be urgent to avoid sight threatening sequelae. The goals of the 
treatment are to stop the replication of bacteria, reduce overactive 
inflammation, minimize pain and other symptoms and encourage 
corneal healing. Treatment is usually in the form of topical 
antimicrobials but occasionally systemic medication may be required. 
Indications for systemic antibiotics include keratitis complicated with 
scleritis, risk of perforation or when endophthalmitis is suspected.  
Fortified topical antibiotics and fluoroquinolones are the ideal treatment 
of bacterial keratitis (Thomas and Geraldine, 2007). Arguably, 
monotherapy with fluoroquinolones is the first line in therapy of most 
ulcers although in vitro studies have shown resistance for some strains 
(Stefan and Nenciu, 2006). The initial broad-spectrum therapy can be 
achieved either by a combination of topical fortified aminoglycoside and 
cephalosporin/ vancomycin eye drops or fluroquinolone eye drops 
monotherapy. This empirical approach is effective in 95% of cases of 
infection (O'Brien et al., 1995). According to one study, when combined 
therapy with cephalosporin and gentamicin was tried to treat eyes with 
infectious keratitis, there was a clinical lack of response in 13% and 
treatment failure in 4%, whereas when ciprofloxacin monotherapy was 
used in another nonrandomized study there were no treatment failures 
in all cases (Ly et al., 2006). There are several causes for failure of 
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fluoroquinolone monotherapy such as inadequate frequency of 
applications and late initiation of therapy. These are considered risk 
factors for eye perforation in patients with infectious corneal ulcers. In 
clinical practice, fluoroquinolones are considered effective empirical 
therapy because of their readily availability and relative safety (Titiyal 
et al., 2006). On the other hand, both fortified vancomycin and 
gentamicin remain at least 95% effective against OS bacteria 
(Marangon et al., 2004b). To achieve the therapeutic levels of the 
antibiotic in the cornea, frequent topical application of the drug is 
recommended. Antibiotic eye drops should be instilled every 5 minutes 
in the first 25 minutes then every 15 minutes for the next hours. Then, 
the frequency can be reduced to one drop hourly according the clinical 
response. Subsequent treatment is decided according to clinical 
response (Kanski, 2011). 
Reduced pain and discharge are the two early symptomatic indicators 
of a favourable response to therapy. The initial signs of satisfactory 
response to treatment are arrest of progression (failure to worsen), 
stabilization of the depth of infiltrate and reduced infectious activity at 
the inILOWUDWH¶V PDUJLQV 7KH RWKHU VXEVHTXHQW signs of improvement 
comprise continuous healing of epithelial defect, clearing of the stromal 
infiltrate with decreasing adjacent oedema and anterior chamber 
reaction. As a general rule, treatment should be continued at least until 
the epithelium has completely healed (one week after the healing of the 
epithelial defect in P. aeruginosa infection) (Yang et al., 2006). 
Corticosteroids can be used to minimize the adverse sequelae of 
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infectious keratitis such as perforation, vascularization, and scarring. 
However, corticosteroids have been associated with inhibition of healing 
and if antibiotic therapy is improper, corticosteroids have been found to 
promote bacterial replication. Hence corticosteroids should only be used 
after initial evidence of successful antibiotic treatment. Interestingly, a 
recent randomized controlled study has shown that the topical steroids 
use did not correlate with any overall improvement in the final visual of 
patients with infectious keratitis (Srinivasan et al.) 
Povidone-iodine may be used to reduce the load of bacteria in corneal 
ulcers before starting antibiotics therapy (Gregori et al., 2006). 
However, a single application of 5% betadine (povidone-iodine) has not 
found to reduce the bacterial load of corneal ulcers more than just 
scraping alone, possibly because of poor penetration and the large 
number of pathogens (Thomas and Geraldine, 2007). 
Surgical intervention 
Surgical intervention is mandatory if stromal necrosis develops to 
perforation. Small perforations with mild necrotic bed of the ulcer can 
be treated by the application of cyanoacrylate corneal glue. If the 
necrosis is extensive or perforation is large, penetrating keratoplasty is 
indicated (Hill, 1986). It has been found that debulking and layer-by-
layer removal of host corneal tissue can protect the iris while doing 
therapeutic keratoplasty in eyes with perforated corneal ulcers with 
incarcerated iris (Vajpayee et al., 2006). 
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In severe bacterial keratitis, it has been reported that early amniotic 
membrane transplantation (AMT) with topical corticosteroid provides 
quick pain relief and allows healing of the epithelium (Gicquel et al., 
2007). Moreover, The transplanted amniotic membrane (AM)  improves 
the healing process, resulting in decreased corneal haze and less 
neovascularization (Keay et al., 2006). Human AM has antibacterial, 
antiangiogenic, anti-inflammatory and antifibroblastic properties. These 
characteristics may play a role in the use of AM transplantation in the 
treatment of infectious keratitis (Barequet et al., 2008). Studies have 
shown that human AMT promotes rapid epithelialization and reduces 
stromal inflammation and ulceration in herpes simplex keratitis 
(Heiligenhaus et al., 2003).  When used with antibiotics as adjunctive 
treatment, AMT enhanced epithelialisation and prevented corneal 
perforation in infectious keratitis. Indeed, AM also promoted wound 
healing, reduced inflammation and neovascularization and improved 
visual acuity without scarring (Barequet et al., 2008, Kim et al., 2001). 
Furthermore, Gicquel et al reported immediate pain relief and epithelial 
healing attributed to early AM transplantation combined with topical 
corticosteroids in patients with severe non healing infectious ulcers 
(Gicquel et al., 2007).  
Conjunctival flaps can also be used to treat peripheral infectious 
ulcerations as the conjunctival vessels help in healing and scarring. 
However, conjunctival flaps should not be placed over a corneal 
perforation (Tuli et al., 2007).  
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After corneal healing, persistent anterior stromal scars can sometimes 
be removed by excimer laser phototherapeutic keratectomy 
(Prochazkova et al.). Deeper scars may require lamellar or penetrating 
keratoplasty. This procedure should preferably be done after closure of 
superficial or deep vessels by performing fine needle diathermy, argon 
laser occlusion or use of anti vascular endothelial growth factors 
(VEGFs) to reduce risk of vascular graft rejection (Pillai et al., 2000).  
1.2.2.2 Parasitic keratitis (Acanthamoeba keratitis) 
Acanthamoeba is a free-living genus of amoeba that is abundant in the 
environment. It survives in diverse conditions and has been isolated 
from soil and dust, air and water (such as ponds, swimming pools, hot 
tubs, and contact lens disinfectant solutions) (Illingworth and Cook, 
1998).  Patients who use contact lenses are at particular risk, they form 
the majority of cases with this infection. Furthermore, co-contamination 
with bacteria appears to be an important risk factor for the adherence 
of Acanthamoeba to hydrogel lenses (Gorlin et al., 1996). Rinsing the 
lenses in tap water may predispose specifically to Acanthamoeba 
infection (Lam et al., 2002). 
1.2.2.2.1 Clinical features 
Generally, patients with Acanthamoeba keratitis complain of symptoms 
like: pain out of proportion of clinical appearance (Azuara-Blanco et al., 
1997), photophobia, tearing and reduced visual acuity with a history of 
contact lens wear (Parmar et al., 2006a). The early signs of 
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Acanthamoeba keratitis can include punctuate epithelial erosions 
(McCulley et al., 2000), epithelial irregularity of vesicular appearance in 
a linear or pseudo-dendritic pattern with little discharge (Azuara-Blanco 
et al., 1997), limbitis, infiltrates in anterior stromal and perineuritis. A 
mild anterior chamber reaction may be seen. There may be a 
dendriform keratitis that is often mistaken for a herpes simplex 
infection. As the condition progresses, a complete or partial stromal 
ring-shaped infiltrate is often observed, usually with an overlying 
epithelial defect (Joseph et al., 2006). In some circumstances, the 
presence of sterile scattered subepithelial and stromal infiltrates, 
especially in the peripheral cornea, may be evident. In advanced cases, 
marked stromal thinning and opacification occur frequently (Parmar et 
al., 2006a). In addition to the sight-threatening keratitis, infection by 
Acanthamoeba can also lead to iritis, hypopyon, scleritis, cataract and 
glaucoma (Umapathy et al., 2005). 
1.2.2.2.2 Diagnosis 
History of contact lens wear with exposure to contaminated water, 
severe pain in the affected eye, negative laboratory cultures for 
bacteria, fungi and viruses, together with a lack of response to 
conventional antimicrobial therapy may suggest Acanthamoeba keratitis 
(Moshirfar et al., 2006). Corneal scrapings should always be performed 
to confirm the diagnosis of Acanthamoeba keratitis. However, corneal 
biopsy may be required if microbiology examination and culture is 
inconclusive. The cysts of Acanthamoeba can be diagnosed by using 
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Gram's and Giemsa stains or by using Calcofluor white stain with 
fluorescent microscope. After performing the corneal scrapings or 
biopsies, the samples are inoculated onto a lawn of E. coli on non-
nutrient agar or buffered charcoal-yeast extract agar to get the best 
recovery rate of the organisms (Dart et al., 2009). More recently, in 
vivo confocal microscope has been used to detect the cysts and 
trophozites in the corneal tissue (Pfister et al., 1996). Impression 
cytology has also given the advantage of diagnosing superficial 
infections by using the histological and molecular analysis. (Sawada et 
al., 2004) Indeed, polymerase chain reaction (PCR) has been shown to 
be a sensitive method of detecting Acanthamoeba¶V'1$LQWKHFRUQHDO
scrapings and tears (Mathers et al., 2000). 
1.2.2.2.3 Treatment 
In the last decade, the main treatment was a combination of 
propamidine with neomycin, paromomycin, and/or imidazoles which 
were effective in only 50% of cases (Ficker et al., 1990). Later, cationic 
antiseptic factors such as polyhexamethylene biguanide (PHMB) and 
chlorhexidine have showed high effectiveness in vitro against 
Acanthamoeba cysts (Elder and Dart, 1995). There is interaction 
between the electropositive biguanide groups and the plasma 
membrane which may compromise the integrity of the 
mucopolysaccharide plug participates in the formation of the cyst (Seal 
et al., 1996). Povidone-iodine 2.5% to 5% solution was also found  to 
be effective on both the trophozites and the cysts (Gatti et al., 1998). 
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Augusto Blanco et al reported that an effective treatment protocol for 
Acanthamoeba keratitis which was combined topical therapy of hourly 
PHMB 0.02% and propamidine isethionate (Brolene) 0.1% along with 
Polyfax (polymyxin B sulphate and bacitracin zinc) ointment four times 
a day. The frequency of the application could be tapered gradually 
according to the clinical improvement. The period of treatment may 
take several months until complete healing and eradication of the 
trophozites and cysts (Azuara-Blanco et al., 1997).  
Corticosteroid application should probably be limited to cases with 
stromal infiltration at the site of the infection and with evident 
improvement of the infectious process (Azuara-Blanco et al., 1997) or 
patients with limbitis, scleritis, or uveitis (Bacon et al., 1993). 
Surgically, AMT has been found to reduce the ocular inflammation, 
pain, and corneal neovascularization in Acanthamoebal ocular infection.  
It can be used in the inflammation phase which may defer any further 
surgical procedure (Bourcier et al., 2004). Penetrating keratoplasty, if 
needed, should be deferred to at least 6 months after complete healing 
to reduce the risk of rejection. However, therapeutic corneal grafting 
could be the only cure for refractive infections with high risk of failure 
(Azuara-Blanco et al., 1997). 
1.2.2.3 Fungal Keratitis 
Fungi are ubiquitous organisms which are frequently seen in the 
developing and tropical countries. Basically, they can be classified into 
filamentous and Yeast-like fungi. In tropical climates, trauma with plant 
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material is considered the main reason of fungal keratitis with 
filamentous fungi (Fusarium, Aspergillus), whereas in cooler climates, 
Yeast-like fungi such as Candida spp (Thomas and Geraldine, 2007). 
Trauma is the most important predisposing factor of the filamentous 
fungi infection, whereas OS disease, systemic disorders, and CL wear 
form the risk factors for Candida infection of the eye. Recently, a multi-
country outbreak of Fusarium keratitis emphasizes that CL wear is a 
major risk factor for fungal keratitis (Thomas and Geraldine, 2007, 
Galarreta et al., 2007). 
1.2.2.3.1 Clinical features 
Filamentous fungal keratitis is a slowly progressive infection with 
serrated margins, raised slough and coloration other than yellow. 
According to one study, the probability of fungal infection if one of the 
previous signs is present was 63%; the presence of all three signs 
suggests an 83% chance of filamentous fungal keratitis (Erie et al., 
1993). However, slow progression keratitis which resembles bacterial 
ulcer with overlying epithelial defect and isolated infiltrate are 
considered frequent features of Candida infection (Thomas and 
Geraldine, 2007). 
1.2.2.3.2 Diagnosis 
A clinical suspicion must be maintained with all corneal ulcers which do 
not respond to the classical antimicrobial treatment, especially with a 
history of chronic corneal disease, prolonged corticosteroid use or 
trauma with vegetable contamination. Also, patients with post LASIK 
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infections are at high risk (Kuo et al., 2001, Sridhar et al., 2000). To 
confirm the diagnosis and begin treatment, laboratory exams are 
required and scrapings for stains and culture should be obtained. 
Gram's stain, Giemsa stain, Gomori's methenamine silver, periodic acid 
Schiff (PAS), Calcofluor white and KOH are specific stains for fungi. 
Blood agar, Sabouraud agar or brain-heart infusion broth are the 
favourite media for fungal culture. However, media used for bacterial 
culture can be used for fungal culture if antibacterial agents are added 
(Thomas and Geraldine, 2007). Deep corneal biopsy is required in any 
case of deep stromal infiltrate with intact epithelium (Yanoff and Duker, 
2004). Furthermore, IVCM may be useful in identification the fungal 
hyphae in the living conea (Winchester et al., 1997).  Recently PCR is 
found to be a sensitive and rapid method in the diagnosis of fungal 
corneal ulcers (Said et al., 2011, Kumar et al., 2005). 
1.2.2.3.3 Treatment 
For filamentous fungi, topical natamycin 5% or econazole 1% are 
considered the first line of treatment, whereas topical amphotericin B 
0.15% is classified as the drug of choice for the candida infection (Said 
et al., 2011, Thomas, 2003). As an initial line of treatment, a 
reasonable approach for fungal keratitis would be a combination of 
amphotericin B 0.1 to 0.3% (which is the drug of choice for Candida) 
and econazole 1% (which is more effective against filamentous fungi). 
(Said et al., 2011) Oral fluconazole (200 mg) can be used in deep 
stromal infiltration (Galarreta et al., 2007, Thomas, 2003, Kalkanci and 
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Ozdek, 2010). For patients with hypopyon, an intravenous injection of 
fluconazole (100 mg) twice daily and atropine drops once daily are 
indicated. Intrastromal corneal injection of amphotericin B (5mg per 0.1 
ml), sub-conjunctival fluconazole (0.5±1.0 ml of a 2% solution) and 
topical fluconazole with oral ketoconazole are other new ways of 
adminstration. (Thomas and Geraldine, 2007) Furthermore, an anterior 
chamber tap with intracameral injection of 5 µg of amphotericin B is an 
extremely useful procedure in the management of fungal ocular 
infections confined to the anterior segment (Sridhar et al., 2002). 
Recently, voriconazole, an agent derived from fluconazole has been 
approved for the treatment of invasive Aspergillosis and for serious 
infections caused by Fusarium species in patients intolerant of, or 
refractory, to other antifungals. Previous in vitro studies have shown 
that voriconazole has fungistatic activity against most yeasts and 
hyaline filamentous fungi. It exhibits dose-dependent pharmacokinetics 
and is well tolerated after oral or parenteral administration with 
resultant high and sustained blood and tissue levels following daily 
doses of 50 to 200 mg. Voriconazole is currently not a FDA approved 
drug for topical ophthalmic use (Ozbek et al., 2006). 
According to Chen et al, when AMT along with antifungal agents were 
used to treat acute culture-proven fungal keratitis in 23 eyes, complete 
epithelialization was achieved in 75% of cases with active disease and 
in all cases with inactive disease (Chen et al., 2006). However, if the 
infection is not controlled with the intensive antifungal therapy, lamellar 
keratoplasty is recommended. Penetrating keratoplasty should be done 
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if lamellar keratoplasty fails, especially, in cases of filamentary fungal 
infection, where lamellar or penetrating keratoplasty may reduce the 
load of the infected tissue and promote healing (Lam et al., 2002). 
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2 Antimicrobial peptides gene expression 
by ocular surface cells in response to 
Acanthamoeba castellanii: An in vitro 
study 
 
2.1 INTRODUCTION 
The ocular surface comprises of cornea, conjunctiva, and tear film. Like 
other mucosal surfaces, it is in direct contact with the environment and 
exposed to environmental pathogens such as bacteria, viruses, fungi, 
and protozoa. It also maintains a population of commensal organisms, 
which have the potential to cause opportunistic disease. To combat 
these threats, the ocular surface has developed innate and adaptive 
immune mechanisms (Knop and Knop, 2007). One important 
component of the innate response is the repertoire of AMPs which can 
be considered to represent the eukaryotic analogues of antibiotics 
(Gordon et al., 2005b, Sang and Blecha, 2008). At the OS, hBD1-3 and 
9, LEAP1- 2, LL37 (McIntosh et al., 2005), and RNase7 (Mohammed et 
al., 2010b) are the main AMPs.  
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Acanthamoeba is a ubiquitous free-living genus of amoeba that can 
survive in diverse conditions. The life cycle of Acanthamoeba has two 
stages: a replicative trophozoite stage that under adverse conditions 
such as extreme temperature, starvation, or osmolarity changes can 
develop into a dormant cyst stage (Cordingley et al., 1996, Jaison et 
al., 1998). Acanthamoeba is notorious as a cause of serious corneal 
infection particularly amongst wearers of soft CL. The infection is 
sporadic but two outbreaks have been recently reported in Chicago and 
Singapore (Por et al., 2009, Joslin et al., 2006). The mechanism by 
which this infection occurs is directly related to the ability of 
Acanthamoeba trophozoites to adhere to mannose glycoproteins on the 
FRUQHDOHSLWKHOLXPYLDWKHDPRHED¶VPDQQRVH-binding receptor (Yang et 
al., 1997, Hurt et al., 2003, Cao et al., 1998). This binding induces 
production of a cytolytic factor, mannose-induced protein (MIP133), by 
the Acanthamoeba (Clarke et al., 2006). Subsequently, a number of 
matrix metalloproteases are activated, killing corneal epithelial cells, 
and penetrating the cornea by dissolution of the basement membrane 
DQGWKHXQGHUO\LQJFROODJHQRIWKH%RZPDQ¶V]RQHDQGVWURPD(Mitra et 
al., 1995, Mitro et al., 1994, Cao et al., 1998).  
Although there are several studies on the gene expression of AMPs in 
OS cells challenged with microbial stimuli, there is no work on AMPs 
expression by any human cell type in response to Acanthamoeba. In 
this study, I characterized the profile of AMPs gene expression by a 
human corneal epithelial cells exposed to one of the most frequently 
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isolated species of Acanthamoeba from corneal infections; 
Acanthamoeba castellanii (Omana-Molina et al., 2010). 
2.2 METHODS 
This study was conducted in collaboration with prof Norjahan Penjwani 
in New England Eye Centre, Tufts University School of Medicine, 
Boston, Massachusetts, USA. The cellular stimulation with 
Acanthamoeba castellanii was performed in the USA whereas the gene 
profile of the studied AMPs was analyzed at our department in 
Nottingham. 
Aseptic conditions were applied in all in vitro experiments. The laminar 
flow air hood and sterile solutions and containers were used at all 
times.  
2.2.1 Human cell culture 
According to previously described protocols (Gipson et al., 2003), the 
Telomerase reverse transcriptase-immortalized human corneal limbal 
epithelial cells (HCLE) were maintained in keratinocyte serum-free 
media (K-SFM; Invitrogen, Carlsbad, CA) supplemented with 0.2 ng/ml 
epidermal growth factor (EGF), 25 µg/ml bovine pituitary extract (BPE) 
DQG  P0 &D&O DW  Û& LQ D  &2 KXPLGLILHG LQFXEDWRU The 
HCLE were sub-cultured in 6-well cell culture plates (9.5 cm2; BD, 
Franklin Lakes, NJ) until confluency was reached and then starved 
overnight in growth supplement and BPE free media before exposure to 
Acanthamoeba.  
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2.2.2 Isolation and culture of Acanthamoeba 
castellanii trophozoites 
Acanthamoeba castellanii trophozoites: An Acanthamoeba strain 
derived from an infected human cornea (MEEI 0184; A. Castellanii, 
genotype T4) was used throughout this study.  The parasites were 
axenically cultured in a proteose peptone-yeast extract-glucose (PYG) 
medium prior to the exposure study (Jensen et al., 1970). 
2.2.3 Acanthamoeba exposure of HCLE 
The final density of the Acanthamoeba used was 2 x 105 amoebae/ ml. 
1.5 ml of amoebae suspension was used for each 60 mm dish. Amoeba 
from PYG media were washed and suspended in the following media: [1 
ml of Non-essential amino acid, 10 ml of 4% BSA and 89 ml of Eagle's 
minimal essential medium, (EMEM) with L-Glutamine] prior to 
stimulating HCLE cells. The confluent HCLE cells were incubated with 
Acanthamoeba castellanii trophozoites and samples were collected at 1, 
3, 6 and 9 and 24 hours. Control samples were obtained from non 
stimulated HCLE. At each time point, the culture media was removed 
and 700 µl of RLT buffer (Qiagen, USA) was added to each well for 15 
minutes until the cells were fully solubilised and the lysate was 
collected and stored at -80oC. Additionally, the suspension of 
Acanthamoeba culture (without cells) was collected separately and spun 
down for 2 minutes at 134000 g. Then, 700 µl of RLT buffer (Qiagen) 
was added and the samples were kept at -80oC for further analysis. All 
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tests were done in triplicate and each of the triplicate set of tests was 
on cells of the same passage. 
2.2.4   Isolation of total RNA  
Total RNA was extracted from each RLT lysate using RNeasy minikit 
4LDJHQ &UDZOH\ 8. DFFRUGLQJ WR WKH PDQXIDFWXUHU¶V LQVWUXFWLRQV
%ULHÀ\ FHOO O\VDWHV ZHUH KRPRJenised with a spin column 
(QIAshredder; Qiagen) and mixed with 70% ethanol in equal volume 
(1:1). The mixture was then applied onto spin columns and centrifuged 
for 15 seconds at 134000 g 7KH¿OWUDWHZDVGLVFDUGHG DQG WKH VSLQ
column was washed with buffer RW1 (Qiagen) and then with buffer RPE 
(Qiagen) by centrifugation. Total RNA was eluted in 15 µl of RNase-free 
water 4LDJHQDQGTXDQWL¿HGXVLQJ WKHNanodrop Spectrophotometer 
(Thermo Fisher Scientific, USA).  
The Nanodrop measures the absorbance of the UV light of the RNA 
sample at 260nm (A260) to determine its concentration. After 
FDOLEUDWLQJ DQG EODQNLQJ WKH PDFKLQH ZLWK ǋ/ 51DVH-free water, the 
89DEVRUSWLRQRIǋ/RIHDFK51$VDPSOHZDVPHDVXUHG,QSULQFLSDO
the UV absorbance at A260 is specific to RNA and DNA, while the 
absorbance at A280 is mainly due to the protein absorption. A value of 
about 2 of the A260/A280 ratio was always sought to define the pure 
RNA (Fleige and Pfaffl, 2006).  
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2.2.5 Complementary DNA (cDNA) synthesis 
Reverse transcription into cDNA of 4 Pg template RNA was carried out 
DFFRUGLQJ WR WKH PDQXIDFWXUHU¶V LQVWUXFWLRQV 4XDQWLWHFW 5HYHUVH
Transcription kit, Qiagen, Crawley, UK). The reaction was performed 
usLQJ D UHYHUVH WUDQVFULSWLRQ NLW 4LDJHQ %ULHÀ\ WRWDO SXULIied RNA 
was mixed with genomic DNA wipeout buffer (Qiagen) on ice. The 
mixture was incubated at 42°C for 3 minutes on a thermal cycler 
(Hybaid Ltd, UK) and then placed on ice. The reverse transcription 
enzyme mix (Quantitect reverse transcriptase, Quantitect RT buffer, 
and RT primer mix; Qiagen) was prepared on ice and mixed with total 
51$PL[WXUH7KH¿QDOPL[WXUHZDVWKHQLQFXEDWHGon a thermal cycler 
at 42°C for 30 minutes, followed by reverse transcriptase deactivation 
at 95°C for 3 minutes. DNA Samples were then stored at   20°C until 
further analysis. In each experiment, one sample without reverse 
transcriptase was prepared to act as a negative control. 
2.2.6 Quantitative real-time PCR  
2.2.6.1 Basics of RT-PCR (Taqman assay) 
Quantitative real-time PCR is an extremely sensitive technique which 
can amplify and simultaneously quantify a specific DNA molecule. It 
follows the same principle of the standard PCR but it is considered 
much more sensitive. Indeed, it can detect the products during the 
reaction progression in real time manner not at the end of the reaction 
(like the standard PCR).  Also, it is rapid and able to detect and 
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quantify very small amounts of specific nucleic acid sequences. In this 
regard, Taqman assays are very sensitive, specific and highly 
reproducible (Bustin 2000; Kuhne and Oschmann 2002). A Taqman 
probe consists of fluorophores dyes which are designed to anneal to the 
specific target DNA.  Before the attachment of the probe to the 
template DNA, the quencher fluorophore reduces the fluorescence 
from the reporter fluorophore. Once the Taqman probe has attached 
to its specific piece of the template DNA after the high temperature 
denaturation, the reaction cools and the primers anneal to the DNA. 
Then, the Taq polymerase begins to add nucleotides and removes the 
Taqman probe from the template DNA (figure 1). This causes 
separation of the quencher from the reporter fluorophores. 
Subsequently, the reporter fluorophore emits its energy which can be 
quantified using a computer. The amount of energy in each cycle is 
directly proportional to the amount of genetic product generated in that 
cycle (Biosystems, 2009). 
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Figure 1. Another three step view of the TaqMan probe working: before the probe is 
met with the Taq polymerase, energy is transferred from a short-wavelength 
fluorophore (green) to a long-wavelength fluorophore (red). When the polymerase adds 
nucleotides to the template strand, it releases the short-wavelength fluorophore, 
making it detectable and the long-wavelength undetectable (Department of Biology, 
2003). 
2.2.6.2 RT-PCR set up 
RT-PCR based on Taqman assays (Applied Biosystems, UK) was used to 
measure the relative gene expression of the human hBD1-3 & 9, 
LEAP1-2, LL37, RNase7 according to established methodologies in our 
department (Abedin et al., 2008, Mohammed et al., 2010a, Mohammed 
et al., 2010b).  
All samples were kept on a cold tray to ensure no nucleic acids 
damage. Pre-optimised Taqman gene expression assays (Applied 
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Biosystems) were used in this study. All RT-PCR reactions were run on 
96 well optical tubes (Stratagene, Europe) in the Mx3005p real-time 
PCR system (Stratagene, Europe). For each sample, the RT-PCR 
H[SHULPHQWDO VHWXS ZDV FDUULHG RXW DV GHWDLOHG LQ WKH PDQXIDFWXUHU¶V
protocol (Applied Biosystems). Briefly, template cDNA was diluted to 
1:5 using nuclease-free water. Each reaction was prepared to 20 µL 
¿QDO UHDFWLRQ YROXPH with 10 µL of 2 × gene expression master mix, 
1 µL of 20 × assay (primers and probe mix; TaqMan; Applied 
Biosystems), 5 µL diluted cDNA, and 4 µL nuclease-free water. Each 
96-well plate was run with the gene of interest and respective 
endogenous control Taqman assay (hypoxanthineguanine 
phosphoribosyltransferase, HPRT) (Applied Biosystems, UK).  
Non-template and non-reverse transcriptase samples were used as 
negative controls. All experiments were done in triplicate. The thermal 
profile of the RT-PCR assays is shown in Table 1  
Table 1. Thermal cycler profile used in this study. The standard profile consistis of three 
stages (activation, hold and cycle. Data collection was performed at cycle stage). 
Thermal Profile of each RT-PCR cycle 
Initial setup/ 1 cycle  each 
Each of 40 cycles 
Denature 
Anneal/ 
Extend 
Activation Hold Cycle 
2 min 50 oC 10 min 95 oC 15 sec 95 oC 1 min 60 oC 
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Details of the target genes and primer codes used in our study are 
listed in Table 2. 
Table 2. showing detailed information about the genes  and primer codes used in our 
study 
  
2.2.6.3 Data analysis: 
The raw RT-PCR data were acquired using the MxPro software (version 
4.01; Stratagene, UK). Then, it was transported to Microsoft Excel 
spreadsheet and analysed using the ƩƩCT method (Bustin, 2000). The 
KHOSRIDVWDWLVWLFLDQZDVVRXJKWDWDOOWLPHV7KHVWDWLVWLFDOVLJQL¿FDQFH
was set at P=XVLQJWKH6WXGHQW¶Vt ±test. Data was represented as 
mean, standard error of the mean (SE) and standard deviation (SD) of 
two independent experiments performed in triplicate. Prism software 5 
Gene Symbol Taqman assay ID Accession number 
HPRT 4333768F NM_000194.1 
DEFB1/Hs00174765_m1 Defensin, beta1/HBD1 NM_005218.3 
DEFB4/Hs00823638_m1 Defensin,beta4/HBD2 NM_004942.2 
DEFB103A/Hs00218678
_m1 
Defensin,beta103A/HBD3 NM_018661.2 
CAMP/Hs00189038_m1 Cathelicidin AMP NM_004345.3 
HAMP/Hs00221783_m1 Hepcidin AMP (LEAP 1) NM_021175.2 
LEAP2/Hs00364834_m1 Liver expressed AMP2 NM_052971.2 
Hs00261482_m1 RNase7 NM_032572.3 
Hs02760065_g1 DEF109 NM_001037380 
50 
 
(GraphPad Software, San Diego, CA) was used for graphical 
representation.  
2.3 RESULTS 
AMPs expression in Acanthamoeba-exposed HCLE showed a statistically 
significant up-regulation in 7 of the 8 studied AMPs.  
HBD1 was the only AMP which showed variable decrease in the gene 
expression. It showed reduced expression at all time points with the 
down-regulation at the 6 hour time point (0.6 fold) reaching statistical 
significance (P=0.038, figure  2A). HBD2 gene expression gradually 
increased with a dramatic and significant four folds increase at 9 hours 
(P=0.036, figure 2B). 
HBD3 gene expression showed a significant up-regulation at 3, 6, and 9 
hours (7 folds, 7.5 folds, and 10 folds, respectively) (P= 0.044, 
P=0.00050, P=0.017 respectively, figure 2C). 
HBD9 gene showed a trend towards decreased expression for the first 6 
hours but this did not reach statistical significance. It increased and 
reached a significantly higher level at the 9 hour time point (1.5 fold, 
p=0.002, figure 2D) 
LL37 gene expression varied slightly over the time course with a slight 
but significant increase at the 9 hours time point (p=0.003, figure 2E) 
LEAP1 gene expression was variable at the earlier time points but was 
significantly unregulated at 9 hours (5 folds increase, p=0.001, figure 
2F). 
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LEAP2 gene expression showed a significant down regulation at the 3 
hours time point (p=0.002, figure 2G) and then a statistically 
significant up-regulation at 6 and 9 hours (2 and 3.5 folds increase, 
p=0.033 and 0.0001 respectively, figure 2G). 
RNase7 gene expression showed significant up-regulation at all time 
points; figure 2H), with the highest expression of 3.5 fold at 9 hours 
(p=0.006, figure 2H). 
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Figure 2 The AMPs gene expression in HCLE stimulated with Acanthamoeba castellani. 
(AC: Acanthamoeba castellani, DEFB109: hBD9) (*p value is less than 0.05, **p value 
is less than 0.01, ***p value is less than 0.001). 
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In samples collected at 24 hours, all the HCLEs were lysed and 
meaningful information could be obtained by RT-PCR.   
Quantitative RT-PCR of cDNA obtained from lysate of Acanthamoeba 
castellani maintained in culture for up to 24 hours did not show any 
AMP expression. 
2.4 DISCUSSION 
AMPs are a component of the innate immune defence and as such 
respond early to any external challenge with microbes. These responses 
are known to occur within a few hours of the microbe interacting mainly 
with the toll like receptors of the surface cells (Ueta and Kinoshita, 
2009). Hence I decided to study the responses in the early time points 
following infection (most host cells had lysed when extending the time 
course study to 24 hours and meaningful information could not be 
obtained by RT-PCR).  
The up-regulation of AMPs and other epithelial-derived components of 
LQQDWH LPPXQLW\ HJ LQÀDPPDWRU\ F\WRNLnes, is thought to be a key 
component of an effective defence against infection at the ocular 
surface (Hazlett, 2004). AMPs contribute to the host defence by direct 
action on microbes and also by augmenting other defence pathways via 
host cell stimulation (Huang et al., 2007a). It is also demonstrated that 
AMPs can work synergistically with more than one AMP working 
together in mounting a host defence response. Two or more AMPs 
acting together may have equally potent antimicrobial effects at smaller 
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concentrations. This strategy may be a way of overcoming undesirable 
side effects of AMPs on host cells seen at higher concentrations 
(McDermott, 2009). 
The anti-amoebic effect of specific AMP (Magainins) has been previously 
established (Schuster and Jacob, 1992, Feldman et al., 1991). Schuster 
et al showed that Magainin peptide in combination with silver nitrate 
and/or other antimicrobial agents have in vitro activity against 
Aanthamoeba trophozoites and cysts (Schuster and Jacob, 1992). 
Sacramento et al have recently shown increased permeabilisation of 
Aanthamoeba castellanii ZLWKSHSWLGHVRIĮ-KHOLFDORUǃ-sheeted AMPs. 
Some of these peptides were hydrolysed by Acanthamoeba culture 
supernatants suggesting enzymatic digestion. They suggested use of 
more specific peptides that are resistant to proteolysis produced by the 
organism or the combined use of the AMPs with specific protease 
inhibitors (Sacramento et al., 2009). This study is therefore of 
relevance as the potential to treat Acanthamoeba corneal infections 
with AMPs has been demonstrated.  
This in vitro study demonstrated statistically significant up-regulation of 
7 AMPs out of 8 studied following interaction of epithelial cells with 
Acanthamoeba castellanii.  
HBD3 has independent broad spectrum in vitro antimicrobial activity 
against Gram-negative bacteria, Gram-negative bacteria, fungi and 
some viruses. This action is least affected by salt found in tear film on 
the ocular surface compared with the other AMPs (Harder et al., 2001, 
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Huang et al., 2007a). In this study hBD3 was the most significant, 
almost doubling the gene expression at three hours and showing a ten 
fold increase at 9 hours. This AMP had the maximum increased 
expression of all AMPs studied and the increase also started at an early 
time point. This was followed by LEAP1, hBD2 and RNAse7. At the 9 
hour time point hBD3 expression was two and a half times more than 
hBD2 and RNAse7 and two times that of LEAP1. This up-regulation 
could suggest a specific anti-amoebic role of the hBD3 on the ocular 
surface. 
LEAP1 showed significant up regulation only at the 9 hour time point. 
This AMP was initially noted for its antimicrobial effects and has been 
linked to iron metabolism (Pigeon et al., 2001). Its expression was 
predominantly detected in the liver and to a much lower extent, in the 
heart. It is now recognized for iron homeostasis and through this 
mechanism may contribute to the innate immunity by restricting iron 
availability to microbes (Ganz, 2006) like lactoferrin which is  a known 
constituent of tears (Flanagan and Willcox, 2009).  LEAP1 has 
demonstrable in vitro antibacterial activity against Gram-positive and 
Gram-negative bacteria as well as the yeasts (Krause et al., 2000).  
Like LEAP1, hBD2 also showed up-regulation of the gene expression at 
 KRXUV 7KLV $03¶V H[SUHVVLRQ LV XS-regulated by pro-inflammatory 
cytokines such as TNF-ĮDQG,/-ǃ(Wang et al., 2003). AT the ocular 
surface, hBD2 is known to be inducible in response to Gram-positive 
and Gram-negative bacteria (McDermott, 2009).  It has potent 
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antimicrobial effect against P. aeruginosa and S. aureus (Huang et al., 
2007a). 
HBD1 is constitutively expressed on the ocular surface and its 
expression does not change much with bacterial infection (Huang et al., 
2007a, Abedin et al., 2008). In this study, with Acanthamoeba too, it 
showed down-regulation at all time points. This could be explained by 
the non-inducible nature of this AMP on the ocular surface (McDermott, 
2009) which could indicate a limited antimicrobial role of the hBD1 in 
infectious diseases. 
LL37 has good activity against both Gram-negative and Gram-positive 
bacteria. Additionally, it has antiviral effects when tested in vitro 
(Huang et al., 2007a, Gordon et al., 2005a). However, in response to 
Acanthamoeba, its up-regulation was not as much as has been reported 
with bacteria and may represent a differential response to protozoan 
infection.  
The expression of hBD9 showed in vitro significant up-regulation at 9 
hours with variable down-regulation at early stages. Our group has 
previously shown down-regulation of hBD9 gene expression in patients 
with Acanthamoeba keratitis (Abedin et al., 2008). This down-
regulation could be related to the fact that all the patients with 
Acanthamoeba keratitis were CL wearers. Interaction of hydrophilic 
contact lenses with epithelial cells in vitro has demonstrated a down-
regulation in expression of hBD2 following exposure to P. aureginosa 
(Maltseva et al., 2007)8QOLNHLQVDPSOHVWDNHQIURPSDWLHQWV¶H\HVin 
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vitro exposure to Acanthamoeba showed up-regulation of hBD9 
suggesting that expression of this AMP is susceptible to external 
influences. 
LEAP2 showed early down-regulation at 3 hours then up-regulation at 6 
and 9 hours, though comparatively less than other AMPs. Although, 
LEAP2 in chickens is known to have killing activities against Salmonella 
spp and Gram-positive bacteria (Townes et al., 2009). It is well 
documented that human LEAP2 is not a microbicidal peptide. The 
secondary structure of this AMP has a negative effect on its 
antibacterial activity in humans (Hocquellet et al., 2009). 
RNase7 exhibits broad spectrum antimicrobial activity in vitro against 
several potentially pathogens like Gram-positive bacteria, Gram-
negative bacteria and Candida albicans. Furthermore, RNase7 shows 
extremely high activity against vancomycin-resistant Enterococcus 
faecium (Harder and Schroder, 2002). In our study, RNase7 gene 
expression revealed remarkable early up-regulation in HCLE in 
response to Acanthamoeba castellani. This continued to increase 
gradually. This finding could suggest a possible role of this highly 
cationic AMP in the anti-amoeba activity. 
There was no AMPs gene expression in samples taken from lysate of 
Acanthamoeba alone which confirmed the specificity of the TaqMan 
probes against the human AMPs genes in the HCLE.   
This study provides a comprehensive profile of the ocular surface AMP 
gene expression in response to A. castellani infection. The profile differs 
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from that seen following bacterial infection and illustrates the 
differential expression in response to different organisms. Although, 
IXUWKHUVWXGLHVRIWKH$03V¶SURWHLQH[SUHVVLRQDUHUHTXLUHGWKLVVWXG\
provides the foundation upon which further studies to elucidate anti 
Acanthamoeba activity of specific AMPs. Acanthamoeba infection of the 
cornea is a serious and sight threatening condition with not licensed 
drug available for its treatment. Dilute disinfectant agents such as 
PHMB and chlorhexidine (Dart et al., 2009) are employed in a non-
specific manner. The potential of using AMPs singly or in combination to 
combat this infection is a promising avenue for further exploration.  
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3 Antimicrobial peptide gene expression by 
ocular surface cells in response to 
Pseudomonas aeruginosa and 
Staphylococcus aureus 
3.1 INTRODUCTION 
S. aureus and P. aeruginosa are common causative organisms of 
infectious keratitis. In fact, P. aeruginosa is the leading cause of 
bacterial corneal infections associated with extended contact lens wear 
(Robertson et al., 2007, Willcox and Holden, 2001, Willcox, 2007). Also, 
S. aureus is a commonly isolated bacterium from the corneal infectious 
infiltrates of people with ocular surface diseases and previous ocular 
surgery (Willcox, 2010, Vajpayee et al., 2007). The in vitro bactericidal 
activity of the human AMPs (human defensins and LL37) against Gram-
negative and positive bacteria is well documented (Huang et al., 2007a, 
Huang et al., 2007b, Harder et al., 2001, Sang and Blecha, 2008, 
Garreis et al., 2010a). 
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Although there are several studies on the gene expression of AMPs in 
human corneal epithelial cells challenged with microbial stimuli, there 
are no reports which address differential expression of AMPs in these 
cells in response to different types of bacteria. The aim of this study 
was to characterize the profile of AMP gene expression in human OS 
cells challenged with the Gram-negative bacterium (P.aeruginosa) and 
the Gram-positive bacterium (S. aureus).   
3.2 METHODS 
Aseptic conditions were applied in all in vitro work. The laminar flow air 
hood (Envair, UK) and sterile solutions and containers were used at all 
times.  
3.2.1 Cell culture 
Simian virus (SV) 40 immortalized transformed human corneal 
epithelial cells (HCECs) were a kind gift from Felicity Rose (School of 
Pharmacy, The University of Nottingham, Nottingham, UK). These cells 
were originally obtanined from immortalisation of primary corneal 
epithelial cells following infection with recombinant SV40-adenovirus 
vector (Araki-Sasaki et al., 1995). 
The cells were maintained in cell culture medium (Epilife; Cascade 
Biologics, Paisley, UK) containing human keratinocyte growth 
supplement (HKGS; Cascade Biologics), antibiotic mixture (gentamicin 
and amphotericin B; Cascade Biologics), and anti±mycoplasma agent 
(Plasmocin; Invivogen, Europe). The HCECs were then plated onto 12-
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well culture plates and grown until they reached 70- FRQÀXHQFHLQ
KXPLGL¿HG FRQGLWLRQV  &22 Û& The cellular confluency and 
health was checked by phase contrast microscopy (Nikon Eclipse 
TS100, Japan) (figure 3). 
 
Figure 3. Healthy HCECs with 70% confluence under the microscope 
 
Upon reaching 70-90% confluency, HCECs were passaged. The 
incubating medium was removed and cells were incubated with 5mL of 
TrypLE Express (Invitrogen, UK) for 5 minutes at 37°C to detach. Then 
HCECs were centrifuged for 5 minutes at 250g. The formed cellular 
pellet was then re-suspended in fresh supplemented Epilife medium and 
split appropriately. In this study, cellular passages 8-14 were used. 
Before bacterial exposure, HCECs were starved overnight in HKGS-free 
media.  
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3.2.2 Bacterial exposure/ stimulation of HCECs 
P. aeruginosa and S. aureus derived from pathogenic human ocular 
isolates were used in this study (Kindly obtained from the Microbiology 
department of the Queens Medical Centre, Nottingham). The bacteria 
were cultured in a blood agar media prior to the stimulation studies and 
were then stored in a 1:1 mixture of Brain-Heart Infusion Broth (BHIB) 
and glycerol in -80oC. Prior to experimentation, bacteria were 
inoculated onto blood agar plates and incubated for overnighWDWÛ&
with 5% CO2. Bacteria were then grown in BHIB medium in the orbital 
shaker overnight at 37ÛC. After 24 hours, 5 ml of the culture was 
centrifuged at 112 × g for 15 minutes and, after washing with PBS, the 
pellet was re-suspended in 10 ML of Epilife by vigorous vortex mixing 
and the optical density of the bacterial suspension was measured at 
620 nm and normalised to 0.2 by dilution in Epilife. The cytotoxic 
effects of serial dilutions of the bacterial suspension on HCECs were 
assessed microscopically. With both bacterial isolates, dilutions of 1:8 
or higher were found to have no observable effects on cell morphology 
after 24 h of incubation. Henceforth, a 1:10 dilution of the suspension 
was used to challenge HCECs. The colony forming units (CFU) of each 
suspension were determined retrospectively by plate count to be 1.3 × 
107 and 2.1 × 107 CFU for S. aureus and P. aeruginosa, respectively. 
Subsequently, confluent HCECs were incubated with 1.5 ml of P. 
aeruginosa or S. aureus suspensions and samples of HCECs were 
collected at 1, 3, 6 and 9 hours. Control samples were obtained from 
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non-stimulated HCECs. At each time point, the culture media was 
removed and 700 µl of RLT buffer (Qiagen) was added to each well for 
15 minutes until the cells were fully solubilised and the lysate was 
collected and stored at -80o C. Also, the supernatant suspension of P. 
aeruginosa and S. aureus (without HCEC cells) were collected 
separately and centrifuged for 2 mins at 287 × g. 700 µl of RLT buffer 
(Qiagen) was added and the samples were kept at -80o C for further 
analysis. All tests were done in triplicate with cells at the same cell 
passage number.  
3.2.3 Isolation of total RNA and cDNA synthesis.  
Total RNA was extracted from RLT lysate using the RNeasy Mini kit. 
Furthermore, reverse transcription into cDNA of 4 Pg of template RNA 
was carried out. A comprehensive description of the used protocol has 
been mentioned in details in Chapter two. 
3.2.4 Quantitative RT-PCR 
RT-PCR analysis was performed to measure the relative gene 
expression of the following AMPs: hBD1-3 and 9, LL37, LEAP1 and 2 
and RNase7. Detailed description of the RT-PCR protocol has been 
mentioned in Chapter two.  
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3.3 RESULTS 
3.3.1 Modulation of AMPs gene expression in 
HCEC cells in response to challenge with 
P. aeruginosa:  
AMPs gene expression in HCECs stimulated with P. aeruginosa showed 
a statistically significant up-regulation in 5 of the 8 AMPs targeted in 
this study (figure 4). Only hBD9 and LEAP1 showed early and 
significant decreases in gene expression. Indeed, hBD9 was 
significantly down-regulated at 1 and 3 hours (figure 4D), whereas 
LEAP1 showed statistically significant decreases at all time points 
(figure 4F). While the gene expression of LEAP2 was variably increased 
(figure 4G), the mRNA level of hBD1, hBD2, hBD3, RNase7 and LL37 
was significantly up-regulated, with LL37 reaching 10-fold increase at 6 
hours (figure 4E).  
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Figure 4. AMP gene profile in HCEC challenged with Pseudomonas aeruginosa. PA: 
Pseudomonas aureuginosa, hBD: human beta defensin, LL37: human cathelicidin, 
LEAP: Liver expressed antimicrobial peptide, RNase7: Ribonuclease 7.  X axis shows 
time points in hours (H). (*p value is less than 0.05, **p value is less than 0.01, ***p 
value is less than 0.001) 
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3.3.2 Modulation of AMPs gene expression in 
HCEC cells in response to challenge with 
S. aureus:  
Each of the studied AMPs showed an overall up-regulation but only 
hBD3, LL37, LEAP2 and RNse7 reached statistical significance at 6, 1, 6 
and 6 hour, respectively (figures 5C, 5E, 5G and 5H, respectively). 
Although it was not statistically significant, only the mRNA of hBD9 
showed an immediate increase at 1 hour followed by a gradual decline 
thereafter (figure 5D).  
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Figure 5. AMP gene expression in HCECs challenged with Staphylococcus aureus. SA: 
Staphylococcus aureus, hBD: human beta defensin, LL37: human cathelicidin, LEAP: 
Liver expressed antimicrobial peptide, RNase7: Ribonuclease 7.  X axis shows time 
points in hours (H). (*p value is less than 0.05, **p value is less than 0.01, ***p value 
is less than 0.001) 
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For all samples, RT-PCR did not detect a product when reverse 
transcriptase was not used during cDNA synthesis thus excluding 
primer binding to genomic DNA and confirming the specific 
amplification of only cDNA (negative control). Similarly, no products 
were generated during negative control RT-PCR reactions of cDNA 
obtained from lysates of P. aeruginosa, or S. aureus maintained in 
culture for 24 hours in the absence of HCECs. 
3.4 DISCUSSION 
At the OS, AMPs form a main component of the innate immune system 
and play a role in protecting the ocular surface from environmental 
challenges besides bridging the innate and adaptive immune systems. 
Interactions between pathogen-associated molecular pattern molecules 
(PAMPs) and host cell pattern recognition receptors (PRRs) such as the 
toll like receptors (TLRs) are considered to be the first step in initiating 
the production of cytokines, other stimulatory factors and AMPs, thus 
initiating innate and adaptive immunity (Mogensen, 2009, Janeway and 
Medzhitov, 2002). At the OS, AMPs are mainly secreted from corneal 
and conjunctival epithelial cells and the neutrophils. Up-regulation of 
$03V DQG LQÀDPPDWRU\ F\WRNLQHV LV FRQVLGHUHG WR EH WKH NH\ WR
achieving effective protection against invading microbes at the OS 
(Hazlett, 2004, Garreis et al., 2010a, Wiesner and Vilcinskas, 2010). 
AMPs participate in innate defence either through direct microbicidal 
activity or by augmenting other defence pathways resulting from 
cellular stimulation (Huang et al., 2007b, McDermott, 2009). More than 
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one AMP can work synergistically to achieve potent microbicidal activity 
at lower concentrations than those required for AMPs acting alone. In 
this way the harmful side effects of AMPs on host cells seen at higher 
concentrations might be minimised (McDermott, 2009, Cassone and 
Otvos, 2010). 
The AMP response to any external insult or microbial invasion is known 
to occur at an early stage; typically these responses occur within a few 
hours of the microbe interacting with the toll like receptors of the 
surface cells (Ueta and Kinoshita, 2009, McDermott, 2009). Of note, 
the in vitro production of hBD3 in response to bacterial challenge is 
exceedingly fast and can occur within minutes of exposure (Garreis et 
al., 2010b). 
In chapter two, the profile of ocular AMPs gene expression in an 
immortalized HCLE challenged with Acanthamoeba castellani was 
shown. All the studied AMPs (except for hBD1) showed significant up-
regulation at a late time point (9 hour) with hBD3 reaching the highest 
levels (10-fold increase) (Otri et al., 2010). Similar comprehensive 
information on the profile of AMP expression following exposure to 
bacterial pathogens is not known. Hence I studied the expression of a 
range of AMPs by corneal epithelial cells challenged with P. aeruginosa 
and S. aureus.  
The obtained data in this study showed that all the studied AMPs were 
constitutively expressed by un-challenged HCEC. The constitutive 
expression of hBD1-3 (McIntosh et al., 2005, McDermott, 2004), hBD9 
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(Abedin et al., 2008, Mohammed et al., 2010a), LL37 (McIntosh et al., 
2005, McDermott, 2004), LEAP 1 & 2 (McIntosh et al., 2005) and 
RNase7 (Mohammed et al., 2010b) in OS cells has been previously 
reported. However, the inducible nature of the hBD3 production has 
also been reported by McIntosh et al who detected a greater 
percentage of hBD3 in OS cultures taken from infected corneas than in 
those from healthy corneas (McIntosh et al., 2005). Moreover, hBD2 
expression was also found to be inducible by conditions mimicking 
injury, inflammation and in response to bacterial products (Gordon et 
al., 2005b, Narayanan et al., 2003, McDermott et al., 2001, McDermott 
et al., 2003, Haynes et al., 1999). 
This study showed an overall up-regulation of 6/8 and 8/8 of the 
studied AMPs following HCEC challenge with P. aeruginosa and S. 
aureus, respectively. This increase was statistically significant in 5 AMPs 
for P. aeruginosa treated cells group and in 4 AMPs for S. aureus-
treated cells. LL37 and hBD2 showed the highest levels of up-regulation 
in both groups, with 9- and 4- fold increases, respectively. The 
expression profiles of the AMPs that were up-regulated were largely 
similar but not identical in cells treated with the two microbes, 
suggesting that the cell response is in part specific for the invading 
organism. This may reflect the different spectrum of PAMPs present on 
Gram-negative and Gram-positive bacteria (Mogensen, 2009).  
HBD1 was up-regulated in the both the P. aeruginosa and S. aureus 
groups reaching statistical significance only in the P. aeruginosa 
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category at the 3 hour time point. Notably, the expression of this gene 
was modest, which is in line with the findings of others. It has been 
reported that hBD1 is constitutively expressed at the ocular surface and 
its expression does not change much with bacterial infection (Huang et 
al., 2007a, Abedin et al., 2008, McDermott, 2009). Moreover, Yuan et 
al have demonstrated the initial down-regulation of hBD1 at the murine 
OS with fungal keratitis. (Yuan et al., 2010) The relative lack of 
responseness of hBD1 gene expression to the bacterial pathogens is 
perhaps not surprising as it has been reported to have only modest 
antimicrobial activity against P. aeruginosa and no activity was detected 
against S. aureus (Huang et al., 2007a). 
At the ocular surface, hBD2 has been known to be inducible in response 
to bacterial infections (Harder et al., 1997) and HCECs have been 
shown to up-regulate hBD2 in response to S. aureus or its exoproducts 
in a TLR2-dependant manner (Kumar et al., 2006) or in response to 
infection with P. aeruginosa (Kumar et al., 2007b, Garreis et al., 
2010b). It is also up-regulated by pro-inflammatory cytokines such as 
TNF-ĮDQG,/-ǃ(Wang et al., 2003, Haynes et al., 1999). According 
to this study, the gene levels of hBD2 showed overall increase in 
response to both microbes, which was statistically significant only in the 
P. aeruginosa group. In accordance with this finding, it has been 
previously reported that hBD2 has only good anti-bacterial activity 
against P. aeruginosa with weak activity against S. aureus strains 
(Huang et al., 2007a). However, Garreis has found that supernatants of 
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P. aeruginosa and S. aureus have significantly up-regulated hBD2 
expression in corneal epithelial cells (Garreis et al., 2010b).  
HBD3 showed gradual but significant increase in gene expression in P. 
aeruginosa treated cells reaching its highest levels at 6 hours of 2.5-
fold. This gene also showed gradual and significant increase in the S. 
aureus treated cells at 6 hour time point. It is known that bacterial 
supernatant such as S. aureus induces hBD3 expression in corneal 
epithelial cells suggesting that hBD3 directly participates in innate 
immune defence (Garreis et al., 2010b). Moreover, hBD3 has 
independent broad spectrum in vitro antimicrobial activity against 
Gram-negative and Gram-positive bacteria, fungi and some viruses. 
Indeed, hBD3 has good activity against both P. aeruginosa and S. 
aureus supporting its antimicrobial role and indicating an important role 
in ocular surface defence (Huang et al., 2007a). The action of this AMP 
is least affected by salt found in tear film on the OS compared with the 
other AMPs (Dhople et al., 2006, Harder et al., 2001, Huang et al., 
2007c, Batoni et al., 2006, Garreis et al.).  
When stimulating the corneal epithelial cells with P. aeruginosa, hBD9 
gene expression showed significant down-regulation at all time points. 
In S. aureus treated cells early up-regulation was observed, which 
gradually and steadily decreased. Interestingly, our group has 
previously shown an ex vivo down-regulation of hBD9 gene expression 
in impression cytology samples taken from patients with infectious 
keratitis and dry eye syndrome (Abedin et al., 2008). Premratanachai 
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et al have reported the down-regulation of hBD9 after in vitro 
stimulation of gingival keratinocytes with Candida albicans 
(Premratanachai et al., 2004). Recently, an initial increase in hBD9 
P51$ OHYHOV IROORZHG E\ D VLJQL¿FDQW GRZQ-regulation in response to 
PAMPs and inflammatory cytokines stimulation has also been reported 
(Mohammed et al., 2010a). 
The gene expression of LL37 was significantly increased in all the P. 
aeruginosa and S. aureus treated cells, showing the highest levels of 
up-regulation in HCEC challenged with P. aeruginosa (9-fold at 6 
hours). Previous studies too have shown LL37 to effectively protect the 
ocular surface from P. aeruginosa infections (Redfern et al., 2011). 
Indeed, LL37 has in vitro bactericidal activity against both Gram-
negative and Gram-positive bacteria in addition to its anti-viral effect 
(Huang et al., 2007a, Gordon et al., 2005a).  LL-37 also has a 
FKHPRWDFWLFHIIHFWRQOHXNRF\WHVVWLPXODWLQJLQÀDmmation (Befus et al., 
1999, Niyonsaba et al., 2001, Mendez-Samperio, 2010). Redfern et al 
have recently reported that the production of LL37 is stimulated by the 
TLR agonists which may play a role in providing the ocular surface with 
direct defence against various pathogens and stimulating the innate 
and adaptive immunities through the immune and inflammatory 
activities (Redfern et al., 2011, Mendez-Samperio, 2010). Huang et al 
has also reported that LL-37 can induce cellular migration and 
production of inflammatory mediators following injury or insult to the 
ocular surface (Huang et al., 2007a, Mendez-Samperio, 2010).    
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The expression of the LEAP1 gene was significantly down-regulated in 
P. aeruginosa-treated cells but did not change in S. aureus-treated 
cells. LEAP1 has demonstrable in vitro antibacterial activity against 
Gram-positive, Gram-negative bacteria and yeasts (Krause et al., 
2000). Specifically, it has potent bactericidal effects against both P. 
aeruginosa and S. aureus. Its expression was predominantly detected 
in the liver and to a much lower extent, in the heart (Krause et al., 
2000). It is now recognized for its physiological role in iron homeostasis 
and through this mechanism may contribute to the innate immunity by 
restricting iron availability to microbes (Ganz, 2006, Pigeon et al., 
2001). At the ocular surface its role as an antibacterial agent may be 
limited but may have a greater role against virus infections, as reported 
by Abedin et al. (Mohammed et al., 2011) 
LEAP2 was up-regulated in all samples but showed a statistical 
significance only in S. aureus-treated cells (though comparatively less 
than other AMPs). Although, LEAP2 have killing activities against 
Salmonella species and Gram-positive bacteria in chickens (Townes et 
al., 2009), it is well documented that human LEAP2 lacks microbicidal 
properties (Hocquellet et al., 2009). 
The RNase7 gene showed early, consistent and statistically highly 
significant up-regulation in cells treated with either pathogen, reaching 
its highest levels in P. aeruginosa-treated cells (5 folds at 1 hour). 
Levels of expression remained elevated throughout the 9-hour 
experimental period in P. aeruginosa-treated cells, but fell back to close 
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to untreated levels by 9 hours in S. aureus-treated cells. RNase7 
exhibits broad spectrum antimicrobial activity in vitro against Gram-
positive bacteria including S. aureus, Gram-negative bacteria including 
P. aeruginosa, and the yeast Candida albicans (Harder and Schroder, 
2002). Notably, RNase7 shows extremely high activity against 
vancomycin-resistant Enterococcus faecium (Harder and Schroder, 
2002, Torrent et al.). The constitutive presence of RNase-7 (both 
protein and mRNA) on human ocular surface was previously reported 
by our group. This expression was increased in response to IL-ǃ
suggesting an active UROHGXULQJLQÀDPPDWLRQUHODWHGWRRFXODUVXUIDFH
infection (Mohammed et al., 2010b). Reithmayer and co-workers 
detected increased levels of RNase7 in normal human scalp skin treated 
with LPS of P. aeruginosa or Escherichia coli, lipoteichoic acid (LTA) 
from Streptococcus pyogenes RUÀDJHOOLQ(Reithmayer et al., 2009). 
This study provides a comprehensive profile of the OS AM3V¶ JHQH
expression in response to important Gram-negative (P. aeruginosa) and 
Gram- positive (S. aureus) bacterial pathogens. The differences in the 
AMP expression profile between these two pathogens illustrates the 
differential expression in response to different organisms, which is likely 
to be a reflection of the different PAMPs associated with these 
pathogens, and their respective PRRs. The potential of using AMPs 
singly or in combination to combat ocular infections is a promising 
avenue for further exploration. 
  
76 
 
 
4 Variable Gene Expression of Human Beta 
Defensins 3 and 9 at the Human Ocular 
Surface in Infectious Keratitis. 
4.1 INTRODUCTION: 
In this chapter the gene expression of hBD3 and 9 in patients with 
infectious keratitis was studied. Impression cytology (IC) was used as a 
method in obtaining the OS samples from those patients.  
IC is a minimally invasive technique of harvesting the superficial layers 
of the ocular surface epithelium by the application of specially designed 
membrane (Singh et al., 2005). It was first described by Egbert et al as 
a minimally invasive conjunctival biopsy (Egbert et al., 1977). By 
comparison, conjunctival biopsies destroy much of the morphological 
information whereas cellulose acetate filter paper preserves its 
morphology and permits the use of histological techniques. Practically, 
impression cytology refers to the application of a piece of biologically 
inert nitrocellulose membranes containing a small amount of cellulose 
acetate filter over the surface of the eye to get the superficial 2 to 3 
layers of the conjunctival or corneal epithelium. The nitrocellulose filter 
is negatively charged. DNA is negatively charged due to the phosphate 
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backbone and will not stick to the nitrocellulose on its own, however, 
any DNA that has been bound by protein (which has positive charge) 
will bind to the membrane (Helwa and Hoheisel, 2010). Originally, IC 
has been used for evaluation of the degree of squamous metaplasia 
and goblet cell numbers in ocular surface diseases such as dry eye, 
Stevens±Johnson syndrome, pemphigoid, and vitamin A deficiency, and 
the effect on these of various therapies. It has also been used to 
demonstrate corneal epithelial abnormalities, including the presence of 
goblet cells indicating a stem cell deficiency disorder (Dart, 1997) 
Recently, this technique has undergone a lot of modifications so it can 
be used to make clinical, molecular and histopathological diagnosis 
(Thiel et al., 1998, Singh et al., 2005, Tseng, 1985). It has been widely 
used to evaluate the gene expression of AMPs on the OS by using RT-
PCR (Connor et al., 1991, Singh et al., 2005).  
HBD9 is a recently discovered AMP at the human OS by our group 
(Abedin et al., 2008). In contrast to most other AMPs, it showed 
reduced ex vivo gene expression in patients with infectious keratitis and 
dry eye disease compared to the healthy controls (Abedin et al., 2008). 
In a previous study, our group showed variable hBD9 gene expression 
in response to activation of innate immune effectors (Mohammed et al., 
2010a). Moreover, in chapter two, it was demonstrated that the in 
vitro gene expression of hBD9 was variably down-regulated at early 
time points and then up-regulated at later time points in human corneal 
epithelial cells co-cultured with Acanthamoeba castellanii (Otri et al., 
2010). Also in chapter three, hBD9 showed an early and significant 
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decrease in its mRNA level in HCECs exposed to P. aeruginosa whereas 
it was variable up-regulation and then gradual down-regulation in cells 
treated with S. aureus.    
HBD3 has an independent broad spectrum in vitro antimicrobial activity 
(Huang et al., 2007a, Harder et al., 2001). In a chapter two, the in 
vitro gene expression of hBD3 was shown to increase about ten fold in 
HCLE challenged with Acanthamoeba castellanii. This increase was the 
highest among the AMPs studied (Otri et al., 2010). Furthermore, as 
shown in chapter three, its gene expression was significantly up-
regulated in OS cells treated with P. aeruginosa and S. aureus.  
Therefore, a conclusion that hBD3 and hBD9 may play significant roles 
in infection control and onset was drawn. Studying their roles during 
microbial infection may lead to a further understanding of the 
mechanisms by which infectious organisms overcome host defences to 
cause infection. Based on the previous results and to improve the 
understanding of the hBD9 and hBD3 roles in response to infection or 
inflammation, I sought to further investigate the ex vivo gene 
expression of these AMPs at the ocular surface. This gene profile was 
studied in patients with different eye infections before and after 
treatment compared to healthy controls.  
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4.2 METHODS 
4.2.1 Overview 
Human OS specimens were obtained by IC from healthy controls and 
patients with Acanthamoeba and Gram negative and positive bacterial 
keratitis, both during active infection and after healing (details are 
mentioned later). The RNA extraction was optimized to improve the 
RNA yield from impression cytology samples. When good quality RNA 
and quantity was obtained, the gene expression of hBD3 and 9 was 
determined using quantitative RT-PCR.  
4.2.2 Ethical approval 
Research was conducted in accordance with the tenets of the 
Declaration of Helsinki. Local ethics committee and National Health 
Service Trust had approved all research (reference number: 
OY100201). 
4.2.3 Impression cytology samples collection 
Following due consent from patients, impression cytology samples were 
collected from healthy controls and patients with infectious keratitis 
during the acute fresh infection and 2-3 weeks after of complete 
healing. This was defined by complete resolution of the clinical infection 
and inflammation which correlates with complete cessation of any 
antibiotic treatment (clinical details of the studied samples are 
mentioned later). Briefly, the cellulose ester filter of pore size 0.45 µm 
was used (Millipore Corporation, Bedford, MA). Each filter disc with a 
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diameter of 13 mm was cut into two halves which were applied to the 
upper OS under topical anaesthesia (Proxymetacaine hydrochloride 
0.5% minims) (Bausch and Lomb, Surrey, UK). The discs were applied 
to cover the upper bulbar conjunctiva and adjacent limbus and 
peripheral cornea, at a site distal to the actual ulcer or abscess (when 
applicable) for 30 seconds and gently peeled off. To obtain the 
maximum yield of RNA, each area was sampled twice using separate 
filters applied sequentially to the same site. The second filter allowed us 
to sample the cells in the deeper layers as well. Cells from both filters 
were then combined in one tube. The samples were stored in RLT buffer 
(Qiagen, Crawley, UK) at -80 °C until RNA extraction. Later, after 
optimizing the RNA extraction, samples were kept in RNA later buffer 
(Qiagen, Crawley, UK) instead of RLT buffer. The samples were then 
stored at -80 °C until RNA extraction. 
4.2.4 Extraction of total RNA 
4.2.4.1 The original method in extracting the RNA 
Total RNA was isolated using RNeasy minikit according to the 
PDQXIDFWXUHU¶V LQVWUXFWLRQV After thawing out the samples in RLT 
buffer, the tubes were briefly vortexed and then the filters were 
removed. The left cellular lysates were homogenized with a QIA-
shredder spin column and mixed with 70% ethanol in equal volume 
(1:1). The mixture was then applied onto spin columns and centrifuged 
DW  J IRU  VHFRQGV 7KH ¿OWUDWH ZDV GLVFDUGHG DQG WKH VSLQ
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column was washed with buffer RW1 and then with buffer RPE by 
centrifugation. Total RNA was eluted in 12 µl of RNase-free water.  
4.2.4.2 The optimized method in extracting the RNA 
This method of RNA extraction was used after failing in getting good 
yields of RNA according to the original method.  
Promptly after removing the filter from the ocular surface, it was dipped 
into a tube with RNA later solution to protect the cellular RNA from 
degradation. The samples were then stored at -80o degree till further 
analysis. At the time of RNA extraction, the sample was thawed out on 
ice, and then the filter was removed and immersed in RLT lysis buffer in 
a separate tube. The residual RNA later buffer was spun down for 5 
minutes at 134000 g, then the buffer was discarded and a RLT lysis 
buffer was added to the pallet and kept in a second tube (to preserve 
the residual cells in the RNA later buffer). The two tubes were left for 
about 10 minutes and then vortexed for 5 minutes, spun for 30 seconds 
at 134000 g. The filter was removed from the first tube and the lysed 
samples in both tubes were combined together in one tube. The lysates 
were then homogenized with a QIA-shredder spin column. The rest of 
the steps of the RNA extraction was performed as mentioned previously 
using the RNeasy Mini Kit and RNeasy Micro Kit (according to the 
original method of RNA extraction mentioned before).  
82 
 
4.2.5 RNA quality and quantity control 
The ultra violet (UV) light absorbance of the eluted RNA and the 
contaminants at 280 and 260 nm wavelengths were assessed using the 
Nanodrop Spectrophotometer 7KHUPR)LVKHU6FLHQWL¿F.  
For the IC samples, RNA quantity was considered as good when it 
measured a value of 45 QJǋO RU PRUH. Also, good RNA quality was 
ascertained when the A260/A280 ratio showed a value of more than 1.8 
(Fleige and Pfaffl, 2006). These previous readings were established 
depending on a previous optimization study at our department and 
based on Weichenhan protocol 
(http://www.science.ngfn.de/dateien/RNA_quality_and_quantity_contro
l.pdf).  
4.2.6 Complementary DNA synthesis 
Reverse transcription of 500 ng template RNA into cDNA was carried 
RXW DFFRUGLQJ WR WKH PDQXIDFWXUHU¶V LQVWUXFWLRQV (Quantitect Reverse 
Transcription kit, Qiagen). Using this reverse transcription kit template 
RNA was mixed with genomic DNA wipeout buffer (Qiagen) on ice, and 
the volume was adjusted with water. The mixture was incubated at 
42°C for 3 minutes on the thermal cycler (Hybaid Ltd). The reaction 
then was placed on ice. The reverse transcription enzyme mix 
(Quantitect reverse transcriptase, Quantitect RT buffer, and RT primer 
mix; Qiagen) was prepared on ice and mixed with total RNA mixture. 
7KH¿QDOPL[WXUHZDVWKHQLQFXEDWHGRQWKHWKHUPDOF\FOHUDW&IRU
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30 minutes, followed by reverse transcriptase deactivation at 95°C for 
3 minutes. Samples were stored at -20°C until further analysis. The 
RNA and cDNA in each impression cytology sample were analysed 
individually and processed for the RT-PCR. In each experiment, one 
sample without reverse transcriptase was prepared to act as a negative 
control. 
4.2.7 Quantitative real-time polymerase chain 
reaction (Taqmann assay) 
As mentioned previously, aseptic conditions were applied while 
preparing the RT-PCR samples. Quantitative RT-PCR analysis was used 
to measure the relative gene expression of the human beta defensins 3 
DQG  K%' DQG K%' DFFRUGLQJ WR WKH PDQXIDFWXUHU¶V SURWRFRO
(Applied Biosystems) and to methods established in our department 
and reported previously (Abedin et al., 2008). Briefly, pre-optimised 
Taqman gene expression assays (Applied Biosystems) were used to 
study each defensin gene and the endogenous control (HPRT). RT-PCR 
reactions were run on a 96-well optical plate (Stratagene) in the 
Mx3005p real-time PCR system (Stratagene). For each sample, the RT-
PCR experimental setup was carried out as detailed in the 
PDQXIDFWXUHU¶VSURWRFRO$SSOLHG%LRV\VWHPV ,QLWLDOO\ WHPSODWHF'1$
was diluted to 1:2 using nuclease-free water to perform the RT-PCR in 
triplicate. Each reaction was prepared to 20  /¿QDO UHDFWLRQ YROXPH
with 10  µL of 2× gene expression master mix, 1  µL of 20× assay 
(primers and probe mix; TaqMan; Applied Biosystems), 5  µL diluted 
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cDNA, and 4  µL nuclease-free water. Appropriate negative (non-
template control and reverse transcriptase control) and positive (HPRT) 
controls were also run in each experiment.  Each 96-well plate was run 
with the gene of interest and respective endogenous control (HPRT). 
The samples were run in triplicate. Non-template and reverse 
transcriptase samples were used as negative controls, whereas and 
HPRT was used as endogenous positive control in each experiment.  
The thermal profile of the RT-PCR cycles was previously described in 
details (in chapter 2). Detailed information about the genes used in 
this study is given in table 1. 
Table 3. Details of genes and accession numbers used in the study (Applied 
Biosystems, Europe) 
Gene symbol Taqman assay ID Accession number 
HPRT 4333768F NM_000194.1 
DEFB103A/Hs00218678_m1 Defensin, beta103A/hBD3 NM_018661.2 
Hs02760065_g1 DEFB109 (hBD9) NM_001037380 
 
4.2.8 Data analysis 
The raw RT-PCR data were acquired using the MxPro software (version 
4.01; Stratagene, UK) and then transported to an Excel spreadsheet. 
The help of a statistician was sought at all times. Depending on the 
2íƩƩ&7 formula, the RT-PCR data were statistically analysed. The 
resultant data was statistically analysed by the Kruskal-Wallis non-
parametric statistical analysis test assuming a non-Gaussian 
distribution of data. Dunn's Test was also used to compare multiple 
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groups. The statistical significance was set at p<0.05. Prism software 5 
(GraphPad Software, San Diego, CA) was used for graphical 
representation.  
4.3 RESULTS 
4.3.1 The RNA yield using the original and the 
optimized methods 
During the first year of our study, 123 impression cytology samples 
(taken from 91 subjects) were analysed (without using the RNA later 
buffer). There were 74 samples taken from healthy controls and 49 
samples obtained from patients with infectious keratitis. All these 
samples showed poor RNA quantity (less than 45 ng/µl) (figure 6).  The 
mean RNA readings were 21±17 ng/µl. These samples were all 
excluded from our RT-PCR analysis.  
After using the optimized method in RNA extraction the RNA readings 
showed a better mean value of 69±59 ng/µl (figure 7).  A total of 89 
impression cytology samples were analysed (29 healthy controls, 31 
patients with active infectious keratitis and 29 patients post healing). Of 
these, only 60 IC samples were processed to RT-PCR analysis (as the 
others showed low RNA yield) and were included in this study. In 
details, there were 24 samples taken from healthy controls (as control 
samples were run with each batch of infected samples, the controls 
were obtained from the same eight healthy volunteers).  Also, 18 
samples from 18 patients were collected during different types of active 
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ocular infection and 18 further samples from the same patients after 
complete healing. Five samples (2 Acanthamoeba keratitis, 2 gram 
negative [1 Kleibsella spp., 1 P. aeruginosa], and 1 gram positive [S. 
aureus] bacterial infections) were excluded from the study due to poor 
post-treatment RNA yields. Details are provided in table 4.  
All samples included in this study showed good RNA quantity (more 
than 45 ng/µl) and quality (A260/A280 ratio of about 2) (figure 7). 
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Figure 6. Poor samples of extracted RNA using the original method of RNA extraction 
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Figure 7. Good samples of extracted RNA using the optimized RNA extraction method 
 
4.3.2 Disease diagnosis 
Disease diagnosis was validated by microbiological examination of the 
corneal scrapings in all cases; except for 3 cases of Acanthamoeba 
keratitis, where the diagnosis was based on the clinical manifestations 
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and distinct double wall cysts on in vivo confocal microscope (IVCM) as 
has been previously reported (Alomar et al., 2009). Details of the 
isolated organisms are elaborated in table 4. 
Table 4. Causative organisms and number of impression cytology samples taken in 
each group.  Spp: species. IVCM: in vivo confocal microscopy. Figures in parentheses in 
middle column are the number where RNA yield was sufficient for analysis. 
Diagnosis During Active infection 
After complete 
healing 
Healthy 
Controls 
Acanthamoeba   
7 
(4 culture positive 
3 IVCM) 
7 (5) 
 
8 
Gram-negative 
bacteria 
6 
(3 Pseudomonas aeruginosa 
1 Haemophilus influenzae, 1  
Moraxella  spp 
1  Kleibsella spp) 
6 (4) 
 
8 
Gram-positive 
bacteria 
5 
(3 Staphylococcus aureus 
2 Pneumococcus spp.) 
5 (4) 
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4.3.3 Gene analysis 
RT-PCR analysis was carried out for hBD3 and hBD9 expression in a 
total of 24 samples from healthy controls 18 samples from active 
keratitis and 13 samples post healing (after excluding 5 cases with low 
RNA yield). 
4.3.3.1 Relative gene expression of hBD3 
HBD3 showed low level of gene expression in all normal control 
subjects. Its expression was up-regulated during all types of acute 
infectious keratitis. This was significantly increased compared to 
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controls (P< 0.05) during acute Acanthamoeba keratitis (about 120 
fold) and returned to almost the level of the control after healing (figure 
8A). Although it was not statistically significant, there was an overall 4 
and 10 fold increase in the gene expression of hBD3 during Gram 
negative and positive bacterial keratitis, respectively. This expression 
showed down-regulation following treatment (which was significant in 
gram positive bacterial infection). Expression almost returned to the 
initial level of healthy subjects after healing of gram negative bacterial 
keratitis (figure 8B). Interestingly, the gene expression of hBD3 showed 
significant further reduction compared to levels in healthy controls after 
treatment of Gram positive infection (figure 8C). 
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Figure 8. Relative gene expression of hBD3 in impression cytology samples taken from 
patients with Acanthamoeba keratitis, Gram negative and positive bacterial keratitis 
compared to healthy controls. (* = p value is less than 0.05) 
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4.3.3.2 Relative gene expression of hBD9 
Assessing hBD9 expression in patients with acute Acanthamoeba 
keratitis, demonstrated significant down regulation (50 fold, P< 0.05), 
which increased again after healing, but not to the level observed in 
healthy controls (figure 9A). Also, in Gram negative bacterial keratitis, 
hBD9 expression modestly decreased during infection and returned to 
near control level following complete healing (figure 9B). In Gram 
positive bacterial keratitis, there was significant 5 fold down-regulation 
in the gene expression during active infection (P< 0.05) which showed 
further decrease after healing (P< 0.05) (figure 9C). 
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Figure 9. Relative gene expression of hBD9 in impression cytology samples taken from 
patients with Acanthamoeba keratitis, Gram negative and positive bacterial keratitis 
compared to healthy control. (* = p value is less than 0.05) 
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4.4 DISCUSSION 
Initially, low yields of RNA were repeatedly obtained in all samples 
taken from the OS of the healthy subjects and patients with infectious 
keratitis. All these samples were excluded from my study leading to a 
failure in recruiting any patients during the first 12 months. In an 
attempt to tackle this problem, RNA later was used depending on 
previous reports which showed its role in preserving the RNA and 
improving its quantity (Sikulu et al., 2011, Freidin et al., Linnarsson, 
2010). Also, vortexing and spinning of the IC filters down were 
introduced depending on a previous experience of one of senior 
lecturers at the Microbiology department at the University of 
Nottingham to provide an effective separation of the OS cells.  
This led to the optimized method in the RNA extraction which improved 
the quantity and quality of the analysed RNA in most cases. However, 
some samples still produced poor RNA yield mainly because of the poor 
cellular yield obtained from infected eyes. Indeed, it was not possible to 
get any good sample from eyes tearing excessively as this prevented 
adherence of the filter paper to the ocular surface. Using the previous 
novel method in optimizing the RNA extraction improved the mean RNA 
quality obtained from 21±17 to 69±59 ng/µl with all samples showing a 
A260/A280 ratio of more than 1.8.  
After the succeeding in improving the RNA yields, RT-PCR analysis of 
the impression cytology was performed. The main purpose was to 
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measure the mRNA of hBD9 and hBD3 in patients with ocular infections 
(during and after the infection) compared to healthy controls.  
The antimicrobial activity of hBD3 but not hBD9 proteins is well 
established (Huang et al., 2007a, Garreis et al., 2010b). Indeed, hBD3 
protein has in vitro bactericidal activity against P. aeruginosa and S. 
aureus. This effect is salt independent, which implicates an active in 
vivo antimicrobial potency in the presence of tears (McDermott et al., 
2006, Harder et al., 2001).  In addition, hBD3 has been linked to the 
initiation of the adaptive immune response through its ability to 
activate dendritic cells in the cornea and conjunctiva (McDermott, 
2009). These multiple roles of hBD3 at the OS are consistent with its 
up-regulation in all cases of acute infectious keratitis, both bacterial 
and Acanthamoeba, demonstrated in this study. When compared with 
healthy controls, it showed a statistically significant 122 fold increase in 
acute Acanthamoeba keratitis, while it showed only 4 and 10 fold up-
regulation in Gram-negative and Gram-positive bacterial keratitis 
respectively. The expression decreased rapidly in all the studied groups 
after healing, returning to almost normal level (controls). Such a 
decrease in AMPs gene expression after the initial up-regulation during 
the acute stage of infection has been previously reported for murine 
fungal keratitis (Yuan et al., 2010). The significant ex vivo up-
regulation of hBD3 gene in patients with acute Acanthamoeba keratitis 
is in keeping with my previous study (chapter two) where hBD3 gene 
expression was shown to up-regulate most significantly among the 
studied AMPs in HCLE treated with Acanthamoeba castellanii 
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trophozoites (showing a 10 fold increase) (Otri et al., 2010). This 
consistent and significant ex vivo and in vitro up-regulation of hBD3 
gene during Acanthamoeba infections could suggest a specific anti-
amoebic role of this gene on the ocular surface. The potential role of 
AMPs as anti-amoebic treatment was previously reported (Feldman et 
al., 1991, Schuster and Jacob, 1992, Sacramento et al., 2009). 
Fieldman and co-workers have shown that the in vitro combination of 
Magainin (a host defense AMP) with silver nitrate is active against 
Acanthamoeba trophozoits and cysts (Feldman et al., 1991). Recently, 
Sacramento et al (Sacramento et al., 2009) reported that beta defensin 
induces permeabilization and relative resistance against Acanthamoeba 
castellanii protease activity, suggesting a possible in vitro anti-amoebic 
activity of AMPs.  
Another important finding of this study was the significant down-
regulation of hBD9 gene expression during acute microbial infections 
(especially Acanthamoeba keratitis, 40 fold decrease). This would 
support the hypothesis that Acanthamoeba specifically targets this gene 
in order to invade the corneal epithelium and bind to the mannose 
receptors, as a first step in its pathogenesis (Clarke and Niederkorn, 
2006). The ability of Acanthamoeba to inhibit this gene could be one of 
the factors related to its virulence. However, the mechanism by which 
Acanthamoeba dampens the defensin-mediated host defence is 
unknown. It has been shown that the binding to the mannose 
glycoprotein on the corneal epithelium via the 136 kDa mannose 
binding protein of the trophozoites can release several proteases that 
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interfere with the host immune-response (Sacramento et al., 2009). 
Most of AMPs are sensitive to proteases and Acanthamoeba is known to 
secret large amounts of proteases (Sacramento et al., 2009). The 
degradation role of secreted proteinase produced from Acanthamoeba 
on host defense proteins (Ig and IL-1) and its participation in 
Acanthamoeba virulence has been previously described (Na et al., 
2002). This study has demonstrated that Acanthamoeba can also 
suppress defensin expression at the gene level. Down-regulation of 
human beta defensins genes in response to inflammatory or infectious 
stimuli has previously been demonstrated (Abedin et al., 2008, 
Premratanachai et al., 2004, Yuan et al., 2010). Premratanachai et al 
have reported the down-regulation of hBD9 gene after in vitro 
stimulation of gingival keratinocytes with Candida albicans 
(Premratanachai et al., 2004). The absence of hBD2 gene expression in 
the limbal region of mice with allergic conjunctivitis compared with 
control has been shown by Ikeda et al (Ikeda et al., 2006). 
Furthermore, Yuan et al have demonstrated the initial down-regulation 
of both hBD1 and hBD2 in the murine OS with fungal keratitis (Yuan et 
al., 2010). Recently, an initial increase in hBD9 mRNA levels followed 
E\DVLJQL¿FDQWGRZQ-regulation in response to stimulation provided by 
pathogen associated molecular patterns and inflammatory cytokines 
has also been reported (Mohammed et al., 2010a). 
Similar to Acanthamoeba keratitis, this study demonstrated a modest 
down-regulation of hBD9 during acute Gram-negative infection which 
was significantly down regulated in Gram-positive bacterial keratitis. 
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After healing, the mRNA level of hBD9 returned almost to control level 
in Gram negative bacterial group but remained down-regulated in the 
Gram positive bacterial group. This variation in return to normal level 
could be a time related phenomenon or may suggest continuing 
subclinical activation at the cellular level. The reduced level of hBD9 
during active bacterial keratitis has already been shown (Abedin et al., 
2008). Whether the reduced expression is a cause or effect of the 
infection is unclear. It remains to be seen what relationship, if any, 
exists between this defensins and the cytokines, which are known to be 
a part of the intracellular signalling cascade. Conversely, Mohammed et 
al (Mohammed et al., 2010a) have found that the human corneal 
epithelial cells treated with Lipopolysaccharides (LPS, a TLR4 agonist) 
and flagellin (TLR5 agonist) of the Gram-negative bacteria and 
Pam3CSK4 (TLR2/TLR6 agonist), a synthetic homologue of 
polysaccharide (cell-wall protein) from Gram-positive bacteria induced 
hBD9 mRNA expression. Thus, it suggests that hBD9 response can vary 
in relation to different pathogenic organisms and between in vitro and 
in vivo conditions indicating a significant role of AMPs at the OS.  
This study demonstrated an optimised method to improve the RNA 
yield obtained from impression cytology samples for RT-PCR 
processing. Also, this is the first study to demonstrate the variable gene 
expression pattern of hBD3 and hBD9 at the OS in infected corneas and 
after healing compared with healthy controls. This report clearly 
indicates the importance of AMP-mediated host defence in different OS 
infections especially vision-threatening Acanthamoeba keratitis. Further 
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studies to explore the potential anti-amoebic activity of hBD3 and the 
key role of hBD9 in the Acanthamoeba keratitis pathogenesis would 
help our understanding of the pathogenesis of corneal infections.Also, 
further analysis of the protein expression of these AMPs during ocular 
infections is needed to determine the overall profile of these AMPs. 
1However, this was not possible in our study because of the limited 
cellular yield of impression cytology samples. 
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5 Does Human Beta Defensin-3 have Anti-
bacterial Effect? 
5.1 INTRODUCTION 
Because of the AMPs potential and potent antimicrobial activity, 
defensins are the most studied AMPs in humans. Among these, hBD3 
protein exhibits strong activity against Gram-positive and Gram-
negative bacteria and fungi, including S. aureus and E.coli) (Harder et 
al., 2001, Song et al., 2009, Huang et al., 2007c, Starner et al., 2005, 
Sahly et al., 2003, Joly et al., 2004). Furthermore, hBD3 protein can, 
unlike other human defensins that are salt sensitive, maintain its broad 
spectrum of activity in the presence of physiological saline which raises 
the possibility of it being potentially used as a topical antimicrobial 
agent on the ocular surface (Huang et al., 2007a, Harder et al., 2001).   
In chapter two, the in vitro gene expression of hBD3 showed ten folds 
increase in HCLE stimulated with Acanthamoea castellani compared to 
controls. This significant up-regulation of hBD3 gene was the most -
significant among all the AMPs studied (Otri et al., 2010). Furthermore, 
in chapter four, the gene expression of hBD3 demonstrated 120 fold 
increase in IC samples taken from the ocular surface of patients with 
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active Acanthamoeba keratitis compared with the healthy controls. 
Also, in chapter three, the in vitro gene expression of hBD3 showed 
significant increase in samples of HCEC treated with both P. 
aureuginosa and S. aureus compared to controls. Furthermore, when 
compared to samples from healthy subjects, the gene expression of 
hBD3 had increased up to 4.5 and 34 fold in IC samples taken from 
patients with Gram-negative and Gram-positive bacterial corneal 
infections, respectively (Otri et al., 2012).    
Based on the results of my previous work and to characterize the 
potential antimicrobial activity of hBD3, I sought to further investigate 
the microbicidal activity of the recombinant protein of HBD3 against 
Gram negative (E.coli) and Gram positive (S. aureus) bacterial isolates. 
5.2 METHODS 
$FFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQVWZRGLIIHUHnt recombinant 
hBD3 (rhBD3) proteins (ABD Serotec, catalogue number: PHP211) and 
(Thermo Scientific, catalogue number: RP87647) were reconstituted in 
200 µl of distilled water to get a final volume of  ǋJ ZLWK D
concentration of 0.1 mg/ml after reconstitution. In addition, in separate 
experiments, these proteins were also reconstituted in 20 µl of 10 mM 
acetic acid and 4 mM of hydrochloric acid as advised by the 
manufacturers to get a final volume of ǋJZLWK D concentration of 
1.0 mg/ml after reconstitution. The bactericidal activities of hBD3 
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(reconstituted with distilled water, acetic acid and hydrochloric acid) at 
concentrations of 5, 10, 20 and 40 µg /ml were tested.  
The antimicrobial activity of hBD3 was tested as previously described 
using the conventional colony counting method (Harwig et al., 1994). 
Suspensions of S. aureus and E. coli isolated from human corneal 
infections were used in this experiment. Briefly, the microorganisms 
were grown in BHIB (OXOID, Hampshire, UK) overnight at 37oC in an 
incubator. Then 50 µl of the suspension were added to 1 ml of the fresh 
BHIB and incubated in an orbital shaker  at 37oC for 3 hours to obtain 
the mid logarithmic-phase cells. An aliquot of 25 ml of the culture was 
centrifuged for 10 minutes and the pellet was re-suspended in 10 ml of 
'XOEHFFR¶V SKRVSKDWH EXIIHUHG VDOLQH PBS) (Sigma-Aldrich, Ayrshire, 
UK). The optical density of 1 ml of the suspension was measured at 620 
nm and recorded a value of 0.2. This optical density corresponds to 
approximately 5×107 colony forming unitis (CFU)/ ml of bacteria 
(Harwig et al., 1994). This suspension was diluted to 5×106 CFU/ ml in 
PBS. Thereafter, 10 µl from each bacterial suspension was added to 90 
µl of a mixture of PBS and hBD3 protein at the concentrations described 
above. This mixture was incubated in at 37oC for 3 hours and then a 10 
fold serial dilution (10-1) was prepared by vortex mixing and 
transferring 10 µl to 90 µl of the buffer. We repeated this process to 
prepare further dilutions (up to 10-8). Ten µl aliquots of each sample 
were spread over the surface of agar base (OXOID, Hapshire, UK). The 
plates were incubated at 37º C for 24 hours. The first dilution at which 
colonies were discrete and culture was not confluent were used to count 
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the total number of colonies, those are only plates with up to 500 CFU 
per plate (Harwig et al., 1994). The mean number of colonies per plate 
multiplied by the dilution ratio enabled the evaluation of colony forming 
units/mL in the original 100 µL incubation mixture. Similarly, bacterial 
suspensions in PBS, in distilled water alone, acetic acid alone and 
hydrochloric acid alone (without hBD3 protein) were used as negative 
controls for each bacterial suspension.  
All assays were done in triplicate and each experiment was repeated 
three times. The numerical data obtained from the mean of the CFU 
count were entered in an Excel spread sheet and exported to the SPSS 
software package (version 16.0 , IBM, Chicago, IL) for statistical 
analysis. The parametric T-test was used to compare between 2 
independent samples (the treated sample and the control). The 
signi¿cance value was set at P < 0.05.  
5.3 RESULTS 
Overall, when using distilled water for reconstitution and compared with 
the negative control (distilled water alone), no significant antimicrobial 
activity of the hBD3 was confirmed. This was applicable at all 
concentrations and against both S. aureus and E. coli. After the use of 
the acetic acid and the hydrochloric acid for reconstitution, hBD3 
protein showed potent activity against the studied bacteria at all 
concentrations. However, when compared with the antimicrobial 
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activity of the acidic solvent alone (without the hBD3 protein), there 
was no significant difference between both groups. 
The following tables illustrate the detailed information about the 
antimicrobial assays.   
5.3.1 Testing the antibacterial effect of the HBD3 
against S. aureus 
5.3.1.1 HBD3 reconstituted in distilled water and tested 
against S. aureus 
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Table 5. Showing the Colony forming units in serial dilutions of S. aureus bacteria 
tested against 40, 20, 10 and 5 µg /ml of HBD3 reconstituted in distilled water. The 
colony forming units were also calculated in bacterial samples treated with distilled 
water alone (as a negative control) at the previous concentrations. The P value of the 
T.test of the difference between the two groups was also calculated and shown. 
Dilution of the 
S. aureus  
10-1 10-2 10-3 10-4 10-5 10-6 10-7 10-8 
Colony forming units in serial dilutions of S. aureus bacteria tested 
against 40 µg /ml of HBD3 
Mean CFU in 
HBD3samples  
NC NC NC NC 23.6±0.6 4.6±0.5 0 0 
Mean CFU in 
water samples  
NC NC NC NC 25.3±1.5 2.3±1.5 0 0 
P value  
N/A N/A N/A N/A 0.15 P=0.09 1 1 
Colony forming units in serial dilutions of S. aureus bacteria tested 
against 20 µg /ml of HBD3 
Mean CFU in 
HBD3samples 
NC NC NC NC 22±1 2.3±5.7 0 0 
Mean CFU in 
water samples 
NC NC NC NC 21±2.6 2.3±5.7 0 0 
P value  N/A N/A N/A N/A 0.57 1 1 1 
Colony forming units in serial dilutions of S. aureus bacteria tested 
against 10 µg /ml of HBD3 
Mean CFU in 
HBD3samples 
NC NC NC NC 21.3±2 
1.6±0.5
7 
0 0 
Mean CFU in 
water samples 
NC NC NC NC 21.6±1.5 
1.3±0.5
7 
0 0 
P value of the 
difference 
N/A N/A N/A N/A 0.83 0.51 1 1 
Colony forming units in serial dilutions of S. aureus bacteria tested 
against 5 µg /ml of HBD3 
Mean CFU in 
HBD3samples 
NC NC NC NC 18.6±0.57 1.6±0.5 
0.33
±0.
5 
0 
Mean CFU in 
water samples 
NC NC NC NC 17±1 
1.6±0.5
7 
0 0 
P value  N/A N/A N/A N/A 0.67 1 0.37 1 
(NC: Not countable, N/A: Not applicable, mean CFU= mean± standard deviation) 
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5.3.1.2 HBD3 reconstituted in 10 mM of acetic acid & 4 
mM of hydrochloric acid and tested against S. aureus 
Table 6. Showing the Colony forming units in serial dilutions of S. aureus bacteria 
tested against 40 µg /ml of HBD3reconstituted in 10mM of acetic acid & 4 mM of 
hydrochloric acid. [Exactly similar results were obtained at concentrations of 20, 10 and 
5 µg /ml of HBD3 (results not shown)] 
Dilution of 
the S. 
aureus  
10-1 10-2 10-3 10-4 10-5 10-6 10-7 10-8 
Mean CFU in 
HBD3samples  
0 0 0 0 0 0 0 0 
Mean CFU in 
samples with 
acetic & 
hydrochloric 
acids 
0 0 0 0 0 0 0 0 
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5.3.2 Testing the antibacterial effect of the HBD3 
against E. coli 
5.3.2.1 HBD3 Reconstituted in distilled water and tested 
against E.coli 
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Table 7. Showing the Colony forming units in serial dilutions of E. coli bacteria tested 
against 40, 20, 10 and 5 µg /ml of HBD3 reconstituted in distilled water. The colony 
forming units were also calculated in bacterial samples treated with distilled water alone 
(as a negative control) at the previous concentrations. The P value of the T.test of the 
difference between the two groups was also calculated and shown. 
Dilution of the 
E. coli  
10-1 10-2 10-3 10-4 10-5 10-6 10-7 
10
-8 
Colony forming units in serial dilutions of E. coli bacteria tested against 40 µg 
/ml of HBD3 
Mean CFU in 
HBD3samples  
NC NC NC NC 26±1 2.3±0.57 0 0 
Mean CFU count 
in water samples  
NC NC NC NC 26±1 2±1 0 0 
P value  N/A N/A N/A N/A 1 0.64 1 1 
Colony forming units in serial dilutions of E. coli bacteria tested against 20 µg 
/ml of HBD3 
Mean CFU in 
HBD3samples 
NC NC NC NC 18.3±2 1.6±0.57 0 0 
Mean CFU count 
in water samples 
NC NC NC NC 
19.3±5
.7 
1.6±0.57 0 0 
P value  N/A N/A N/A N/A 0.46 1 1 1 
Colony forming units in serial dilutions of E. coli bacteria tested against 10 µg 
/ml of HBD3 
Mean CFU in 
HBD3samples 
NC NC NC NC 
20±1.7
3 
2±1 0 0 
Mean CFU count 
in water samples  
NC NC NC NC 
20±1.5
2 
2±1 0 0 
P value  N/A N/A N/A N/A 0.81 1 1 1 
Colony forming units in serial dilutions of E. coli bacteria tested against 5 µg 
/ml of HBD3 
Mean CFU in 
HBD3samples 
NC NC NC NC 
18.6±0
.57 
1.3±0.57 0 0 
Mean CFU count 
in water samples 
NC NC NC NC 
18.3±1
.5 
1.6±0.57 0 0 
P value  N/A N/A N/A N/A 0.74 0.52 1 1 
 (NC: Not countable, N/A: Not applicable, mean CFU= mean± standard deviation) 
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5.3.2.2 HBD3 reconstituted in 10 mM of acetic acid & 4 
mM of hydrochloric acid and tested against E. coli 
Table 8. Showing the Colony forming units in serial dilutions of E. coli bacteria tested 
against 40 µg /ml of HBD3reconstituted in 10mM of acetic acid & 4 mM of hydrochloric 
acid. [Exactly similar results were obtained at concentrations of 20, 10 and 5 µg /ml of 
HBD3 (results not shown)] 
Dilution of 
the E. coli  
10-1 10-2 10-3 10-4 10-5 10-6 10-7 10-8 
Mean CFU in 
HBD3samples 
0 0 0 0 0 0 0 0 
Mean CFU in 
samples with 
acetic & 
hydrochloric 
acids 
0 0 0 0 0 0 0 0 
 
5.4 DISCUSSION: 
The antibacterial activity of HBD3 has been reported in relation to 
Gram-positive and Gram-negative bacteria (Joly et al., 2004, Huang et 
al., 2007a, Song et al., 2009, Garcia et al., 2001a). My previous in vitro 
studies with Acanthamoeba showed that corneal cells infected with this 
organism demonstrated a 10 fold significant increase in gene 
expression for hBD3. This led to believe that hBD3 may have 
amoebecidal activity as well. To test this hypothesis, it was imperative 
that we establish and optimised antibacterial activity of our acquired 
samples of HBD3 such that they could be then run in parallel with 
experiments to evaluate anti amoebicidal activity if any. My primary 
aim was not to merely repeat previous experiments to confirm publised 
data on antimicorbial activity of HBD3. E.coli and S. aureus were 
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selected as was done by others (Joly et al., 2004, Huang et al., 2007a, 
Song et al., 2009).  
The antibacterial activity of hBD3 protein will depend on the source of 
the molecule and the nature of the solvent in which it is dissolved for 
use in the experiments. With regard to the former, two human rhBD3 
sourced from ABD Serotec and Thermo Scientific companies were used. 
According to the manufacturer, the rhBD3 was expressed in E.Coli. It 
consisted of 45 amino acids, with a molecular weight of 5.1kD (ABD 
Serotec) and 4.3 kD (Thermo Scientific) as described in the methods 
section. The commercially available rhBD3 used in similar studies were 
all 45 amino acid long and 5.1 kD weight (Nuding et al., 2009, Starner 
et al., 2002, Starner et al., 2005, Liberatore et al., 2009). All of these 
rhBD3 were reported to exhibit antimicrobial activity against Gram-
positive bacteria (S. aureus) and Gram-negative bacteria (E.coli) by the 
manufactureres. Furthermore, they were all expressed in E. coli and 
refolded before purification.  
My initial results using the rhBD3 reconstituted in distilled water were 
inconclusive. No antibacterial activity was demonstrable. Hence, 
DFFRUGLQJ WRPDQXIDFWXUHU¶V LQVWUXFWLRQV , UHFRQVWLWXWHG WKH UK%' LQ
acidic medium using acetic acid in set one of experiments and HCl in 
another. The acidic solvent media was used as controls and I was 
surprised to note that all antibacterial activity could be attributed to the 
acid rather than to the protein. Indeed, when the antibacterial activity 
of the rhBD3 dissolved in acidic media was compared with the acidic 
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media alone (control), the differences were not statistically significant. I 
concluded that the acidic solvent was responsible of the antibacterial 
effect, and by itself stopped the growth of the bacteria at all dilutions. 
Importantly, the potent in vitro antibacterial activity of the acetic acid 
has been documented before (Rhee et al., 2003, Thorp et al., 1998, 
Nagoba et al., 1997, Moussa et al., 2009, Larsen et al., 2011). To 
support this contention that in some of the previously reported studies 
the acidic solvent could be responsible for the antibacterial effect rather 
than the hBD3 tested, I comprehensively reviewed the literature related 
to the microbicidal effect of the recombinent hBD3 and focused onto 
the methodolgy in preparing the protein and testing its anti-microbial 
effect. This yielded interesting results discussed below.  
The potent antibacterial activity of the commercially available rhBD3 
against oral Gram-negative and positive bacteria has been previously 
reported by Joly et al using the radial diffusion method. However, acetic 
acid was used for hBD3 reconstitution without testing its effect alone as 
a negative control (Joly et al., 2004).  In another study, Nuding et al 
have also used the acetic acid for reconstitution of the commercially 
available rhBD3. They reported in the methods section that they had 
used the solvent (acetic acid) as a negative control but have not 
reported the results of the negative control in their paper. They 
concluded that hBD3 protein had good activity against dominant 
anaerobe genera of the gut, using the conventional colony count 
method (Nuding et al., 2009). It has also been reported by Starner et 
al in two separate studies that HBD3 reconstituted in acetic acid 
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exhibited a unique spectrum of anti-bacterial activity against isolates 
from lung sepsis in the neonate (Starner et al., 2005) and against 
Haemophilus influenza (Starner et al., 2002). However, in both studies, 
radial diffusion method was used and no negative control of acetic acid 
alone was prepared. Fazakerley et al have also reported the 
antibacterial activity of the HBD3 against canine Staphylococcus 
pseudintermedius.  As the previous studies, they have used the acetic 
acid for protein preparation without testing against the acetic acid alone 
as a control (Fazakerley et al., 2010). Moreover, Maisetta et al tested 
the hBD3 protein activity against gingival bacteria. They also used 
acetic acid for the hBD3 reconstitution and did not use any negative 
control (Maisetta et al., 2011). Recently, the bactericidal activity of one 
of the commercially available hBD3 has been proved to be active. This 
protein was reconstituted in physiological saline (instead of acetic acid) 
and it showed activity against S. aureus and E.coli using the 
conventional colony count method (Liberatore et al., 2009). The same 
protein with the same catalogue number but reconstituted in acetic acid 
has also shown to be active against different types of Nocardia. 
Importantly, it was tested against the acetic acid as a negative control 
and showed potent broad spectrum activity against some types of 
Nocardia whereas others showed resistance (Rieg et al., 2010). It is 
possible that this hBD3 product has the right formulation to 
demonstrate true antibacterial activity. However, this specific sample 
was not available for us to try.  
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On the other hand, the anti-bacterial activity of the synthesized 
analogue of the in-house HBD3 which was recombinantly cloned or 
chemically synthesized has been shown to be active against most 
bacteria. The cloning process comprises encoding the cDNA with amino 
acids containing the natural form of HBD3 into vectors while the 
chemical synthesis involving enzymatic reactions to arrange the amino 
acids and cysteine bonds in an order identical to the naturally secreted 
hBD3. In most of the studies which used these methods of preparing 
the hBD3 protein, derivatives of acetic acid or hydrochloric acids were 
involved in the preparation process and it is not clear if attempts were 
made to get rid of acetic acid before the final test (Song et al., 2009, 
Sahly et al., 2003, Garcia et al., 2001a, Hoover et al., 2000, Scudiero 
et al., 2010). However, it was technically not practical to compare our 
results using the commercially available hBD3 with the cloned or 
chemically synthesized hBD3 used in other studies. Interestingly, the 
original study reporting novel bactericidal activity of hBD3 was by 
Harder et al who demonstrated a salt-insensitive broad spectrum of 
potent antimicrobial activity against many potentially pathogenic 
microbes. Recombinant hBD3 expressed in Escherichia coli and 
chemically synthesized hBD3 were shown to be indistinguishable from 
naturally occurring peptide with respect to their antimicrobial activity 
using the conventional colony count method. Trifluoroacetic acid was 
used in preparing the hBD3 without testing its antimicrobial as a 
negative control (Harder et al., 2001). It has also been shown by many 
authors that the use in house hBD3 was active against different 
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pathogenic bacteria. Acetic acid was used for reconstitution in all these 
studies but no results were reported about testing it alone as a 
negative control (Garcia et al., 2001a, Sahly et al., 2003, Hoover et al., 
2000, Scudiero et al., 2010). Differently, Song et al have reported that 
the rhBD3 prepared by cloning was active against the intracanal 
bacteria. They used phosphate-buffered saline for dissolving which 
served as a negative control. No acetic solvents were used in this study 
(Song et al., 2009). 
In this study, in the product data sheets accompanying the ABDseroTec 
HBD3 samples, it was specifically claimed that the hBD3 protein 
exhibits antimicrobial activity against S. aureus and E. coli ³([KLELWV
antimicrobial activity against Gram-positive bacteria S.aureus and 
Gram-negative P. aeruginosa and E. coli´7KH7KHUPRVFLHQWLILFSURGXFW
sheet, however, reported the general antibacterial activity of their 
SURGXFW ³KDYLQJ D ZLGH UDQJLQJ DQWLPLFURELDO DFWLYLW\´ $V RXU
conclusions contradicted this claim we corresponded with the 
companies to obtain their experimental protocols, which we hoped to 
duplicate in our lab. I specifically requested the manufacturers to send 
us the protocol used by them in confirming the antimicrobial activity of 
the rHBD3. The manufacturers were very co-operative and initially 
confirmed that they had tested the antimicrobial activity of these HBD3 
but later acknowledged that the protein was only tested in chemotaxis 
assay (not antibacterial assay). In addition, the online datasheet of 
HBD3 (catalogue number: PHP211) on the ABDseroTec website has 
EHHQFKDQJHGWR³([KLELWVFKHPRWDFWLFDFWLYLW\RQPRQRF\WHV´ZLWKRXW
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mentioning anything about its antimicrobial activity 
(http://www.abdserotec.com/product/defensin-beta-3-recombinant-
protein-php211.html). 
7KHILQDOFRPPXQLFDWLRQIURP$%'VHUR7HFVWDWHG³Thank you for your 
patience. My sincere apologies but the labs have advised me that they 
have been unable to setup the antimicrobial assay for the HBD3. The 
original assay was performed by an external lab that we no longer have 
access to. The labs, however, have confirmed the peptide to be active 
by chemotaxis (on monocytes). I appreciate that there would be 
significant differences between the chemotaxis assay and the 
antimicrobial assay and that a chemotactically active BD-3 may not 
QHFHVVDULO\UHWDLQLWVDQWLPLFURELDOSURSHUWLHV´ 
A refund was requested from one of the companies (ABDseroTec) and 
was gratefully received. On the other hand, the final communication 
from Thermo Scientific stated: ³8QIRUWXQDWHO\ZHKDYHQRW WHVWHG WKH
protein in a proliferation assay, only in chemotaxis assays on several 
GLIIHUHQW FHOO W\SHV 7KHUHIRUH ZH FDQ¶W FRPPHQW RQ \RXU SURWRFRO ,
have attached the chemotaxis protocol that we use for the bioassay. 
Perhaps you can test the functionality of the protein in the chemotaxis 
DVVD\V´ 
Surprisingly, the rhBD3 from Thermo Scientific company (catalogue 
number: RP-87647) has been discontinued afterwards 
(http://www.pierce-antibodies.com/beta-3-Defensin-Recombinant-
Protein--RP87647.html) 
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This study highlights the technical pitfalls that might affect 
experimental studies and adhering to basic principles, such as use of 
proper controls, is essential. With regard to the antimicrobial efficacy of 
HBD3, even though we were unable to demonstrate this, the available 
evidence from a few well conducted studies would suggest that its gene 
expression is up-regulated in infections (Otri et al., 2010, Garreis et al., 
2010b, Huang et al., 2007c) and that it does have a microbicidal effect 
against a range of organisms (Song et al., 2009, Liberatore et al., 
2009, Rieg et al., 2010). 
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6 Corneal Densitometry as an Indicator of 
Corneal Health 
6.1 INTRODUCTION 
Infectious corneal ulcers are important causes of ocular morbidity and 
may lead to severe visual loss if not diagnosed and treated properly. 
Prompt diagnosis and close follow up are essential for better visual 
results. At present, clinical examination is the mainstay for the early 
diagnosis of the infectious keratitis. The depth and dimensions of the 
infectious corneal infiltrate and the size of the epithelial defect provide 
important information about the response to treatment.  
Sequential anterior segment photography over the course of an 
infectious keratitis lesion can allow evaluation of ulcer and infiltrate 
dimensions.  The physician can review the series of photos and 
evaluate response to therapy. This method is however fairly subjective 
and suffers from the limitation related to differences in magnification 
and exposure at different visits making exact comparison difficult 
without use of image analysis software.  Recently, corneal imaging has 
been used as a means of recording extent of infiltrate and determining 
the initial response to treatment. The new technology of anterior 
segment optical coherence tomography is very useful in observing the 
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progress of corneal infections. It can provide numerical values of the 
dimensions and depth of the infiltration and the overall inflammatory 
state of the cornea with high quality cross sections of the entire cornea 
(Konstantopoulos et al., 2008, Konstantopoulos et al., 2007). 
Furthermore, in vivo confocal microscopy is another new technology 
which can provide cellular and sub-cellular images of the corneal tissue 
at various depths and help in the diagnosis of fungal or Acanthamoeba 
keratitis but does not identify bacteria (Daxer et al., 1998). These 
technologies are however not available in all centres and there is 
always a need for novel approaches to quantify the extent and depth of 
ulcers and infiltrates and use this information in analyzing the healing 
process, in particular the response to the treatment.  
Scheimpflug photography of the anterior segment is also a relatively 
new imaging modality and is superior to the slit-lamp photography.  In 
comparison to anterior segment OCT, it provides better quantification of 
light scattering and can help in assessing corneal infiltrates (Wegener 
and Laser-Junga, 2009). The OCULUS Pentacam (Oculus Inc., 
Germany) is a non-invasive optical system which takes up to 50 cross-
sectional images of the entire anterior segment within 2 seconds 
depending on the Scheimpflug principle (Oculus, 2003, Cho et al., 
2010).  
To understand the Scheimpflug image principle, a description of three 
planes should be known: the film, the lens and the sharp focus planes 
(figure 10). The film plane is a flat imaginary surface upon which the 
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film is fixed. The lens plane is another flat imaginary surface passing 
through the optical centre of the lens. If these two planes are not 
absolutely parallel, they will intersect along a straight line. The plane of 
sharp focus is a third imaginary surface positioned such that any object 
lying on it will be imaged sharply (by the lens) on the film plane. For an 
ordinary camera, the three planes are parallel to one another and so 
they never intersect. 
 
Figure 10. The angles of the ordinary camera, using the example of a photographic lens 
(Merklinger, 1992). 
The Scheimpflug principle states that if a lens is tilted such that the 
lens plane intersects the film plane, the plane of sharp focus must also 
pass through that same line of intersection (figure 11). The line formed 
by the intersection of the lens plane, film plane and plane of sharp 
focus will be called the Scheimpflug line. The major advantage of 
Scheimpflug over other imaging techniques is that the entire depth of 
the structure imaged is in focus. This provides impressive image 
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sharpness even in scenes with significant depth of field, not like the 
ordinary camera (figure 12) (Merklinger, 1992).  
 
Figure 11. The angles of the Scheimpflug principle, using the example of a photographic 
lens (Merklinger, 1992). 
 
Figure 12 With a normal camera, when the subject is not parallel to the image plane, 
only a small region of the text is in focus. Conversely, with Scheimpflug dependent 
devices, the whole text will be clear even with non-parallel planes.   
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Depending on the previous principle, Oculus Pentacam has specifically 
been designed to assess the anterior segment of the eye from the 
anterior corneal surface to the posterior lens surface in a single scan 
without contacting the cornea. The Pentacam requires minimal 
experience for image acquisition(Buehl et al., 2006), it simultaneously 
provides complete corneal pachymetry, corneal topography, 
densitometry of cornea (measuring the scattering of the light) and lens 
including opacities and anterior chamber analysis (depth, angle, and 
volume) (Oculus, 2003). The ability to measure changes in corneal 
transparency non-invasively and objectively could enable more precise 
monitoring of progression and improve patient management.  
Corneal densitometry has previously been used to assess and quantify 
the degree of sub-epithelial corneal haze and stromal scarring in 
refractive surgery patients (van de Pol et al., 2001, Takacs et al., 1995, 
Matsuda et al., 2007). The use of this novel technique is assessing 
corneal transparency in patients with infectious keratitis has not been 
reported before and could provide a useful standard when assessing the 
clarity of cornea during and after corneal infections.  
The aim of this study was to measure the corneal density of the clear 
FRUQHDV RI KHDOWK\ VXEMHFWV WR HVWDEOLVK µQRUPDO¶ YDOXHV DQG WKHQ WR
investigate the imaging capabilities of the Pentacam in patients with 
microbial keratitis at the active stage of the disease and during the 
healing process.  
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6.2 METHODS 
7KLV SURVSHFWLYH VWXG\ ZDV DSSURYHG E\ 4XHHQ¶V 0HGLFDO &HQWUH
University Hospitals NHS Trust (reference number: 1487). 
6.2.1 Normal Eyes 
After obtaining informed consent, 64 eyes of 40 healthy controls were 
studied. Routine slit-lamp examination was carried out before Pentacam 
scanning (Oculus Pentacam Rotating Scheimpflug Camera; Oculus, 
Wetzlar, Germany) to exclude any corneal opacity. The automatic 
release mode of the Pentacam was used to determine when correct 
focus and alignment with the corneal apex had been achieved. This 
reduced operator dependent variables associated with manual 
scanning. Imaging was performed using the 50 scans setting obtained 
in 2 seconds. Pentacam examination was carried out and densitometry 
values were ascertained by two different methods: 
6.2.1.1 Corneal densitometry at different points:  
Corneal density was measured at four different axes (180, 45, 90 and 
135) at 5 different points along each axis - the centre of the cornea, 
1.5 mm either side of centre and 3.5 mm either side of centre (figure 
13). Overall, the densitometry measurements of the central point of the 
cornea, the central 3 mm, and the peripheral 7 mm for each axis were 
reported. The measurements of temporal, nasal, inferior, and superior 
halves of the cornea were also assessed by mixing and matching 
between values. 
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Figure 13 The figure illustrates the 4 axes (45, 90, 135 and 180 degrees) and the 5 
points on each axis where densitometry was performed. The inner points were 1.5 mm 
and the outer were 3.5 mm from the centre. 
 
The corneal density (densitometry) was measured using the caliper 
tools provided by the Pentacam Oculus software. This allowed the 
operator to mark a point on the cross sectional scan of the cornea 
(from epithelium to endothelium) and the software calculated the 
densitometry value at the defined point (figure 14A). The average 
readings and the standard deviations were then calculated. 
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Figure 14. This figure shows the two different methods in measuring the density of the 
cornea: the densitometry at different points (A) and the densitometry of the total cross 
sectional areas (B). 
 
6.2.1.2 Corneal densitometry of total cross sectional 
area:  
The central 7 mm area of the cross section of the cornea along each of 
the 4 axes (180, 45, 90 and 135) was manually defined (figure 14B) 
and densitometry was then automatically measured for the entire area. 
The density was measured using the caliper tools by assigning the 
specified area on the cross sectional scan of the cornea and the 
software calculated the densitometry value of that defined area. The 
average and the standard deviation readings were then recorded. 
For densitometry readings at each point, the instrument gives a 
maximum, a minimum and an average reading. Similarly, measuring 
corneal density of the total cross sectional area gives a maximum and 
an average (but not minimum) reading. These were recorded 
separately. 
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6.2.2 Patients with Bacterial keratitis 
Informed consent was obtained from all recruited subjects. Routine slit-
lamp examination was carried out and the location, depth and diameter 
of the corneal infiltrates were recorded. Pentacam examination was 
then performed prior to any intervention such as for taking samples for 
microbiological examination by corneal scrapes. 
Fifty two patients with bacterial keratitis who presented to the eye unit 
LQ 4XHHQ¶V 0HGLFDO &HQWUH LQ 1RWWLQJKDP 8. ZHUH Srospectively 
studied. Sixteen patients were excluded from this study. Of these, 13 
patients had un-reliable Pentacam images as indicated by the reliability 
threshold of the instrument. Inability of the patient to fixate, 
photophobia, excessive tearing and discharge and poor patient 
cooperation due to pain and eye condition were factors that prevented 
good readings from being obtained. A further three patients were 
excluded because they defaulted on scheduled follow up visits.  
Thirty six patients were thus available for analysis. In these, the 
Pentacam examination was carried out at two time points; at 
presentation and 4 to 6 weeks after the complete resolution (complete 
cessation of treatment). The automatic release mode of the Pentacam 
was used in all examinations. The density (densitometry) of the stromal 
infiltrate was measured using the caliper tools. The principles of 
measuring densitometry at specific points and across a cross sectional 
area, were applied to the patients with keratitis as well.  
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Figure 15. Densitometry in patient with active infectious keratitis. A demonstrates 
active central infectious keratitis (dark arrow) and the furthest away point of clear 
cornea (dotted point). B illustrates the Pentacam overview of the corneal ulcer. C shows 
how to measure the corneal density during the active stage of infection at two different 
points: the central involved ulcer (central point) and the furthest away point of clear 
cornea (at the periphery). D shows how the total cross sectional area of the infiltrate 
was measured. All the measurements were calculated at the same axes. 
 
6.2.2.1 Corneal densitometry at specific points 
The corneal density was measured at the site of maximal infiltrate by 
placing one caliper arm on the epithelial surface of the cornea and the 
second arm on the endothelial surface passing through the centre of 
the infiltrate. Densitometry was also performed at a point in clear 
cornea furthest away from the infiltrate, just within the limbus (figures 
15C and 17C). The location of this point on the morphometry grid was 
noted and densitometry at the same point was measured at each visit. 
For densitometry readings at each point, the instrument gives a 
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maximum, a minimum and an average reading. These readings were 
analyzed separately. 
6.2.2.2 Corneal densitometry of total cross sectional 
area:  
The area over which the infiltrate extended was manually defined using 
the caliper arms and densitometry of the entire defined area was 
measured (figures 15D and 17D). For densitometry readings of cross 
sectional area, the instrument gives a maximum and an average 
reading. These readings were analyzed separately.  
After 4-6 weeks of complete healing of keratitis with residual scarring 
(figures 16A and 16B & 18A and 18B), the average densitometries at 
the same point and of the same area on the same axis were measured 
again using the principles described above, regardless of the location of 
the scar tissue (figures 16C and 16D & 18C and 18D). 
The corneal thickness measurements for the infected areas were also 
ascertained from the Pentacam imaging in all eyes examined. All scans 
and measurements were carried out by the same investigator. 
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Figure 16. Densitometry in patient with healed infectious keratitis. A shows the corneal 
scarring after the full healing of the active ulcer of the previous patient (dark arrow) 
and the furthest away point of clear cornea (dotted arrow). B reveals the Pentacam 
overview of the corneal scar. C illustrates the densitometry at the central scarring 
(central point) and at the furthest away point of clear cornea (at the periphery). D 
shows how the total cross sectional area of the infiltrate was measured. All the 
measurements were calculated at the same axes. 
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Figure 17 Another example of Densitometry in patient with active infectious keratitis. A 
demonstrates active central infectious keratitis (dark arrow) and the furthest away 
point of clear cornea (dotted point). B illustrates the Pentacam overview of the corneal 
ulcer. C shows how to measure the corneal density during the active stage of infection 
at two different points: the central involved ulcer (central point) and the furthest away 
point of clear cornea (at the periphery). D shows how the total cross sectional area of 
the infiltrate was measured. All the measurements were calculated at the same axes. 
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Figure 18 Another example of Densitometry in patient with healed infectious keratitis. A 
shows the corneal scarring after the full healing of the active ulcer of the previous 
patient (dark arrow) and the furthest away point of clear cornea (dotted arrow). B 
reveals the Pentacam overview of the corneal scar. Fig 8C illustrates the densitometry 
at the central scarring (central point) and at the furthest away point of clear cornea (at 
the periphery). D shows how the total cross sectional area of the infiltrate was 
measured. All the measurements were calculated at the same axes. 
 
6.2.3 Statistical analysis 
The numerical data obtained from the study points or cross sectional 
areas were entered in an Excel spread sheet and exported to the SPSS 
software package (version 16.0 , IBM, Chicago, IL) for statistical 
DQDO\VLV 7KH VLJQL¿FDQFH YDOXH ZDV VHW DW P<0.05. After testing the 
normality of the obtained data, the relevant test was performed. The 
parametric T-test or the non parametric Mann Whitney test were used 
to compare between 2 independent samples, whereas Wilcoxon test 
was performed to show the difference between two non parametric 
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related samples. The correlation between two non-parametric groups 
was analyzed using Spearman rank test. 
6.3 RESULTS 
6.3.1 Control group 
The mean age of the 40 healthy subjects studied was 35±14 years, 
(range from 23 to 76 years). Twenty four were males and 16 were 
females.  Of the 64 eyes examined, there were 31 left eyes and 33 
right eyes. No statistical relationship was found between gender of the 
subjects and the values of the densitometry (Man Whitney, P>0.05). 
Additionally, no correlation was found between the densitometry 
readings and the age of the healthy subjects (Spearman correlation: 
0.845, P>0.05). 
6.3.1.1 Densitometry:  
 The densitometry values by the two different methods are shown in 
table 9. The densitometry measured at different points ranged from 9 
to 17.4 and the densitometry of total cross sectional area ranged from 
10 to 20.5. For the healthy controls, there was no statistical difference 
between the measurements of the densitometry examined by the two 
different methods i.e. point measurements and area measurement 
(Mann Whitney, P>0.05). When the densitometry values were 
compared at different points, there was no statistically significant 
difference between the upper and lower corneal halves and the nasal 
and temporal sides. Similarly, no significant difference of the 
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densitometry readings was observed between the central 3 mm and the 
peripheral 7 mm. Furthermore, when densitometry values from right 
and left eyes were compared for the different locations, no statistically 
significant difference was noted.  The Mann Whitney test was used for 
all comparisons (P>0.05). 
Table 9 Densitometry values of healthy controls. (N/A: not applicable) 
 Average Maximum Minimum 
Densitometry at 
different points 
12.3 ± 2.4 19±4.4 4.7±0.9 
Densitometry of 
total cross 
sectional area 
12.99 ± 2.58 22± 4.1 N/A 
 
6.3.2 Study group with infectious keratitis 
Thirty six eyes of 35 patients were studied (18 left and 18 right eyes) 
with mean age of 43 ± 13 years, (range from 19 to 84 years). There 
were 17 males and 19 females. The mean period between the initial 
and the last densitometry measurements was 51 days (range 35 to 177 
days) 
There was a statistically significant difference between the mean age of 
the healthy controls and the patients with infectious keratitis (T-test for 
2 independent groups, P<0.05).  
6.3.2.1 Microbiological Results 
Of the 36 eyes studied, corneal scrapes were not done for 3 eyes; 16 
showed no growth and the remaining 17 cases showed S. aureus (6), P. 
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aeruginosa (3), Gram positive bacillus (2), Moraxella (1), kleibsella (1), 
Coliform (1), Propionibacterium (1) Pneumococcus (1) and 
Acanthamoeba keratitis (1). 
6.3.2.2 Clincal examination 
Slit lamp examination of the 36 eyes with infectious keratitis revealed 
19 eyes with central corneal infection (within the central 4 mm) and 17 
with peripheral lesions. Thirteen of the 36 eyes had deep infectious 
infiltrates (more than 50% depth). The mean diameter of these 
infectious infiltrates was 2.5 mm (range 1 to 5.5 mm).  
6.3.2.3 Pachymetry 
The mean pachymetry was 544 ± 74 µm micrometers (range 372 to 
630 µm). There was no correlation between the pachymetry and 
densitometry readings (spearman rank correlation= 0.057, P>0.05).  
6.3.2.4 Densitometries at site of infection 
6.3.2.4.1 Densitometry by point method  
As shown in table 10, the maximum, minimum and average 
densitometries values at specific corneal points during the acute 
infection showed statistically important increase when compared to the 
values after complete healing (Wilcoxon, P<0.0001 for each 
comparison).  
Table 10 Densitometry measurements at points of infection in both the acute stage and 
4-6 weeks after complete resolution. 
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 Mean Maximum  Minimum  
Densitometry 
during acute 
infection 
47.6±12 
 
91.8±18 
 
 
24.6±14.5 
 
Densitometry 
after complete 
healing 
38.1±13 76.7±23.5 
 
14.2±8 
 
 
6.3.2.4.2 Densitometry of total cross sectional area of infection  
Similarly, the average and maximum densitometries of cross sectional 
areas during active infection were significantly more than the readings 
after complete healing (Wilcoxon, P<0.0001) (Table 3).  
There was no statistical difference between the densitometries 
measured at different points (table 10) and of total cross sectional area 
(table 11) (Mann Whitney, P > 0.05).  
There was no correlation between the pachymetry and the 
densitometry values obtained by the point method (spearman 
correlation: -0.19, P>0.05). Similarly, no correlation was found 
between the pachymetry and the densitometry values obtained by the 
total cross sectional area method (spearman correlation: -0.145, 
P>0.05).  
The densitometry values from patients were also compared to controls. 
There was significant increase in the average, maximum and minimum 
corneal densitometries during active infection compared with the 
control readings (Mann- Whitney, P < 0.0001 for each comparison). 
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There was no correlation between the densitometry readings and the 
diameter of the infiltrates (Spearman rank correlation= 0.25, P> 0.05) 
nor was there any significant statistical relationship between the 
densitometry values and the location or depth of the infiltrates (Mann 
Whitney test, P > 0.05) 
Table 11 Densitometry measurements of total cross sectional area of infection in both 
the acute stage and 4-6 weeks after complete resolution. 
 Mean Maximum  
Densitometry during 
acute infection 
58.4±19.5 89.4±17.8 
Densitometry after 
complete healing 
33.4±17.3 62.14±25 
 
6.3.2.5 Densitometries at points of furthest away clear 
cornea  
The corneal densitometry values obtained from the clear cornea at a 
point furthest away from the active infection were significantly lesser 
than readings obtained from the site of active infection at all stages 
(Mann-Whitney, P < 0.0001) (Table 12). Interestingly, the 
densitometry readings in the furthest away clear cornea of the infected 
eye showed a significant increase when compared with healthy controls 
both during the active infection and after complete healing (Mann- 
Whitney, P < 0.0001) (Table 12). Clinically, the active infiltration was 
replaced by scar tissue. The clear cornea furthest away from the 
corneal infiltrate showed significant decrease in densitometry after 
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complete healing when compared with the values of the same points 
during the active keratitis (Wilcoxon test, P < 0.0001). 
Table 12 Shows the corneal densitometry values  1. Of healthy controls and 2. At sites 
of infectious infiltrates and 3. At points of clear cornea furthest away from the 
infiltrates; during active infection and 4-6 weeks after complete clinical resolution. 
 Mean Maximum Minimum 
Densitometry of 
healthy controls 
12.3±2.4 19±4.4 4.7±0.9 
Densitometry at 
site of acute 
infection 
47.6±12 
 
91.8±18 
 
 
24.6±14.5 
 
Densitometry at 
site of infection 
after complete 
healing 
38.1±13 76.7±23.5 
 
14.2±8 
 
Densitometry of 
furthest away 
point of clear 
cornea during 
infection 
29±19 47.5±29 8.6±4.9 
Densitometry of 
furthest away 
point of clear 
cornea after 
complete healing 
20±11 33.3±22 8.2±5.2 
 
6.4 DISCUSSION 
The Pentacam Scheimpflug system is a relatively new imaging modality 
which is superior to slit-lamp photography in many aspects. It can 
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provide valid and reproducible data in evaluating the entire corneal 
tissue with minimal examiner experience (Shankar et al., 2008b, 
Shankar et al., 2008a). It provides precise information about corneal 
topography, corneal and lens densitometry and the anterior chamber 
anatomy (Oculus, 2003).  
Densitometry of the corneal tissue provides information about the 
clarity of the cornea. The normal cornea does not absorb visible light 
and light scatter is minimal. Densitometry therefore gives an indication 
of the transparency of the cornea. With the Pentacam, densitometry of 
the whole cornea is possible in a single scan. The density is 
standardized from 0 to 100. Therefore, 0 means the cornea shows no 
clouding and 100 means the cornea is completely opaque (Cho et al., 
2010). The major sources of light scattering are the anterior superficial 
corneal epithelial cell layer and the posterior corneal endothelium. As 
expected from an optically transparent tissue, the normal cornea 
scatters light predominantly at the air/tear film and tear film/cornea 
interface where the change in the index of refraction of light is greatest 
with only minor scattering by structures inside corneal tissue, e.g. 
nerves and cell nuclei. The corneal stroma maintains its clarity through 
the regular arrangement of collagen fibrils in a lattice-type structure in 
lamellar sheets. It is both the spacing of the fibrils within the 
arrangement and the size of the collagen fibrils that influence clarity 
(Maurice, 1957, O'Donnell and Wolffsohn, 2004). Moreover, The very 
precise organization of the extracellular matrix (ECM) surrounding 
these collagen fibrils can also play a major role in corneal transparency. 
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The ECM confers unique water-holding properties and preserves the 
hydration of the corneal tissue within its normal limits.(Fini, 1999, 
Maurice, 1957) The state of corneal hydration (which is maintained at 
75%) is another important factor in corneal transparency (Daxer et al., 
1998, O'Donnell and Wolffsohn, 2004). 
In bacterial keratitis, the cornea is invaded with inflammatory cells and 
microbes and swells. Light scatter increases with a loss in transparency 
due to the disruption of the collagen matrix caused by the inflammation 
and infection (Fernando H Murillo-Lopez, 2010). After healing of 
infectious keratitis, the resultant corneal scarring is another significant 
cause of reduced corneal transparency.  
To our knowledge, the evaluation of corneal densitometry as a measure 
of corneal transparency has not been reported in the literature. In this 
study we established the densitometry of normal corneas and also used 
the technique to obtain quantitative data in patients with corneal 
infections. This enabled us to objectively measure progress or response 
to therapy. We found that the average corneal densitometry of the 
healthy controls is 12.99 ±2.58 and 12.3 ± 2.4 using two different 
methods of analysis. It did not correlate with age and gender. These 
normal values could be used as bench marks for future studies 
undertaken to evaluate corneal pathology. In infectious keratitis, the 
corneal stroma in the area of infection swells and undergoes necrosis 
and the keratocytes shows apoptosis as a protective phenomenon 
against the infective organisms (Vemuganti et al., 2004). Depending on 
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microbial toxins and pro-inflammatory cytokines released, acute 
inflammatory cells (mainly neutrophils) surround the site of infection 
causing necrosis of the stromal lamellae and ulceration. Different 
bacterial toxins and enzymes (including elastase and alkaline protease) 
may be produced during corneal infection, contributing to the 
destruction of corneal tissue (Fernando H Murillo-Lopez, 2010, 
Vemuganti et al., 2004).  
In normal controls, the total densitometry value is made up of 
epithelial, stromal and endothelial reflectivity, of which the epithelial 
component has the greatest contribution. In our study, all patients had 
corneal ulcers and hence were lacking the epithelial layer. Despite this 
the total densitometry values were still higher in areas of infection. 
Moreover, when the minimum densitometry values, which indicate 
stromal reflectivity, of patients and controls are equated, a more valid 
FRPSDULVRQFDQEHPDGH7KHVWURPDO UHIOHFWLYLW\RISDWLHQWV¶ FRUQHDV
was much higher than that of controls.   
We found that, although densitometry values were greatest at the site 
of active infection/infiltration, the values were also increased, compared 
to controls, at areas of clear cornea furthest away from the infection. 
This increase was statistically significant when compared to normal 
controls.  This suggests that a much wider area of the cornea, if not the 
entire cornea is affected by the infective focus and responds 
dynamically to the insult at any specific site. This could be related to an 
increase in host inflammatory cells in the corneal tissue as they migrate 
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from the limbus towards the focus of infection and also to the 
µDFWLYDWLRQ¶ RI VWURPDO NHUDWRF\WHV LQ DQ LQIHFWHG FRUQHD 6WXGLHV RQ
patients undergoing refractive surgery have reported keratocyte 
activation, which can persist for months after the intervention 
(Vesaluoma et al., 2000, Moilanen et al., 2003, Erie, 2003, Erie et al., 
2003). Interestingly though the densitometry at a point of clear cornea 
furthest away from the involved area declined as the infection resolved, 
it continued to show increased values, compared to controls, even after 
complete healing of the ulcer. This suggests that the effects of infection 
persist beyond 4 weeks after clinical healing and factors such as 
keratocyte activation and disappearance of invading white cells take 
longer to return to normal. Thus clinically visible resolution of signs 
may not correspond with a return to complete physiological normality, 
which is likely to take longer. We expect that over time the 
densitometry of the cornea at points furthest from the infiltrate will 
return to normal but a longer follow up will be required to ascertain 
this.  
In some patients, pre-existing changes related to corneal 
transplantation for example, could also have contributed to this 
persistent increase in densitometry values. Similarly, in our study, the 
values of corneal densitometry of the scarred areas after complete 
healing were statistically more than the values of the controls. The lack 
of the corneal clarity in the affected areas is attributed to the scar 
formation with an increased number of scar keratocytes (fibroblasts), 
change in extra cellular matrix composition, increase in the number of 
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collagen fibrils and the irregular order of these fibrils (Fini, 1999, 
Vemuganti et al., 2004). After corneal healing, there is a change in 
collagen from the original type I collagen (25±30 nm)  to type III 
collagen that is typically present in an area of corneal haze or scarring 
and has a larger fibre diameter (30±50 nm) (Anderson et al., 1996, 
SundarRaj et al., 1990). 7KHVH ODUJHUDQG LUUHJXODUVWURPDO¿EULOV FDQ
cause an increase in the amount of light scatter. The corneal light 
scattering resulting from the scarring was less than the scattering 
related to active infection. This is likely to be due to the elimination of 
inflammatory cells and the microbial colonies.  
No correlation between the pachymetry and the densitometry values 
was found. This is probably because of the fact that there were several 
cases where the affected area was thin with surrounding infiltration or 
abscess. The overall densitometry readings were thus very high despite 
the low pachymetry.  
The main limitations of our study were the short period of follow up 
after complete healing of the infectious keratitis and the small number 
of the healthy controls. Additionally, the significant difference between 
the age of the healthy controls and the patients with infectious keratitis 
was another drawback although our statistical analysis showed that 
there was no correlation between age and densitometry readings. The 
Pentacam instrument itself was limited in capturing reliable images in 
some patients who had frequent blinking, photophobia, excessive 
tearing or discharge and poor cooperation or fixation. 
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Light scattering from active infectious corneal infiltrates is more than 
that resulting from the corneal scarring after healing. Subclinical 
activation of the keratocytes and/or inflammation in clear cornea 
furthest away from the corneal infection suggests that the host 
response extends far beyond the immediate area of infection and 
indeed may occur through the entire cornea. These changes persist 
beyond 4 weeks, which was the duration of follow up of this study.  
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7 Profile of Sight Threatening Infectious 
Keratitis: A Prospective Study 
7.1 INTRODUCTION 
Infectious keratitis is an avoidable and treatable sight-threatening 
disease that can affect the young and old alike. Despite improvements 
in treatment, infectious corneal ulcers remain a threat with the 
potential for permanent and severe visual loss adding to the social and 
healthcare burden of the individual and the community.  The morbidity 
from severe corneal ulcers (loss of vision, duration of hospital stay and 
surgical intervention) (Wong et al., 2003) is totally different from that 
of mild corneal infections. Demographic and geographic factors affect 
the distribution of the causative organisms of infectious corneal 
ulceration. Regional differences can be considerable and diagnostic and 
therapeutic resources have to be tailored to the specific needs of a 
given region. Moreover, the profile of organisms, drug efficacy and 
resistance change over time necessitating standard protocols of 
diagnosing and treating infectious keratitis to be reviewed regularly. 
Comprehensive studies of severe sight threatening infectious keratitis 
are therefore important as they provide useful information on the 
predisposing factors, aetiology and visual outcomes thus informing the 
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development of management strategies and protocols. In this regard, 
prospective studies are more valuable as they provide detailed 
information on the current profile of the disease.  
We have conducted a prospective study of the sight threatening 
infectious keratitis in Nottinghamshire, England over a period of 3 
years. The aim was to ascertain the incidence, demography, 
predisposing factors, clinical and microbiological diagnosis, treatment 
given, follow up duration, visual outcomes and complications in patients 
with severe infectious corneal ulceration. 
7.2 METHODS  
This study followed the Tenets of the Declaration of Helsinki and was 
approved by the Queens Medical Centre, University Hospitals NHS Trust 
(No. 1487). All patients who were diagnosed with severe corneal 
infections at the Queens Medical Centre, Nottingham, UK, under the 
care of two consultants, between Sep 2007 and Sep 2010 were 
recruited in this study. Informed consent was obtained from all 
patients. Severe corneal ulcers were defined as sight threatening 
corneal infections that needed to be treated intensively and urgently, 
this included at least one of the following criteria: remarkable visual 
loss without any other attributable cause, part of the lesion within the 
central 4 mm of the cornea, peripheral location with more than 2 mm 
diameter, any hypopyon or significant pain (Keay et al., 2008, Dart et 
al., 2008). Viral infections were excluded. The following data were 
obtained from all subjects: personal details, duration of symptoms, 
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date of admission (if applicable) and previous treatment (if any). The 
predisposing factors, initial visual acuity (VA), ocular signs, medical 
treatment including drugs, dose and duration,  length of hospital 
admission (if applicable), any surgical intervention, complications and 
final visual outcome, were recorded for all patients. Corneal scrapings 
when undertaken, the culture results and whether tested sensitivities 
affected the course of treatment were also noted. Corneal scrapings 
were smeared on to glass slides for gram stain and inoculated on to 
agar plates (blood agar, chocolate agar and Sabouraud dextrose agar) 
for microbiological culture. Special media made of non-nutrient agar 
plates inoculated with E coli were used when Acanthamoeba keratitis 
was suspected. All cultures were incubated for at least one week (up to 
3 weeks in Acanthamoeba keratitis). 
All visual acuities were measured using LogMar recordings. Visual 
DFXLW\RIFRXQWLQJ¿QJHUV&)KDQGPRYHPHQWV+0OLJKWSHUFHSWLRQ
(LP) and no light perception (NLP) were recorded as LogMar values of 
1.7, 2, 4 and 5 respectively (Steinberg et al., 1994, Wong et al., 2003). 
SPSS software version 16 (IBM, Chicago, IL) was used for statistical 
analysis in this study. The seasonal variation was analysed using one 
way ANOVA test and Benferroni correction. Patients were divided into 
two groups; bacterial keratitis and Acanthamoeba keratitis. Mann 
Whitney test was used to compare the healing period between the AK 
and BK groups, whereas Wilcoxon test was performed to report the 
change of the VA after treatment. Correlation between the prolonged 
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healing period in relation to age and poor presenting VA was evaluated 
using bivariate correlation. Cox Regression test was used to examine 
the effect of the predisposing factors, sex, previous steroids use, 
location, depth and diameter of the ulcer on the time taken to complete 
healing. 
7.3 RESULTS 
7.3.1 Demographics 
A total of 143 eyes of 129 patients were studied. There were 55 left 
(38.4%), 60 right (41.9%), and 14 bilateral (9.7%) cases. Females and 
males were equally distributed; 66 Female (51.1%) and 63 males 
(48.8%). The average age was 52.8 years (SD= 22.1) ranging from 9 
to 99 years. 
7.3.2 Seasonal variations 
Interestingly, there were more corneal infections during summer time 
(June, July and August) compared with other seasons.  The number of 
cases during summer time was significantly higher than the number 
during autumn (P= 0.041). The detailed seasonal variation of incidence 
is shown in table 13. 
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Table 13. Seasonal distribution of the severe infectious keratitis in Nottinghamshire in 
Autumn (September, October and November), Winter (December, January and 
February), Spring (March, April and May) and Summer (June, July and August). 
2007    Autumn 
    6 
2008 Winter Spring Summer Autumn 
 8 16 21 8 
2009 Winter Spring Summer Autumn 
 7 10 19 6 
2010 Winter Spring Summer  
 10 8 11  
 
The time interval between awareness of first symptoms and 
presentation to hospital ranged from 0 to 33 days, median= 3 days 
(average= 4.97, SD= 5.64). 
Thirty one patients were managed as out-patients and 98 were 
admitted for in-patient treatment. The period of admission ranged from 
2 to a total of 45 days, (median= 6 days and mean= 9±13 days). 
Seventy five percent of patients with longer period of hospital stay 
(more than 9) days were over 60 years old.The total period of 
treatment ranged from 5 to 875 days, median= 45 days (The longer 
period of treatment was among Acanthamoeba keratitis patients, 
ranged from 95 to 875 days, median= 154 days, whereas the median 
period of management of bacterial keratitis was 33.5 days ranging from 
5 to 280 days). 
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7.3.3 Microbiology 
Corneal scrapings were done for 127 of the 143 eyes. 53 (41.7%) eyes 
showed positive growth and 74 (58.26%) eyes revealed no growth. 
Sixteen eyes were not scraped. Twenty six eyes (49%) yielded gram 
positive bacteria, 18 (33.9%) had gram negative bacterial infections 
and 9 (16.9%) demonstrated Acanthamoeba. Details of the organisms 
isolated are elaborated in table 14. 
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Table 14. Isolated organisms by culture (Mixed corneal infections were seen in 5 cases; 
Staphylococcus aureus with Moraxella and Diphtheroids, Acanthamoeba with 
Aspergillus, Pseudomonas aeruginosa with Streptococcus G, Pseudomonas aeruginosa 
with Staphylococcus epidermidis and Propionibacteria with Corynbacteria) (CL: Contact 
lens, HSK: Herpes simplex keratitis, OCP: Ocular cicatricial pemphegoid) 
Causative organism Number of eyes (out 
of the total 53 eyes) Predisposing factors 
Amoeba 
Acanthamoeba 9 (16.9%), 3 cases of 
which were bilateral 
  4 Monthly &  3 daily disposable CL 
  2 None 
Gram Positive Bacteria 
Staphylococcus.aureus 
 
10 (18.8%) 
3 Suture related abscess   
2 Immunosuppression 
1 Severe blepharitis 
1 Failed graft  
1 Atopic Keratoconjunctivitis 
1 Recurrent HSK 
1 dry eye & monthly CL 
 
Pneumococcus 
 
5 (9.4%) 
2 Severe dry eye 
1 HSK 
1 Suture related abscess 
1 Pseudophakic Keratopathy 
 
Staphylococcus epidermidis 
 
4 (7.5%) 
1 Recurrent HSK 
1 Neurotrophic keratopathy 
1 Dry eye 
1 Failed PK & stem cell failure 
 
Corynbacteria diphtheroides 
 
4 (7.5%) 2 Failed PK 
1 Spastic entropion, 1 OCP 
 
Propionibacteria 
 
2 (3.7%) 1 Failed PK & ectropion 
1 Monthly disposable CL  
 
Streptococcus viridans 
 
1 (1.8%)   1 Recurrent HSK 
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Gram Negative Bacteria 
Pseudomonas aeruginosa 
 
8 (15%) 
3 Monthly CL wear 
1 Suture related abscess  
1 Pseudophakic keratopathy 
1 Ramsay Hunt, corneal  
1 Failed corneal graft 
1 Recurrent HSK 
 
Morxella 3 (5.3%) 
1 Recurrent corneal erosions 
1 Suture related abscess 
1 Immunosuppression 
 
Haemophilus influenza 2 (3.7%) 1 Immunosuppression 
1 None 
 
Coliform 2 (3.7%) 1 Monthly CL wear 
1 Exposure keratopathy 
 
Stenotrophomonas 
maltophilia 1 (1.8%) 1 Failed corneal graft 
 
Kingella Kingae 1 (1.8%) 
1 Monthly disposable CL 
 
Kleibsella 1 (1.8%) 1 Pseudophakic bullous  
keratopathy 
 
 
 
7.3.4  Predisposing factors: 
Ocular surface disease was the most common predisposing factor 
(32.8%). In this respect, a background of HSK was the main risk factor 
(almost half of the cases with ocular surface disease). CL wear and 
previous ocular surgeries were also common being 26.5% and 20.2% 
respectively. Chronic topical steroids use was a shared risk factor in 
40% of cases. The predisposing factors and their detailed distribution 
are shown in table 15. 
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Table 15. Predisposing factors of the severe corneal infections (HSK: Herpes simplex 
keratitis, OCP: Ocular cicatricial pemphegoid, HZO: Herpes zoster ophthalmicus) 
Predisposing factor No. (%) out of 143 eyes Total. (%) out of 143 
eyes 
Ocular Disease 
20 (13.9%) Recurrent HSK 
8 (5.5%) Bullous keratopathy 
5 (3.4%) Dry eye 
6 (4.1%) Blepharitis 
3 (2%) Neurotrophic keratopathy 
2 (1.4%) OCP 
2 (1.4%) Neovascular glaucoma 
1 (0.7%) HZO 
47 (32.8%) 
Contact Lens Wear 
(7 bilateral cases) 
31 (21.6%) Monthly disposable 
7 (4.8%) Daily disposable 38 (26.5%) 
Previous Ocular surgery 
10 (6.9%) Failed corneal graft 
11 (7.7%) Corneal suture related 
2 (1.4%) Exposed lid sutures related 
4 (2.8%) Cataract 
2 (1.4%) Glaucoma 
29 (20.2%) 
Eyelids abnormalities 
3 (2%) Ectropion 
2 (1.4%) Entropion 
4 (2.8%) Exposure 
9 (6.3%) 
Corneal trauma 
1 (0.7%) Foreign body related 
3 (2%) Chemical burn  4 (2.8%) 
Systemic diseases 
2 (1.4%) Malignancy 
2 (1.4%) Rheumatoid arthritis 
2 (1.4%) Graft versus host disease  
1 (0.7%) Hepatitis C 
1 (0.7%) Liver failure 
1 (0.7) Immunosuppressive drugs 
1 (0.7%) Diabetes 
10 (7%) 
Mixed factors 
1 (0.7%) Failed graft with ectropion 
1 (0.7%) Failed graft with recurrent 
HSK 
2 (1.4%) 
Unknown cause 4 (2.8%) 4 (2.8%) 
Chronic topical steroids use  57 (40%) 57 (40%) 
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7.3.5 Acanthamoeba Keratitis 
There were 17 cases treated as Acanthamoeba keratitis (12 cases with 
monthly disposable CL, 3 with daily disposable CL and 2 with unknown 
predisposing factors). Out of these, 9 cases were culture proven and 8 
cases were clinically suspected and confirmed by in vivo confocal 
microscopy In all cases of culture positive Acanthamoeba, it showed 
images with morphology of Acanthamoeba cysts.  
7.3.6 Clinical Signs 
Central location of the keratitis was noted in 51% of patients (all 
Acanthamoeba keratitis and pneumococcal infections and in 7/8 of P. 
aureginosa infections. Additionally, 7/8 of P. aeruginosa cases, 5/10 of 
S. aureus and 3/5 of Pneumococcus showed deep infiltration into the 
stroma. Diffuse superficial punctuate keratopathy was the main sign of 
all Acanthamoeba keratitis that presented at an early stage, whereas 
deep central infiltration with > 6 mm diameter was the feature in 
Acanthamoeba keratitis cases that presented at a late stage. Hypopyon 
was seen in 37.6% of cases, (6/8 of P. aeruginosa, 4/4 of coagulase 
negative cocci, 4/5 cases of Pneumococcus and 6/10 of S. aureus). 
There were 9 cases with plaque hypopyon (3/10 of S. aureus). The 
relevant clinical signs of all cases with microbial keratitis are shown in 
table 16. 
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Table 16. Clinical signs of microbial keratitis. Acanthamoeba keratitis cases comprise all 
clinically and culture positive cases (17 cases) (Gram-/+: Gram negative or positive bacteria, 
AK: Acanthamoeba keratitis, SA: Staphylococcus aureus, PA: Pseudomonas aeruginosa, 
SP: Streptococcus pneumonia, SE: Staphylococcus epidermidis, SPK: Superficial 
punctuate keratopathy) 
Signs N (%) Gram-  Gram+  Acanthamoeba No growth 
No 
scrape Highlights 
Location 
of the 
ulcer 
Central 73 
(51%) 15 13 
17 (9 culture 
positive) 26 2 
All AK and 
SP 
infections 
and 7/8 of 
the PA 
cases were 
central 
Peripheral 
70 (49%) 11 5 0 40 14  
Depth of 
the 
ulcer 
Deep 53 
(37%) 9 12 
7 (5 culture 
positive) 20 5 
7/8 with PA, 
5/10 with 
SA and 3/5 
with SP 
showed 
deep 
corneal 
infiltrate 
Superficial 
90 (63%) 17 6 
10 (4 culture 
positive) 46 11  
Size 
< 3mm, 
56 (39%) 5 7 0 39 5  
> 3mm< 
6mm, 54 
(37.7%) 
10 15 2 (2 culture positive) 22 5  
>6mm, 20 
(14%) 3 4 
5 (4 culture 
positive) 5 3 
All the 5 AK 
cases were 
at late 
stage with 
stromal 
involvement 
No 
epithelial 
defect, 13 
(9%) 
0 0 10 (3 culture positive) 0 3 
Diffuse 
SPK were 
the main 
sign in all 
AK cases at 
early stage 
AC 
reaction 
Hypopyon 
54 
(37.6%) 
11 14 4 18 0 
6/8 with PA, 
4/4 with SE 
and, 4/5 
with SP and 
6/10 with 
SA. 
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7.3.7 Complications 
All subjects with AK required a prolonged period of treatment (median= 
154 days, ranged from 55 to 875 days). In addition, all Pneumococcal 
and most P. aeruginosa patients showed a refractory course. Melting 
and thinning were seen in 35 patients (14 had infectious keratitis on a 
recurrent HSK background, of which 8 developed globe perforation). 
Most Pneumococcal infections were associated with melting and 
thinning. Serious ocular complications due to infectious keratitis are given 
in table 17. 
  
155 
 
 
Table 17. Complication of severe microbial keratitis (AK: Acanthamoeba keratitis, SA: 
Staphylococcus aureus, PA: Pseudomonas aeruginosa, SP: Streptococcus pneumonia, 
SE: Staphylococcus epidermidis, HSK: Herpes simplex keratopathy, BK: Bullous 
keratopathy) 
Complications N out of 143 (%) Highlights 
Refractory course of treatment 
(more than the median= 45 days) 70 (48.9%) 
17/17 AK 
5/5 SP 
7/8 PA 
[28 had ocular surface disease 
(10 HSK), 22 CL wearer and 16 
with previous eye surgery] 
High IOP 9 (6.2%) 2/9 AK 
Melting and thinning 35 (24.4%) 
4/17 AK 
4/5 SP 
4/8 PA 
2/3 Moraxella 
(14 cases had history of recurrent 
HSK) 
Perforation 14 (9.8%) 8 Recurrent HSK 
Deep corneal neovascularization 16 (11.1%) 
4 Recurrent HSK 
3 BK 
Bullous Keratopathy 2 (1.4%) 2/17 AK 
Cataract 4 (2.8%) 2/17 AK 
Recurrent infection 7 (4.9%)  
Choroidal detachment 1 (0.7%)  
 
7.3.8 Visual acuity change 
In the Acanthamoeba keratitis group, there was no significant 
difference between the mean VA before and after the treatment (Initial 
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and final VA were 0.5 ± 0.6 and 0.6 ± 1.3, respectively, P= 0.65). In 
BK group, there was statistically significant improvement in the mean 
VA after the treatment (initial and final VA were 1.4 ± 1.3 and 1.3 ± 
1.4, respectively, P= 0.015) (Wilcoxon test was used in the analysis). 
Six cases ended up with NPL because of total cupping of the optic nerve 
discs (4 cases referred from other hospitals).  
7.3.9 Period of healing: 
7.3.9.1 The effect of multiple factors on the period of 
healing 
The effect of multiple variants (central location, depth, diameter of the 
ulcer, predisposing factors, sex and steroid use) on the healing period 
was studied using the Cox regression test in the Acanthamoeba and 
bacterial keratitis groups. 
In the AK group, the central and deep location of the infection 
correlated with prolonged treatment (P= 0.035 and 0.022 respectively), 
whereas the deep location and the previous use of steroids were 
statistically important factors on the treatment period in the BK group 
(P= 0.0001 for both). 
7.3.9.2 Correlation between the old age and the initial VA 
and the period of healing 
There was strong positive correlation between the prolonged course of 
management and the old age (R=0.3, P=0.001, Spearman) and poor 
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initial VA (R=0.4, P=0.0001, Spearman) in the bacterial keratitis group. 
Acanthamoeba keratitis patients showed no such correlation. 
7.3.9.3 Healing period in the Acanthamoeba keratitis and 
BK group 
When compared with the BK patients, AK group by itself was a risk 
factor for refractory and prolonged period of therapy in our study (P= 
0.0005; Mann Whitney). 
 
7.3.10 Treatment 
7.3.10.1 Medical Treatment 
All patients received antibiotics as the first line treatment either 
individually or as a combination with other eye drops. The detailed 
protocols of treatment are elaborated in table 18. 
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Table 18. Medical treatment of severe infectious keratitis (AK: Acanthamoeba keratitis, 
BK: bacterial keratitis, HSK: Herpes simplex keratitis) 
Treatment Medication 
Number of 
cases (n=143) 
(%) 
Highlights 
Bacterial 
keratitis 
Topical fortified cefuroxime 
(10%) & gentamicin 
(1.5%) 
n=79 (61.2%)  
Topical ciprofloxacin n=24 (18.6%)  
Topical chloramphenicol n=3, 2 (32%),  
Topical ofloxacin n=3, 2 (32%  
Topical fortified 
vancomycin(25mg/ml) & 
gentamicin(1.5%) 
n=2 (1.55%)  
Topical levofloxacin n=1 (0.77%)  
Acanthamoeba 
keratitis 
Topical polyhexamethylene 
biguanide (PHMB) 
(0.002%) and Brolene 
(0.1%) (With or without 
Chlorhexidine 0.002%) 
n=17 (13%) 
Antibiotics was 
always used in 
addition to the 
disinfectants in 
the management 
of the AK 
Adjuctive 
treatment 
Systemic Acyclovir n= 24 (16.7%) 
20 with BK with 
HSK background, 
3 AK  and 1 no 
growth 
Topical and systemic 
Antifungal agents such as 
econazol and amphotrecin 
B 
n= 4 (2.8%) 
2 BK and 2 AK (1 
mixed infection 
of AK & 
Aspergillus). 
Topical lubrication n= 52 (36.4)  
Topical cyclopentolate 1% n= 109 (76.2%)  
Topical steroid 
 
n= 25 (17.5%) 
After initial 
treatment with 
antibiotics when 
clinical signs of 
response were 
observed 
 
7.3.10.2 Surgical procedures 
A number of surgical procedures were required in our patients. These 
were related to the lids, puncta, lacrimal sac, cornea and eye pressure 
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control. Details of surgical procedures and their indications are given in 
table 19. 
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Table 19. Therapeutic interventions in refractory microbial keratitis. Therapeutic 
interventions in refractory microbial keratitis (AK: Acanthamoeba keratitis, SA: 
Staphylococcus aureus, PA: Pseudomonas aeruginosa, SP: Streptococcus pneumonia, 
SE: Staphylococcus epidermidis, HI: Haemophilus influenza, DCR: 
Dacrocystorhinostomy, FNDI: Fine needle diathermy, AMT: Amniotic membrane 
transplantation) 
Procedure Indication N (%) Highlights 
Corneal gluing Corneal perforation 
14 
(9.7%) 
8 recurrent HSK 
Corneal biopsy 
Acanthamoeba suspicion with 
poor response to treatment 
4 
(2.8%) 
2 AK 
Conjunctival 
hooding 
perforated infectious ulcer 3 (2%) 1 HI, 1 SA and 1 PA 
Stromal 
puncture 
Bullous keratopathy 
1 
(0.7%) 
1 PS 
FNDI 
To treat lipid keratopathy or 
intra or preoperative for PK 
4 
(2.8%) 
 
Cataract 
extraction 
To improve the vision 
6 
(4.2%) 
3 AK 
Hot grafts Therapeutic grafts 
5 
(3.5%) 
Out of the 12 grafts, 10 
grafts remained clear  
Cold grafts To improve the vision 
7 
(4.9%) 
 
AMT Non healing epithelial defects 
8 
(5.6%) 
 
Inferior 
punctual plugs 
Severe dry eyes and non-
healing epithelial defects 
7 
(4.9%) 
 
Tarsorrhaphy Non healing epithelial defects 
7 
(4.9%) 
 
Botox Injections Non healing epithelial defects 
6 
(4.2%) 
 
Ahmed valve Uncontrolled IOP 
1 
(0.7%) 
 
Diode laser 
Uncontrolled IOP with poor 
VA 
1 
(0.7%) 
 
DCR 
Recurrent corneal infection 
and dacryocystitis 
1 
(0.7%) 
 
Eyelid correction 
2 Entropion 
2 Ectropion 
4 
(2.8%) 
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7.4 DISCUSSION: 
This prospective study recruited 129 consecutive patients (143 eyes) 
with sight threatening corneal infections over a period of three years in 
Nottinghamshire area. This is the first study of this kind for 
Nottinghamshire and should serve as a reference base for future such 
studies in time to come. There was a peak of incidence during summer 
time (June, July and August). One other UK based study has reported a 
similar peak incidence in the summer months (Ibrahim et al., 2009).  
As expected, most cases were unilateral. Corneal infections constitute 
the major cause of unilateral blindness in the world (Whitcher et al., 
2001). However, in our study we also had 14 bilateral cases, of which, 
7 were contact lens wearers. In addition, 31 of the unilateral cases 
were contact lens wearers highlighting contact lens wear as an 
important risk factor for unilateral and bilateral infectious keratitis.  
The average period of symptoms before presentation was 4.97±5.64 
days [mean ± standard deviation (range <1 to 33 days)]. This 
contrasts with the reported periods in New Zealand of 8.9±15.5 days 
(Wong et al., 2003) and India of 2-5 weeks (Panda et al., 2007). These 
differences could relate to cultural issues, social and financial status, 
awareness, distance to nearest eye care facility and other issues. 
Among the 98 patients who were admitted for intensive treatment the 
mean period of admission was 9±13 days (range 2 to 45 days) which 
corresponds to a similar retrospective study carried out in France in 
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which 300 cases were recruited, where the mean stay was 9 days 
ranging from 3 to 60 days (Bourcier et al., 2003). In another study in 
New Zealand the mean in-patient stay was 5.8 days. (Wong et al., 
2003) The New Zealand study was retrospective, included 103 cases 
presenting over 2 years with only one case of Acanthamoeba. Our 
mean stay of bacterial keratitis patients (87% of cases) (excluding 
Acanthamoeba) was 8.4 days. Saeed et al reported a lower average of 
6.3±4.2 days of in-patient stay in Ireland. This study too was 
retrospective, carried out over two years and included 90 cases. Six 
percent of their cases were due to Acanthamoeba infection (Saeed et 
al., 2009). Acanthamoeba keratitis patients and older age group 
patients in general tend to have a longer hospital stay and a more 
prolonged course of treatment. 
The duration of therapy required can be quite variable depending on 
WKHWLPHWRSUHVHQWDWLRQFDXVDWLYHRUJDQLVPDQGSDWLHQW¶VJHQHUDODQG
ocular health. In our study the course of management extended over a 
median of 45 days ranging from 5 to 420 days. In one patient with 
Acanthamoeba keratitis, treatment was given off and on, extending 
over 875 days culminating in a corneal graft. However, when 
Acanthamoeba keratitis patients were excluded, the median period of 
management of bacterial keratitis was 33.5 days ranging from 5 to 280 
days which corresponds with another French study (Bourcier et al., 
2003). 
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The follow up period was much longer than another UK study (average 
11.5 days, range 7-42 days) (Ibrahim et al., 2009) mainly because of 
the bias towards recruiting severe cases of BK in our study. The median 
period of Acanthamoeba keratitis treatment in our study was 192 days 
which correlates with that reported in the literature (Dart et al., 2009). 
According to published reports, microbiological culture from corneal 
scrapes reveals positive results in only 52% to 65% of cases (Garg, 
2010). In our study, only n=53 (41%) showed positive cultures, 
whereas n=74 (58.26%) returned with no growth. The positive culture 
yields in the UK have been variously reported in different studies. Rates 
of 19%, 39%, 60% and 63.8% have been reported (Dart et al., 1991, 
Saeed et al., 2009, Dart, 1988, Ibrahim et al., 2009). In the latter two 
studies the liquid medium of brain heart infusion (BHI) culture medium 
was used in conjunction with the agar plates for microbial isolation. 
Using agar plates instead of BHI to inoculate the corneal sample in our 
study could be a possible explanation for our low isolation rate. 
Schaefer et al have previously reported that 90% of the positive 
cultures were in BHI medium, whereas only 53% were positive in agar 
plates (Schaefer et al., 2001). However, our results correlates with 
another recent study form Germany which has reported a positive 
culture rate of 43% (148/346) although they have used both BHI and 
agar plates for bacterial recovery (Prokosch et al., 2011). Equally one 
can also make a more positive comment that despite the low culture 
rates, we were successful in treating the infection with our choice of 
antibiotics in almost all cases of bacterial keratitis. This suggests that 
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using two broad spectrum antibiotics with efficacy against gram positive 
and gram negative organisms is a sound practical approach. We also 
feel that besides choice of the correct medium for culture, attention to 
some detail could improve culture results. These include the following: 
removal of all discharge from the ocular surface prior to scraping; 
scraping from the advancing edge of the ulcer; taking an adequate 
amount of sample from multiple sites (in big ulcers); ensuring that 
culture plates and tubes cover a range of microbes (including aerobic 
and anaerobic bacteria, fungi and mycobacteria if suspected) and are 
brought to room temperature (warm) before inoculating samples and 
not placed back in the refrigerator; avoiding delay between inoculation 
and transport to appropriate incubator in the microbiology facility; 
liaising with the microbiologists to ensure that samples are adequately 
handled and having a dedicated ocular microbiologists who has 
experience in handling small samples as are often obtained from the 
cornea 
Treatment with antibiotics prior to corneal scraping can affect culture 
positive rates. The culture negative cases in our study were 74 (58 %). 
Of these, 11 had topical antibiotic treatment prior to scraping. 
Nevertheless, all drops were stopped for 24 hours prior to scraping. 
Thus factors other than pre-scrape antibiotic therapy can influence 
culture positive/negative rates. We also did not find any difference in 
the various pre-disposing factors between culture positive and negative 
cases with regard to CL wear, HSK, previous surgery, and other 
predisposing factors. The clinical signs showed no difference compared 
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with the culture positive cases. The response to treatment too was not 
different. The median period to healing in cases with culture negative 
results was 43 days, which was not different from that of eyes with 
culture positive results (P>0.05; 0DQQ:KLWQH\´ 
In our culture positive group, the commonly isolated organisms were S. 
aureus, P. aeruginosa and Acanthamoeba with positive culture results 
in 10, 8 and 9 out of the overall 53 culture positive cases, respectively 
where culture samples were taken. Together, they formed 53% of the 
isolated microbes. The similar positive rate between the S. aureus 
(19%), P. aeruginosa (15%) and Acanthamoeba species (17%) was 
unexpected. In most studies P. aeruginosa and S. aureus have been 
shown to be the most common isolated organisms but not the 
Acanthamoeba. This could be as a result of a growing tendency towards 
use of soft CL but is more likely related to the tertiary referral nature of 
patients attending with severe keratitis thus increasing likelihood of the 
diagnosis of Acanthamoeba.  S. aureus and P. aeruginosa but not the 
Acanthamoeba seem to be important organisms isolated in many other 
UK studies, where they formed half of the isolated organisms. (Saeed 
et al., 2009, Dart, 1988) However, this was not the case in another UK 
study where the Acanthamoeba and Staphylococcus epidermidis formed 
35% (Seal et al., 1999) and 32% (Ibrahim et al., 2009) of the patients  
respectively. 
Mixed corneal infections were seen in 5 cases. Four of these patients 
were over 60 years old and had a refractory course of treatment with 
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poor visual outcome. Such a correlation between the old age and the 
mixed corneal infections has not been commented upon before. 
Ocular surface disease was the most common predisposing factor in our 
study (32.8%) as has also been reported by Pachigolla and Schaefer 
(Pachigolla et al., 2007, Schaefer et al., 2001). CL wear and previous 
ocular surgery were the second and third common predisposing factors 
in 26.5% and 20.2% of cases respectively. In the CL group 18.5% were 
daily disposable CL wearers and 81.5% were 2 to 4 weekly disposable 
CL users. There was association between Acanthamoeba keratitis and 
the CL wear, as 15 out of 17 cases who were treated as Acanthamoeba 
keratitis were CL users with a predominance of the monthly disposable 
CL (73.3%). Interestingly, CL wear was reported in only one case of the 
10 with S. aureus keratitis and in 3 cases of the 9 with P. aeruginosa 
keratitis. This correlation between keratitis due to P. aeruginosa and 
Acanthamnoeba and the use of CL has been well documented 
(Panjwani, 2010, Willcox, 2007). Schaefer et al have shown the weak 
correlation between the CL wear and S. aureus corneal infection 
(Schaefer et al., 2001). The most frequent risk factors for large 
infectious corneal ulcers (more than 6 mm) were CL wear (23.5%), 
bullous keratopathy (23.5%), stem cell failure (17.6%) and failed 
corneal grafts (11.7%).  The commonest isolated organisms in this 
category were Acanthamoeba (29.4%), S. aureus (17.6%) and P. 
aeruginosa (11.7%). All the Acanthamoeba cases were at late stage of 
the stromal infiltration. Large epithelial defects in such a setting could 
be due to the compounding effect of topically applied disinfectants and 
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antibiotics. (Dart et al., 2009) Most corneal infections with P. 
aeruginosa, Pneumococcus, S. aureus organisms and all with 
Staphylococcus epidermidis infection showed hypopyon. Plaque 
hypopyon was found mainly among cases with S. aureus infections. Of 
the 5 cases of Pneumococus keratitis, 4 presented with thinning and 
melting. This was the largest single etiological group amongst the 35 
cases of melting and thinning suggesting that pneumococcal infection is 
an important risk factor for corneal melts in addition to the P. 
aeruginosa and Acanthamoeba. Seventy patients showed refractory 
course of treatment which lasted for more than 45 days (the median 
period for management in our study). Ocular surface disease (mainly 
HSK and bullous keratopathy), previous eye surgery and CL wear were 
the main predisposing factors in this setting.  In addition, all subjects 
with Acanthamoeba keratitis and Pneumococcal keratitis and almost all 
the P. aeruginosa cases fell in this category. The severe nature of 
corneal infection with Pneumococcus and P. aeruginosa has been 
previously demonstrated in a similar study (Wong et al., 2003). The 
refractory and prolonged course of treatment in Acanthamoeba keratitis 
has also been well documented. (Dart et al., 2009, Kashiwabuchi et al., 
2008) In conformity with another study (Constantinou et al., 2009), 
elderly people with bacterial keratitis required a prolonged course of 
management. Similarly, poor initial VA correlated with a refractory 
course and prolonged treatment in the BK group. Acanthamoeba 
keratitis patients showed no such correlation. Moreover, Acanthamoeba 
keratitis as a disease was a risk factor for refractory and prolonged 
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period of therapy when compared with bacterial keratitis. Deep corneal 
infections are known to follow a severe and refractory course of 
infection requiring prolonged management. (Bourcier et al., 2003) In 
our study, deep infiltrates were associated with a protracted healing 
period with more than 84% of the patients with deep infectious keratitis 
demonstrating a prolonged course to resolution. 
Most of the predisposing factors seemed not to significantly affect the 
period of healing. However, previous chronic steroid use in association 
with ocular surface disease was a significantly important factor, Indeed, 
it was a shared predisposing factor in 40% of cases. Most cases 
associated with chronic steroid use had a refractory course of bacterial 
keratitis with poor visual outcome. The association of topical steroid 
usage and ocular surface disease in prolonging the duration of 
management and poor visual outcomes has previously been 
highlighted. (Wong et al., 2003, Bourcier et al., 2003)  
Previous HSK was the main risk factor for corneal perforation (57%) 
and deep corneal neovascularisation (56%). Herein, the main indication 
for corneal gluing was infectious keratitis with previous HSK (57% of 
cases). The visual morbidity resulting from recurrent HSK keratitis can 
lead to corneal scarring, thinning and neovascularisation which may 
determine the outcome of any subsequent bacterial corneal infection 
(Kaye and Choudhary, 2006). 
Topical fortified cefuroxime & gentamicin or ciprofloxacin as a 
monotherapy have been shown to have a positive impact on severe 
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infectious keratitis. (Gokhale, 2008) These drugs were the major 
treatment modalities for all bacterial keratitis cases in our study. There 
were 5 cases that were initially treated as viral infection and then 
switched to other regimes. The pseudo-dendritic epitheliopathy of the 
Acanthamoeba keratitis which could be misdiagnosed as viral keratitis 
has been previously reported. (Dart et al., 2009, Tanhehco and Colby, 
2010) Anti Acanthamoeba agents (PHMB & brolene with or without 
chlorhexidine) and antibiotics were used in all Acanthamoeba keratitis 
cases. 
Corneal grafting had been done for a total of 12 patients (7.7%). Five 
patients underwent therapeutic corneal grafting for non-healing corneal 
infection (2 with Acanthamoeba keratitis, 1 with Pneumococcal keratitis 
and 2 with no growth) and 7 had optical corneal grafting after the 
infection had healed. Of these, 10 corneal grafts remained clear and 
two failed (over 9 months follow up). Both failures were related to hot 
grafts done for Acanthamoeba keratitis. In both cases the infection did 
not recur. According a comprehensive literature review by Sharma et al 
(Sharma et al., 2010), therapeutic corneal grafting can eradicate 
bacterial infection in 90 ± 100%  of cases with a clear graft after 1 year 
in 69 ± 100%. Worse prognosis for therapeutic corneal grafts in 
Acanthamoeba keratitis was reported in the same review, as a cure rate 
of 45 ± 81 % and a survival rate of 45% after one year. 
In addition, Kashiwabuchi et al observed that 40% of eyes with hot 
grafts due to refractory Acanthamoeba 
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ZLWK VLJQL¿FDQWO\ VKRUWHUJraft survival (P<0.01) (Kashiwabuchi et al., 
2008). One of our failed Acanthamoeba keratitis grafts also had high 
post op IOP requiring an Ahmed valve. 
Six cases ended up with NPL because of total cupping of the optic nerve 
discs. All these cases showed refractory course of resolution with high 
IOP readings throughout the course of disease. The initial VA was 
significantly poor in most of these cases (3 with HM, 2 with LP). In only 
one case with Acanthamoeba keratitis, the initial VA was 0.3 LogMar. Of 
this group, 3 cases showed no growth, 1 with P. aeruginosa, 1 with 
Kleibsella oxytoca and 1 with Acanthamoeba keratitis. All of these cases 
were treated medically except for the Acanthamoeba keratitis case 
which ended up with hot corneal graft because of non-healing ulcer. 
Interestingly, the predisposing factor in 4/6 patients was the 
pseudophakic bullous keratopathy. This strongly emphasises the 
importance of measuring and controlling the IOP during any infectious 
keratitis. In conclusion, this study found that ocular surface disease was 
the most common predisposing factor for sight threatening infectious 
keratitis. In this respect, herpes simplex keratitis was a significant 
association. Refractory course of treatment was mainly documented in 
patients with ocular surface disease (mainly HSK and bullous 
keratopathy), CL wear and previous eye surgery. All subjects with 
Acanthamoeba and Pneumococcal keratitis and almost all the 
Pseudomonal infections showed prolonged course of treatment. Visual 
loss due to raised IOP during infectious keratitis was a main concern. 
Paying special attention to the IOP values during the treatment of the 
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infectious corneal ulcers is essential. Therapeutic corneal grafting was 
an effective and safe treatment for patients with refractory infections 
keratitis. Using of BHI in conjunction with the agar plates could improve 
the positive culture yields of the corneal scrapes. However as the 
clinical outcome of culture positive and culture negative cases was no 
different one could argue that a routine culture in all cases may not be 
essential if treatment with two broad spectrum antibiotics is employed 
at the outset. 
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8 Profile of Sight Threatening Infectious 
Keratitis in Nottinghamshire: A 
Retrospective Study 
8.1 INTRODUCTION 
We conducted a retrospective study of the sight threatening infectious 
keratitis in Queens Medical Centre, Nottinghamshire, England over a 
period of 4 years. The aim of our study was to document the incidence, 
demography, predisposing factors, clinical and microbiological 
diagnosis, treatment given, follow up duration, visual outcomes and 
complications in patients with severe infectious corneal ulceration. 
Another important purpose of our study was to compare the results of 
this study with another prospective study (over 3 years) which we had 
done in a trial to define the overall profile of the infectious keratitis in 
Nottinghamshire over a total period of 7 years.  
8.2 METHODS 
Between September 2003 and September 2007, all patients with severe 
infectious keratitis who were admitted in the Eye ward (C25) at Queens 
Medical Centre (QMC), Nottingham, UK were recruited in this study. 
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(After September 2007, we have conducted another prospective study 
which is described in details in another chapter). 
The following data were obtained from the clinical notes of all subjects 
(when possible): personal details, the predisposing factors, visual 
acuity (VA), corneal scraping culture results, ocular signs, medical 
treatment including drugs, dose and duration, any surgical intervention, 
complications and final visual outcome. All visual acuities were 
transferred intR /RJ0DU UHFRUGLQJV 9LVXDO DFXLW\ RI FRXQWLQJ ¿QJHUV
(CF), hand movements (HM), light perception (LP) and no light 
perception (NLP) were recorded as LogMar values of 1.7 and 2, 4 and 5 
respectively (Steinberg et al., 1994, Wong et al., 2003). 
SPSS 16 software was used. Patients were divided into two groups, 
Acanthamoeba keratitis and bacterial keratitis. The seasonal variation 
was analysed using one way ANOVA test and Benferroni correction. 
Mann Whitney test was used to compare the healing period between 
the Acanthamoeba keratitis and BK groups, whereas Wilcoxn test was 
performed to report the change of the VA after treatment. Correlation 
between prolonged healing period in relation to age and VA at 
presentation was evaluated using bivariate correlation. Cox Regression 
test was used to examine the effect of the predisposing factors, sex and 
previous steroids use on the time taken to complete healing. 
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8.3 RESULTS 
8.3.1 Demographics 
A total of 95 eyes of 92 patients were included. There were 47 left 
(49.4%), 45 right (47.3%), and 3 bilateral (3.1%) cases. Females and 
males were almost equally distributed; 47 Female (51.1%) and 45 
males (48.9%). The average age was 56 years (+/- 24.4) and ranged 
from 7 to 95 years 
8.3.2 Seasonal variations 
Overall, there were 24 cases in autumn, 13 in spring, 26 in summer 
and 28 cases during the winter time (Autumn: September, October and 
November, Winter: December, January and February, Spring: March, 
April and May and Summer: June, July and August). The estimated 
number of studied cases during the summer and autumn was 
significantly more than the number in spring (one way ANOVA test, P< 
0.01). The seasonal variation of incidence is shown in table 20. 
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Table 20. Seasonal distribution of the severe infectious keratitis in Nottinghamshire, 
Autumn (September, October and November), Winter (December, January and 
February), Spring (March, April and May) and Summer (June, July and August). 
2003    Autumn 
    5 
2004 Winter Spring Summer Autumn 
 6 3 5 7 
2005 Winter Spring Summer Autumn 
 5 4 8 10 
2006 Winter Spring Summer Autumn 
 6 4 7 9 
2007 Winter Spring Summer  
 7 2 7  
 
8.3.3 Period of treatment 
The mean period of hospital admission was 8±11 days (range 4 to 35 
days). The number of cases in which the total period of treatment was 
clearly documented were 92/95 (in 3 cases, the follow up period was 
not documented accurately and thus excluded from this calculation). 
The total period of treatment ranged from two weeks to 2 years, 
median = 45 days (mean = 67.1±90.9). When analysed separately, the 
longer period of treatment was among Acanthamoeba keratitis patients, 
ranged from 4 months to 2 years, median= 165 days (mean = 287 ± 
267), whereas the median period of management of BK was 45 days 
ranged from two weeks 13 weeks except one case where it was 6 
months (in a refractory case of bacterial keratitis) (mean = 54 ± 51). 
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8.3.4 Microbiology 
Corneal scrapings were done in 93 of the 95 eyes. 36 (39%) eyes 
showed positive growth and 57 (61%) eyes revealed no growth. Of the 
culture positive samples, 17 eyes (47.2%) yielded gram negative 
bacteria [16 cases of P. aeruginosa and 1 case of coliform bacteria], 11 
(31%) showed gram positive bacterial infections [5 S. aureus, 4 
Staphylococcus epidermidis, 1 pneumococcus and 1 Strepococcus 
viridians], 5 eyes (14%) had Acanthamoeba keratitis (one bilateral 
case), 2 (5.5%) demonstrated fungal infection and 1 (2.5%) with 
atypical mycobacteria. Table 21 shows the isolated organisms and 
related predisposing factors. 
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Table 21. The isolated organisms and the correlated predisposing factors 
Isolated organism Number of eyes (out of 36 
culture positive eyes) Predisposing factors 
Amoeba 
Acanthamoeba 5 (13.8%) 5 CL wear 
Gram-negative Bacteria 
Pseudomonas aeruginosa 16 (44.4%) 
12 CL wear 
1 Bullous keratopathy 
1 Loose suture 
2 Failed conreal grafts 
Coliform 1 (2.7%) 1 CL wear 
Gram-positive Bacetria 
Staphylococcus aureus 5 (13.8%) 
1 CL wear 
2 Suture related 
2 Failed corneal graft 
1 Immunosuppression 
1 Decompensated cornea after 1 
)XFK¶VHQGRWKHOLDOG\VWURSK\ 
 
Staphylococcus epidermidis 4 (11.1%) 
1 CL wear 
1 Previous HSK infection 
1 Post vitrectomy 
1 Bullous keratopathy 
pneumococcus 1 (2.7%) 1 Immunosuppression 
Streptococcus viridans 1 (2.7%) 1 Eczema and dry eyes 
Fungi 
Candida albicans 1 (2.7%) 1 Exposure keratopathy 
Candida barabsilosis 1 (2.7%) 1 Failed corneal graft with 
steroid use 
Mycoplasma 
Atypical mycobacteria 1 (2.7%) 1 CL wear 
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There were 3 bilateral cases (one case with Acanthamoeba keratitis in 
CL wearer, one case with P. aeruginosa in decompensated cornea 
UHODWHGWR)XFK¶VHQGRWKHOLDOG\VWURSK\DQGRQHFDVHVKRZHGQRJURZWK
after LASIK surgery) 
8.3.5 Predisposing factors 
Ocular surface diseases (35.8%) and Contact lens wear (31.5%) were 
the main predisposing factors for the corneal infections; together they 
formed about two thirds of cases. All cases with Acanthamoeba keratitis 
and 12/16 of the P. aeruginosa cases were CL wearer. There was only 
one CL wearer among the S. aureus infections (out of the 5 isolated S. 
aureus keratitis). The detailed risk factors for infectious keratitis are 
elaborated in table 22.  
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Table 22. The factors which predispose to infectious keratitis 
Predisposing factor No. (%) out of the 95 eyes Total. (%) out of the 95 
eyes 
Contact Lens Wear 
(2 bilateral cases) 
29 soft CL wear 
1 Rigid gas permeable CL 
30 (31.5%) 
Ocular Disease 
11 Previous herpes simplex 
keratitis (HSK) 
8 Dry eyes 
7 Bullous keratopathy 
3 Neovascular glaucoma 
2 Non healing epithelial defects 
)XFK¶VHQGRWKHOLDOG\VWURSK\ 
1 ocular cicatricial pemphegoid 
(OCP) 
1 Steven Johnson syndrome 
 
34 (35.8%) 
Previous Ocular surgery 
5 Failed grafts 
5 Suture related 
1 Intravitreal Avastin injections 
1 Vitrectomy 
1 previous LASIK 
13 (13.7%) 
Eyelids abnormalities 
4 Exposure keratopathy 
2 Ectropion 
1 Entropion 
7 (7.4%) 
Corneal trauma 
1 Electrical burn 
2 Corneal abrasion 
3 (3.1%) 
Systemic diseases 
2 Diabetes 
1 Rheumatoid arthritis 
1 Thyroid dysfunction 
4 (4.2%) 
Infection of the lacrimal sac 1 Chronic dacryocystitis 1 (1%) 
No predisposing factors 3 cases 3 (3.1) 
Steroids use Shared factor in ocular surface diseases 43 (45.2%) 
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8.3.6 Signs 
Hypopyon was seen in 41/95 cases (12/16 P. aeruginosa 2/5 S. aureus, 
3/4 S epidermidis). All Acanthamoeba keratitis cases showed no 
hypopyon. The location of the ulcer was not well documented in 17/95 
cases and thus excluded. Out of the remaining 78 cases, 39 revealed 
central location (all the Acanthamoeba keratitis showed central 
location). The thickness of the infiltrate was not documented in 31/95 
cases, the infiltrate showed deep position (more than 50%) in 29/64 (in 
4/5 cases with Acanthamoeba keratitis and 3/5 of S. aureus and 12/16 
cases with P. aeruginosa). Additionally, out of the 60/95 documented 
cases, the ulcer was more than 6 mm in 9 cases (all cases with 
Acanthamoeba keratitis and 8/16 of P. aeruginosa cases were in this 
category), between 3 and 6 in 37 cases and less than 3 mm in 14 
cases. 
8.3.7 VA during and after  
Out of the 92 cases with documented follow up period, 15 cases were 
excluded because of the non-documented VA either before or after the 
infections. In the remainder 77 cases, the median VA during the acute 
infections was 1 (the mean was 1.4 ± 1.3). After the complete healing, 
the median VA became 0.48 and the average improved to 1.2 ± 1.5. 
The improvement in VA after the treatment was statistically significant 
(P < 0.01). When calculating the change in VA in the Acanthamoeba 
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keratitis and bacterial keratitis groups separately, there was no 
significant difference between the VA during and after the 
Acanthamoeba keratitis infection (P>0.05), whereas the improvement 
in VA in the BK group was statistically significant (P<0.005) 
8.3.8 Complications 
Out of the 92/95 cases with documented follow up period, 38/92 
showed prolonged course of healing which was more than the median 
period of healing (median= 45 days). Eighteen cases showed no 
growth, 9/16 P. aeruginosa, 5/5 Acanthamoeba keratitis, 2/5 SA, 1/1 
Streptococcus viridians, 1/1 Pneumococcus, 1/2 Candida and 1/1 case 
with atypical Mycobacteria Melting and thinning was seen in 35 patients 
(6/16 of them were caused by P. aeruginosa). Non healing infection 
was documented in 3 cases which needed evisceration (2 with no 
growth and 1 Pneumococcus). Ocular complications due to infectious 
keratitis are given in table 23. 
  
182 
 
 
Table 23. Complication of microbial keratitis (AK: Acanthamoeba keratitis, PA: 
Pseudomonas aeruginosa, SA: Staphylococcus aureus, S epidermidis: Staphylococcus 
epidermidis and HSK: herpes simplex keratitis) 
Complications N out of 92 (%) Highlights 
Refractory course of treatment (more 
than the median= 45 days) 38  
High IOP 5 
3 no growth, 1 AK and 1 PA 
 
Melting and thinning 23 
12 no growth, 6 PA, 1 AK, 1 SA and 
1 S edpidermidis , 1 Pneumococcus 
and 1 atypical Mycobacteria 
Perforation 14 8 no growth, 3 PA, 1 AK, 1 SA and 1 S edpidrmidis 
Deep corneal neovascularization 8 6 had previous gluing and 2 cases 
with previous HSK 
Bullous Keratopathy 1 1 AK 
Cataract 2 1 AK and 1 no growth 
Recurrent infection 3 2 SA and 1 no growth 
Non-healing infection leading to 
Evisceration 3 2 no growth and 1 Pneumococcus 
 
8.3.9 Correlation between Healing period and age 
and correlation between healing period and 
initial VA in bacterial and Acanthamoeba keratitis 
patients 
Out of the 36 eyes with positive culture results, bacterial keratitis (31 
cases) and Acanthamoeba keratitis (5 cases) were analysed as different 
groups. Relevant data was available for all the culture positive cases.   
In both groups (bacterial and Acanthamoeba keratitis) there was no 
correlation between the initial VA and the prolonged period of 
treatment (P>0.05) However, in the bacterial keratitis group there was 
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correlation between the old age and the prolonged period of healing 
(R=0.4, P<0.001, Spearman) which was not demonstrated in the 
Acanthamoeba keratitis group. The correlation between the prolonged 
period of healing and the delay in presentation could not calculated 
because the required information was not documented properly. 
8.3.10 Period of healing 
The effect of multiple variants (predisposing factors, sex and steroid 
use) on the healing period was studied using the Cox regression test in 
the Acanthamoeba keratitis and bacterial keratitis groups. In the former 
group, none of the previous factors seemed to affect the course of 
healing, whereas the previous use of steroids was the only statistically 
important factor affecting the period of treatment in the bacterial 
keratitis group (P< 0.001) 
8.3.10.1 Healing period in the Acanthamoeba and bacterial 
keratitis groups 
When compared with the bacterial keratitis patients, Acanthamoeba 
keratitis was a risk factor for refractory and prolonged period of therapy 
in our study (P<0.001) 
8.3.11 Treatment 
8.3.11.1 Medical Treatment 
In 3 cases, the treatment was not documented in the notes and 
excluded from this analysis. All the other 92 patients received 
184 
 
antibiotics as the first line treatment either individually or as a 
combination with other eye drops. The most common used antibiotics 
were topical fortified cefuroxime (5-10%) & gentamicin (5%) (n=71, 
77.1%), topical ciprofloxacin as a monotherapy or as a combination 
with other topical eyedrops (n=26, 28.3%), chloramphenicol as a 
monotherapy or as a combination with other topical eyedrops (11, 
12%) and fortified vancomycin (25mg/ml) & amikacin (25mg/ml) (n=2, 
2.2%). A combination of topical anti Acanthamoeba agents: 
polyhexamethylene biguanide (PHMB 0.02%) or chlorhexidine 0.02% 
& Brolene 0.1% with topical antibiotics were used for Acanthamoeba 
keratitis (n=5, 2.1%). Antifungal agents such as topical amphotericin 
and systemic fluconazole were used in 3 cases (2 Candida infections 
and one atypical Mycobacterial keratitis). Acyclovir was used in 13 
cases (all 11 cases with previous HSK and 2 cases with refractory 
course of healing which showed no growth). Topical corticosteroids 
were used in 22 cases of bacterial keratitis after the initial signs of 
response to treatment were documented. In addition, topical lubrication 
was used in 47 cases and dilating agents were used in 90 cases. 
8.3.11.2 Surgical procedures 
A number of surgical procedures were required in our patients. These 
were related to the lids, puncta, lacrimal sac and cornea.  
Corneal grafting was carried out in 10 cases (3 cold corneal grafts and 
7 therapeutic hot grafts). Most of the grafts remained clear except for 
one therapeutic graft for Acanthamoeba keratitis which failed shortly 
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after the penetrating keratopathy and needed cold grafting. In all 
cases, corneal grafting succeeded in eliminating the infectious keratitis 
with no recurrence of the original infection on the corneal grafts. Details 
for surgical procedures and their indications are given in table 24. 
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Table 24. Therapeutic interventions in refractory microbial keratitis (NG: No growth, 
AK: Acanthamoeba keratitis, PA: Pseudomonas aeruginosa, SA: Staphylococcus aureus, 
S epidermidis: Staphylococcus epidermidis, AMT: Amniotic membrane transplantation, 
DCR: Dacryostorhinostomy) 
Procedure Indication N (%) out of the 95 cases Highlights 
Corneal gluing Corneal perforation 12 (12.6%) 
8 NG, 1 AK, 1 PA, 1 
SA and 1 S 
epidermidis 
Conjunctival hooding perforated infectious ulcer 2 (2.1%) 1 NG and 1 PA 
Fine Needle Diathermy 
of corneal vessels 
To treat lipid keratopathy or 
intra or preoperative for PK 1 (1.1%) 1 NG 
Cataract extraction To improve the vision 2 (2.1%) 1 NG and 1 AK 
Hot grafts Therapeutic grafts  7 (7.4%) 
3 NG, 1 PA, 1 AK, 1 
SA and 1 S 
epidermidis 
Cold grafts To improve the vision 3 (3.1%) 1 PA, 1 AK and 1 NG 
Replacement of 
corneal suture 
To re-suture graft host 
dehiscence 1 (1.1%) PA 
 
AMT 
Non healing epithelial defects 2 (2.1%) 2 NG 
Inferior punctual plugs 
 
Severe dry eyes and non 
healing epithelial defects 1 (1.1%) NG 
Tarsorrhaphy Non healing epithelial defects 5 (5.2%) 5 NG 
Botox Injections Non healing epithelial defects 5 (5.2%) 5 NG (2 cases needed tarsorrhaphy later) 
Intrvitreal injection of 
antibiotics Endophthalmitis 2 (2.1%) 2 NG 
DCR Recurrent corneal infection 
and dacryocystitis 1 (1.1%) NG 
Eyelid correction 
2 Entropion 
2 Ectropion 
2 (2.1%) 2 NG 
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8.4 DISCUSSION 
The main purpose of this retrospective study was to ascertain whether 
there were any emerging or evolving trends in microbial keratitis over 
the period of the prospective and retrospective studies. This could could 
give an idea about the overall profile of the infectious keratitis in 
Nottinghamshire and East-midlands area over a period of 7 years.   In 
fact, the findings of the two studies were almost identical which 
probably confirmed the reliability of these studies and also indicated 
that the profile of infection had not changed over the study period. The 
findings of the prospective study have already been discussed in a 
chapter 7.  
In the following discussion, a comparison of the data obtained from this 
retrospective study with these resulted in the prospective study will be 
illustrated.  
This retrospective study recruited 92 in-patients (95 eyes) with severe 
corneal infections over a period of four years in Nottinghamshire area. 
There was significantly higher number of patients during the summer 
time. The same trend was also reported in the prospective study. 
Another UK based study has also reported the peak incidence of 
infectious keratitis during the summer time (Ibrahim et al., 2009).  
The average period of warning symptoms before presentation was not 
documented properly in most cases and thus this calculation was 
excluded from this study.  
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The mean period of hospital admission was 8±11 days (range 4 to 35 
days). This almost corresponds to the mean period of admission in our 
prospective study (mean of 9±13, range 2 to 45). It also correlates to a 
similar retrospective study carried out in France where the mean stay 
was 9 days (ranging from 3 to 60 days). (Bourcier et al., 2003) 
However, Saeed et al have reported a lower average of 6.3 ± 4.2 days 
of in-patient stay in a retrospective study in Ireland (Saeed et al., 
2009). Furthermore, in another study in New Zealand the mean in-
patient stay was 5.8 days (Wong et al., 2003).  
The course of treatment extended over a median of 45 days in this 
study. This was identical to the median period of our prospective study. 
However, when Acanthamoeba keratitis cases were excluded the 
median remained 45 days whereas it was 33 days in the prospective 
study. This may be due to the difference in the patients recruited in the 
two studies. In the retrospective study patients admitted with severe 
keratitis were included, whereas in the prospective study out-patients 
with severe keratitis and in-patients were included. If the decision to 
admit for treatment is an indicator of severity then it is possible that in 
the latter group the response was overall quicker due to the inclusion of 
the out-patients. The median period of treatment in Acanthamoeba 
keratitis cases in the retrospective study was 165 days, whereas it was 
154 days in the prospective study. The treatment period was longer 
than another UK based study in Portsmouth (average 11.5 days, range 
7-42 days) (Ibrahim et al., 2009). This was mainly because of the bias 
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towards recruiting severe cases of infectious keratitis in QMC in our 
study. 
Interestingly, only 39% of eyes showed positive growth from the 
corneal scrapings, whereas 61% of eyes revealed no growth. This was 
even less than the positive rate of our prospective study where 41% 
showed positive cultures and 58.26% returned with no growth. 
Worldwide, the microbiological culture from corneal scrapes reveals 
positive results in only 52% to 65% of cases. (Garg, 2010) The positive 
culture yields in the UK are variously reported as 19%, 39%, 60% and 
63.8% in different studies (Dart et al., 1991, Saeed et al., 2009, Dart, 
1988, Ibrahim et al., 2009). In the studies with 60 and 63.8% positive 
rate, a brain heart infusion liquid culture medium (BHI) has been used 
in conjunction with the agar plates for microbial isolation. Using agar 
plates (without BHI) for culturing of the corneal scrapes at the QMC 
could be a possible explanation of our low isolation rate. Schaefer et al 
have previously reported that 90% of the positive cultures were in BHI 
medium, whereas only 53% were positive in agar plates (Schaefer et 
al., 2001). However, a German study has recently reported a positive 
culture rate of only 43%(148/346) even though they used both BHI 
and agar plates for bacterial recovery (Prokosch et al., 2011). 
The most common isolated organisms in our study was P. aeruginosa 
(16/36, 44%). Equally, Acanthamoeba and S. aureus were the next 
most common isolated organisms, (5/36, 14% each). All together, they 
formed about 3/4 of all culture positive cases. In the prospective study, 
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however, similar positive rate between the S. aureus (19%), P. 
aeruginosa (15%) and Acanthamoeba species (17%) was documented. 
These three organisms together were responsible of about half of the 
culture positive cases. According to the literature, P. aeruginosa and S. 
aureus have been shown to be the most common isolated organisms in 
many studies (Saeed et al., 2009, Dart, 1988). Though still uncommon, 
Acanthamoeba keratitis is an increasingly identified infection at our 
centre, probably because of the tertiary nature of our patient base and 
because of the growing tendency of the CL wear (Das et al., 2007). 
Similar to the findings of the prospective study, ocular surface disease 
was the most common predisposing factor (35.8%) as has also been 
reported by Pachigolla and Schaefer (Pachigolla et al., 2007, Schaefer 
et al., 2001). CL wear was the second most common predisposing 
factor (in 31.5% of cases). The type of contact lens was not well 
documented in most cases.  
Interestingly, all the 5 cases with Acanthamoeba and 12/16 of the P. 
aeruginosa were CL wearers.  CL wear was reported in only one case 
out of the 5 cases with S. aureus keratitis. The correlation between 
corneal infections due to P. aeruginosa & Acanthamnoeba and the CL 
use has been well reported (Panjwani, 2010, Willcox, 2007). 
Furthermore, Schaefer et al have shown the weak correlation between 
the CL wear and S. aureus corneal infection (Schaefer et al., 2001). 
Also, in accordance to the findings of our prospective study, topical 
corticosteroid use was a shared predisposing factor in 45.2% of cases. 
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The wide use of topical steroids in patients with severe infectious 
keratitis has previously been reported. (Wong et al., 2003) 
Although there was a lack of documentation in many cases, the clinical 
signs of the corneal infections showed similarity to those found in the 
prospective study.  In fact, the large infectious corneal ulcers (more 
than 6 mm) were reported in 4/5 of the Acanthamoeba keratitis cases, 
3/5 of S. aureus and 12/16 of P. aeruginosa infections. As documented 
in the prospective study, most corneal infections with P. aeruginosa 
(12/16), S. epidermidis (3/4), S. aureus (2/5) showed hypopyon. All 
Acanthamoeba keratitis cases did not show a hypopyon. Of note, 38/92 
showed refractory course of treatment which lasted for more than 45 
days (the median period for management in our study). Of these, all 
the Acanthamoeba keratitis cases and 9/16 of the P. aeruginosa were in 
this category. The refractory and prolonged course of treatment in 
Acanthamoebl and P. aeruginosa keratitis has been well documented 
(Dart et al., 2009, Kashiwabuchi et al., 2008, Willcox, 2007). There was 
no significant improvement of the visual acuity in the Acanthamoeba 
keratitis group whereas the final visual acuity was significantly better in 
the bacterial keratitis group. This could be explained by the fact that 
many patients with Acanthamoeba keratitis had been diagnosed and 
treated at the late stage of deep stromal infiltration and had 
devastating consequence despite treatment. This, however, was not the 
case in the bacterial keratitis group where most patients were 
diagnosed and treated at early stage with antibiotics which were 
effective and prevented further visual loss in most cases.  
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Acanthamoeba keratitis as a disease, was a risk factor for refractory 
and prolonged period of therapy when compared with bacterial 
keratitis. As found in the prospective study, a correlation between the 
old age and the prolonged period of healing was only found in the 
bacterial keratitis group. Most of the predisposing factors seemed not to 
significantly affect the period of healing. However, previous chronic 
steroid use in association with ocular surface disease was a significantly 
important factor. The association of topical steroid usage and ocular 
surface disease in prolonging the duration of management and poor 
visual outcomes has previously been highlighted. (Wong et al., 2003, 
Bourcier et al., 2003)  
Topical fortified cefuroxime & gentamicin (dual therapy) or ciprofloxacin 
as a monotherapy have been shown to have a positive impact on 
severe infectious keratitis. (Gokhale, 2008) These drugs were the major 
treatment modalities for all bacterial keratitis cases in our study. Anti 
Acanthamoeba agents (PHMB or chlorhexidine & brolene) and 
antibiotics were used in all Acanthamoeba keratitis cases. Corneal 
grafting was done for a total of 10 patients (7 therapeutic hot grafts 
and 3 optical cold corneal grafts). In the hot grafts category, there 
were 2 CL wearers with refractory Acanthamoeba keratitis, 2 with S. 
aureus infection (1 suture related in a corneal graft, and 1 HSK), one 
with P. aeruginosa keratitis (failed graft) and 2 with no growth (1 
severe blepharitis and 1 HSK). Most of the grafts remained clear except 
for one therapeutic graft for Acanthamoeba keratitis which failed shortly 
after the penetrating keratopathy and needed another grafting. In all 
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cases, corneal grafting succeeded in eliminating the infectious keratitis 
with no recurrence of the original infection on the corneal grafts. 
Therapeutic corneal grafting can eradicate bacterial infection in 90 ± 
100% of cases with a clear graft after 1 year in 69 ± 100%. (Sharma et 
al., 2010). These findings mirror the findings of the prospective study 
with regard to the need of corneal grafts.   
The main limitation of this study was the lack of sufficient clinical 
documentation in some cases which is an inherent issue in 
retrospective studies. 
In conclusion, this retrospective study showed consistent findings 
compared with the previous prospective study. It showed that ocular 
surface disease and CL wear were the most common predisposing 
factors for sight threatening infectious keratitis. Culture yields from 
clinically apparent infectious keratitis cases were poor. Use of brain 
heart infusion culture medium in conjunction with the agar plates could 
improve the positive culture rates from corneal scrapes. Refractory 
course of treatment was mainly documented in patients with ocular 
surface disease, CL wear and previous eye surgery. All subjects with 
Acanthamoeba and most P. aeruginosa keratitis required prolonged 
course of treatment. Therapeutic corneal grafting was an effective and 
safe treatment for patients with refractory infectious keratitis. 
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9 Summary, general discussion and 
Conclusion 
The ocular surface is permanently in contact with environmental 
pathogens. Commensal microbes, which inhibit the mucosal surface of 
the OS, have also the potential to cause opportunistic infections. This 
can lead to severe infectious keratitis which can cause permanent loss 
of vision. To combat against these harmful challenges, the innate 
immunity on the OS plays a vital role. AMPs are an important 
component of this innate response. They are natural effectors of the 
defence system with broad spectrum antimicrobial activity and cell 
signalling functions.  
9.1 OVERVIEW: 
In this thesis, the molecular and clinical aspects of infectious keratitis 
were studied. The in vitro gene expression of the ocular AMPs was 
described while stimulating OS cells with different microbes. Also, the 
AMPs gene profile was tested in healthy people and compared with the 
profile in patients with active infectious keratitis and after healing. 
Furthermore, the commercially available HBD3 protein was studied for 
its antibacterial activity. In contradiction to the published literature, no 
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evidence of such activity was concluded.  Clinically, this 
studydemonstrated for the first time the role of corneal densitometry, 
as measured by Rotating Scheimpflug Camera (Oculus Pentacam) in 
the follow up of patients with infectious keratitis. Comprehensive 
prospective and retrospective studies of the profile of sight threatening 
corneal infections in Nottinghamshire over a period of 7 years were also 
carried out. 
9.2 BRIEF DESCRIPTION 
In chapter two, the gene level of the ocular AMPs in OS cells stimulated 
with Acanthamoeba castellanii, a known ocular pathogen, was 
comprehensively studied. This was the first study to examine the profile 
of AMPs in relation to protozoal infections. The hBD3 gene expression 
was noted to be the most significantly up-regulated molecule amongst 
the studied AMPs. This suggested that AMPs, notabley hBD3, may play 
a possible role in combating Acanthamoebic infection at the ocular 
surface. This was followed by a study on the examination of the mRNA 
levels of the AMPs during in vitro challenge of OS cells with Gram-
negative and Gram-positive bacteria (in chapter three). In both groups, 
LL37 was found to be significantly up-regulated compared to other 
AMPs. This too was the first comprehensive study to show the gene 
profile of ocular AMPs in response to the stimulation with two different 
pathogens (P. aeruginosa and S. aureus). Together with the results 
obtained in chapter two led to the conclusion thatmodulation of ocular 
AMP gene expression was pathogen-dependent. However, one of the 
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drawbacks of this study was using two different types of the OS cells. 
HCEC were used in the bacterial stimulation study and HCLE for 
Acanthamoebal challenge. This was mainly due to a technical reason in 
that the Acanthamoeba stimulation was carried out in the laboratory of 
one of our collaborators (prof. Panjawani) in the USA. The treated 
samples were sent to our laboratory for gene analysis. The AMPs gene 
profile of the HCEC stimulated with bacteria was conducted entirely in 
our department where we have standardised our experiments with the 
HCLE cells.  
In chapter four, the ex vivo gene profile of the ocular AMPs in patients 
with infectious keratitis was studied. Because the lack of the RNA yields 
of IC samples, an optimized method of RNA extraction was adopted and 
the gene profile of only hBD3 and hBD9 was studied (based on the 
UHVXOWVRIRXUJURXS¶VSUHYLRXVZRUNDQGRQWKHUHVXOWVRIWKH LQYLWUR
studies in this thesis). IC samples were taken from healthy subjects 
and in patients with keratitis both during active infection and after 
healing of infectious keratitis (Acanthamoebal and bacterial keratitis). A 
total of 60 IC samples were taken; 24 were from healthy controls. 
During acute Acanthamoeba keratitis, and in accordance with the in 
vitro results, hBD3 levels were markedly increased, whereas hBD9 was 
significantly down-regulated. The overall pattern of gene change was 
similar in bacterial keratitis but with less significance. This study 
confirmed that not all AMPs behave similarly, some are up-regulated 
and some down-regulated, suggesting diverse role of AMP in infection 
and inflammation. This study also referred to a possible specific role of 
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AMP-mediated host defence in Acanthamoebal keratitis because of the 
significant increase of the hBD3 
AMPs including hBD3 have been reported to have antibacterial activity. 
As we discovered markedly increased gene up-regulation for hBD3 
during Acanthamoeba infection we inferred that this protein may have 
anti Acanthamoebal activity as well. To test this hypothesis it was 
imperative to establish and optimise the antibacterial activity of the 
commercially acquired samples of hBD3 such that they could be then 
run in parallel with experiments to evaluate anti amoebicidal activity if 
any. Thus and to confirm the published data on antimicorbial activity of 
hBD3 against E.coli and S. aureus, a study to ascertain this activity in 
chapter five was undertaken. The antimicrobial activity of two types of 
commercially available recombinant hBD3 was tested using the 
conventional colony counting method. Distilled water or acidic solvents 
used for hBD3 preparation were used as negative controls. 
Interestingly, the reported antibacterial activity of hBD3 could not be 
confirmed. In fact, the achieved bactericidal activity was attributed to 
the acidic solvent rather than the hBD3 protein itself. This was not 
consistent with other reports which confirmed the potent antibacterial 
activity of this protein. However, by further investigating the 
methodology of these studies, it was found that most of these studies 
did not use a proper negative control which might have affected their 
results. Subsequently, the anti-Acanthamoebal assay of hBD3 protein 
could not be invetigated.  
198 
 
In another chapter (chapter six), the possible role of the corneal 
densitometry measured by the Pentacam machine in monitoring 
patients with infectious keratitis was studied. In this study the normal 
densitometry values of the human cornea was also established. Sixty 
four eyes of 40 healthy controls and 36 eyes of 35 patients with 
bacterial keratitis were studied. A Pentacam system was used to study 
corneal density. Corneal densitometries in subjects with bacterial 
keratitis were recorded during the active stage and 4-6 weeks after 
complete healing. Densitometry was recorded at the site of infection 
and at a point in clear cornea furthest away from the infectious 
infiltrate. Corneal thickness was also measured. The mean 
densitomerty value of normal corneas was 12.3 ± 2.4. In infectious 
keratitis the densitometry values were greatest at the site of the active 
infection and significantly more than in controls. The densitometry 
values at a point of clear cornea furthest away from the site of infection 
were also significantly higher than in controls during active disease but 
failed to return to normal values despite complete resolution of  
infection. The density of the infiltrates was much higher than that of 
residual scars following healing of ulcers.  No correlation was found 
between the pachymetry and the densitometry values. Densitometry of 
active infectious corneal infiltrates was found to be more than that 
resulting from the corneal scarring after healing. Persistent increase in 
density of clear cornea furthest away from the focus of corneal infection 
suggested that the host response extends beyond the immediate area 
of infection and indeed may occur through the entire cornea. These 
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changes persisted beyond 4 weeks, which was the duration of follow up 
of this study. It was concluded that densitometry can be used as an 
objective measure of the corneal response to infection and to monitor 
response to therapy.  
In chapter seven, cases with serious infective keratitis presenting to 
Queens Medical Centre in Nottingham over a 3 year period were 
prospectively studied. Detailed information on the aetiology, culture 
UHVXOWV VLJQV 	 V\PSWRPV WKH WUHDWPHQW JLYHQ DQG WKH SDWLHQW¶V
response was collected and statistically analysed. In total, 143 eyes of 
129 patients were enrolled. The important risk factors were ocular 
surface disease (32%), CL wear (26%) and previous ocular surgery 
(20%). Old age, deep infiltration, steroid use and poor initial vision 
were risk factors for prolonged course of treatment in bacterial 
keratitis. Corneal scrapings were done in 89% of the cases but positive 
results were obtained only in 41.7%. S. aureus was the most common 
isolated bacteria (18.8%). Acanthamoeba and P.aeruginosa were the 
second and third common causative organisms (16.6% and 15%, 
respectively). Overall, 8.3% needed corneal grafting which survived in 
83.3% and eradicated infection in 100%. 
Finally, in chapter eight, the profile of sight threatening infectious 
keratitis in Nottingham over a 4 year period was studied 
retrospectively. The results obtained were very similar to the 
prospective study. A total of 95 eyes of 92 patients were examined.  
Corneal scrapings were done in 93 of the 95 eyes (98%). In total, 36 
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eyes (39%) showed positive growth and 57 eyes (61%) revealed no 
growth.  Of the culture positive samples, 16 eyes (44.4%) yielded P. 
aeruginosa. Ocular surface diseases (35.8%) and CL wear (31.5%) 
were the main predisposing factors for the corneal infections; together 
they formed about two thirds of cases.  Corneal grafting was carried out 
in 10.5% of cases. Most of the grafts remained clear except for one 
therapeutic graft for Acanthamoeba kaertitis. In all cases, corneal 
grafting succeeded in eliminating the infectious keratitis with no 
recurrence of the original infection in the corneal grafts. The main 
limitation of this study was its retrospective nature which could not 
provide proper documentation of clinical details in some cases.  
Based on chapters seven and eight, we made certain recommendation 
for increasing the culture positive yield of microbial culture results 
depending on culturing the samples on BHIB media in addition to the 
agar plates. 
9.3 GENERAL DISCUSSION AND CONCLUSION 
In this thesis, the main focus was on the infectious keratitis as a 
disease which could cause blindness if not diagnosed and treated 
properly. An attempt to cover some important clinical and molecular 
aspects of the corneal infections has been achieved. The main aim was 
to improve the understanding of the infectious keratitis which can lead 
to better approach, diagnosis and management in the future.  
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The clinical findings of this study described the specific aspects of the 
microbial keratitis in Nottinghamshire. It involved 2 separate studies 
about the profile of sight threatening in Nottinghamshire: retrospective 
and prospective. Interestingly, both studies almost showed identical 
findings.  In fact, they showed that ocular surface disease and CL wear 
were the main predisposing factors of corneal infections in 
Nottinghamshire. Also, consistent with other European studies, 
Pseudomonas aeruginosa and Staphylococcus aureus were the main 
causative organisms. Importantly, Acanthamoeba keratitis showed 
growing tendency especially among CL wearers. Furthermore, these 
studies concluded that using BHIP in addition to the agar plates may be 
necessary to improve the positive isolation rate of the corneal scrapes. 
The current practice in QMC depends only on using agar plates for 
growing microbes from corneal samples. A recommendation about 
adding BHIB to agar plates has been passed to Microbiology 
Department in QMC to improve the isolation rate of the corneal samples 
in the future. 
Depending on the results of the clinical studies and based on previous 
work in the Ophthalmology Department in QMC,  the in vitro and in vivo 
gene expression of the AMPs in ocular surface cells infected with Gram 
negative and Gram positive bacteria and Pseudomonas was studied.  
Interestingly, in the in vitro study, while stimulating the OS cells with 
the Acanthamoeba the hBD3 gene expression was the most 
significantly up-regulated molecule amongst the studied AMPs. 
Moreover, while challenging the OS cells with Pseudomonas  aeruginosa 
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and Staphylococcus aureus, LL37 was found to be more significantly 
up-regulated compared to other AMPs. This in vitro study was the first 
comprehensive study to show the gene profile of ocular AMPs in 
response to the stimulation with different pathogens (Gram negative 
and Gram positive and Acanthamoeba). This suggested that AMPs hBD3 
and LL37 may play a possible role in combating ocular surface 
infections. Also, it concluded that modulation of ocular AMP gene 
expression was pathogen-dependent. 
The next step in this thesis was to further investigate the results of our 
in vitro study and confirm its novel findings. The ex vivo gene profile of 
all the ocular AMPs in patients with infectious keratitis was intended to 
be studied. Because the lack of the RNA yields of IC samples, and also 
the difficulty in taking multiple samples from patients with painful and 
infected eyes, it was not possible to study the gene profile of all the 
ocular AMPs. Indeed, over a period of about 14 months, 123 IC 
samples showed poor yields of RNA. Thereafter an optimized method to 
get reasonable yield of RNA sufficient for RT-PCR processing of each 
sample was developed. Despite the improved and optimized method of 
RNA extraction, the yield of RNA in the majority of IC samples was only 
sufficient to study the mRNA level of 2 AMPs. The main focus of this 
study was on the Acanthamoeba keratitis because of its growing 
tendency and because the AMPs profile has never been tested in such 
infection before. Thus, hBD3 and hBD9 were chosen for this study. 
Indeed, hBD3 showed very significant expression in OS cells challenged 
with Acanthamoeba SP in the in vitro study, whereas hBD9 was 
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previously shown to be down-regulated in different types of corneal 
LQIHFWLRQVDFFRUGLQJWRRXUJURXS¶VSUHYLRXVZRUN 
The gene expression of the hBD3 and hBD9 was studied in samples 
taken from patients with infectious keratitis resulted from Gram 
negative and Gram positive bacteria in addition to Acanthamoeba. 
These samples were taken using the impression cytology technique 
during the acute infection and after complete healing and the gene 
expression of the studied AMPs was compared with the level in healthy 
subjects. As mentioned previously, the main goal of this study was to 
focus on the studied AMPs profile in Acanthamoeba keratitis and 
compare it with that in Gram negative and positive bacterial keratitis 
and in healthy subjects. During acute Acanthamoeba keratitis, and in 
accordance with the in vitro results, hBD3 levels were markedly 
increased, whereas hBD9 was significantly down-regulated. The overall 
pattern of gene change was similar in bacterial keratitis but with less 
significance. The changes in the AMPs expression persisted even 4-6 
weeks after total healing of the infectious keratitis. This study 
confirmed that not all AMPs behave similarly, some are up-regulated 
and some down-regulated, suggesting diverse role of AMP in infection 
and inflammation. This study also referred to a possible specific role of 
AMP-mediated host defense in Acanthamoebal keratitis because of the 
significant increase of the hBD3. Also, it suggested possible role of the 
AMPs in future diagnosis as they can be used as markers for diagnosis 
along with the results of the corneal scraping.  
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One limitation of this study was that the gene expression of the AMPs 
was studied without testing the levels of the proteins encoded. This was 
because the cell yield from IC was barely sufficient to allow examination 
of two AMPs. Studying the protein expression depends on obtaining a 
reasonable amount of cells. It was extremely difficult to repeat the IC 
sampling for multiple times in patients with corneal infections because 
of the soreness and lacrimation. Furthermore, the protein hBD9 and its 
antibody were not available at the time of our study, so it was not 
possible to perform immunostaining study of the IC samples.  
After confirming the significant and consistent increase of the hBD3 in 
OS cells during the Acanthamoebal infection in the in vitro and the ex 
vivo studies, the anti-amoebic of the HBD3 protein was further 
investigated. To test this hypothesis it was imperative to establish and 
optimise the antibacterial activity of the commercially acquired samples 
of hBD3 such that they could be then run in parallel with experiments 
to evaluate anti amoebicidal activity if any. Thus and to confirm the 
published data on antimicorbial activity of hBD3 against E. coli and S. 
aureus, a study to ascertain this activity in was undertaken. The 
antimicrobial activity of two types of commercially available 
recombinant hBD3 was tested. Distilled water or acidic solvents used 
for hBD3 preparation were used as negative controls. Interestingly, the 
reported antibacterial activity of hBD3 could not be confirmed. Indeed, 
all the achieved bactericidal activity was attributed to the acidic solvent 
rather than the hBD3 protein itself. This contradicted with other reports 
which confirmed the potent antibacterial activity of this protein. 
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However, by further investigating the methodology of these studies, it 
was found that most of these studies did not use a proper negative 
control. The conclusion of this study was: Technical errors and non-
adherence to basic principles, such as use of proper controls, might 
affect the reliability of the experimental studies. On account of this 
unexpected result, the anti-Acanthamoebal assay of hBD3 protein could 
not be pursued. 
The final study in this thesis involved investigating the possible role of 
the corneal densitometry measured by the Pentacam machine in 
monitoring patients with infectious keratitis. In this novel study, the 
corneal densitometry in patients with bacterial keratitis was measured 
during the active stage and 4-6 weeks after complete healing. The 
densitometry values at the point of the active infection and at a point of 
clear cornea furthest away from the site of infection were significantly 
higher than those in healthy corneas. These readings failed to return to 
normal values after complete resolution of infection. The corneal 
density of the infiltrates was much higher than that of residual scars 
following healing of ulcers. Persistent increase in density of clear cornea 
furthest away from the focus of corneal infection suggested that the 
host response extends beyond the immediate area of infection and 
indeed may occur through the entire cornea. These changes persisted 
beyond 4 weeks, which was the duration of follow up of this study. This 
may correlate with the findings of our ex vivo study which showed 
persistent changes in the AMPs expression even 4-6 weeks after 
complete healing. That could possibly lead to the conclusion that sub-
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clinical changes may persist after the total clinical resolution of the 
infectious keratitis. Further studies with longer follow up period may be 
warranted to confirm this hypothesis.    
In this thesis, one step forward towards better understanding of the 
infectious keratitis was achieved. Indeed, the novel findings of the 
clinical studies included: recognizing the most common predisposing 
factors of the corneal infections in Nottinghamshire area, the most 
common causative organisms (including the surprisingly growing 
tendency of the Acnanthamoeba) in addition the importance of using 
the BHIB in addition to the agar plates to improve the isolation rate of 
the corneal scraping. Furthermore, the novel use of the Pentacam 
machine in the follow up of the patients with infectious keratitis was 
investigated. 
On the other hand, the molecular studies described the comprehensive 
in vitro and ex vivo gene profile of the AMPs in OS cells infected with 
Gram positive, Gram negative bacteria and Acanthamoeba. In fact, this 
thesis suggested that there may be potential of using the AMPs either 
in the diagnosis or in the treatment of the microbial keratitis in the 
future. Finally, the previously reported antimicrobial activity of the 
HBD3 protein could not be demonstrated in this study and that was 
attributed to the lack of using proper controls in previous studies 
mentioned in the literature. 
The suggested future work could include the following: 
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1- Further study to investigate the ex vivo profile of all the AMPs on the 
OS in patients with infectious keratitis with longer follow up period.  
2- Further study to demonstrate the protein expression of the AMPs in 
patients with infectious keratitis compared with healthy people. 
4- The potential antimicrobial use of the AMPs proteins will need to be 
investigated 
5- The potential use of the AMPs gene expression (as markers) in the 
diagnosis of the infectious keratitis will need to be investigated 
3- Further study to confirm the corneal densitometry changes in 
patients with infectious keratitis with longer follow up period. This is 
mainly to define the period when the corneal densitometry values 
returned to normal levels after the resolution of the infection; this could 
be correlated with the molecular changes in the AMPs gene levels in 
those patients.     
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